NCR 2007

National Cancer
Registry Report
2007
Malaysia Cancer Statistics Data and Figure
Ministry of Health Malaysia
National Cancer Registry, Malaysia

ISBN 978-983-3433-87-2
Published by:
National Cancer Registry
Ministry of Health, Malaysia
Authors:
Zainal Ariffin Omar. MD, MPH, MSc (Epid)
Nor Saleha Ibrahim Tamin. MD, MPH (Occ. Health)
Copyright Ministry of Health Malaysia
All rights reserved. This report may not be reproduced, in
whole or in part, in any form or means, electronic or
mechanical, including photocopying, without written
permission from publisher.
Suggested citation: O Zainal Ariffin, I.T Nor Saleha. NCR
Report 2007, Ministry of Health, Malaysia. 2011
Year of publication: 2011 (Feb)
Produced & Distributed by:
Non-Communicable Disease Section (NCD)
Disease Control Division
Level 6, Block E10, Complex E
Federal Government Administrative Centre
62590, Putrajaya
Tel: 603 8883 4145 Fax: 603 8888 6277
Website: http://www.moh.gov.my
Content
PREFACE
ACKNOWLEDGEMENTS
LIST OF TABLES
LIST OF FIGURES
12
LIST OF APPENDICES
14
1.0
INTRODUCTION
16
2.0
BACKGROUND
16
2.1
Geography
16
2.2
Population
16
2.3
Health Status
19
3.0
OBJECTIVE OF NCR
19
4.0
METHODS
19
4.1
List of State Cancer Registries
19
4.2
Source of data
20
4.3
Denominator (population-at-risk estimates)
20
4.4
Numerator figures
20
4.5
Reference population
20
4.6
Pathology and morphology
21
4.7
Multiple primaries
21
4.8
Staging
21
4.9
Quality control
21
4.10
Description of statistical methods
21
4.10.1
Crude incidence rate (CR)
21
4.10.2
Age-specific rate (AR)
21
4.10.3
Age-standardised rate (ASR)
21
4.10.4
Standard error (SE)
22
4.10.5
95% Confidence Limit of ASR (95% CL)
22
4.10.6
Cumulative rate (CR74)
22
4.10.7
Cumulative risk (CumR)
22
National Cancer Registry Report
Malaysia Cancer Statistics Data and Figure 2007
5.0
6.0
REPORT SUMMARY
5.1
Overall cancer incidence and burden
23
5.2
Variation in cancer incidence by sex and ethnicity
23
5.3
Staging
23
CANCER INCIDENCE IN MALAYSIA 2007
24
6.1
Overall cancer incidence
24
6.2
Age variations
27
6.3
Cancer in children
28
Cancer incidence by site
29
6.4.1
Sex differences in cancer incidence by site and major ethnicity
29
6.4.1.1
Cancer incidence in Malay, by sex and site
29
6.4.1.2
Cancer incidence in Chinese, by sex and site
30
6.4.1.3
Cancer incidence in Indian, by sex and site
32
6.4
7.0
8.0
23
SELECTED CANCER SITES
34
7.1
Female Breast
34
7.2
Colorectal
36
7.3
Lung
38
7.4
Nasopharynx
40
7.5
Cervix Uteri
42
7.6
Lymphoma
44
7.7
Leukaemia
46
7.8
Ovary
48
7.9
Stomach
49
7.10
Liver
51
7.11
Prostate
53
7.12
Oral
54
CANCER INCIDENCE BY STATE, 2007

8.1
56
Five most frequent cancer in each state, Malaysia 2007
56
8.1.1
Federal Territory of Kuala Lumpur
56
8.1.2
Selangor
58
8.1.3
Perak
60
8.1.4
Pahang
62
8.1.5
Kelantan
64
8.1.6
Penang
66
8.1.7
Johor
68
8.1.8
Kedah
70
8.1.9
Terengganu
72
8.1.10
Malacca
74
8.1.11
Sabah
76
8.1.12
Sarawak
78
8.1.13
Negeri Sembilan
80
8.1.14
Perlis
82
Preface
his is the National Cancer Registry (NCR) second report since it was handed over to Public Health Programme from
the Department of Radiotherapy and Oncology, Kuala Lumpur Hospital in 2006, and the first NCR report produced
using the CanReg system. Prior to this, the CanReg system which was produced by the International Agency for
Cancer Research was being used only by the Regional Cancer Registries, namely, the Penang, Kelantan, Pahang, Johor,
Sabah and Sarawak Cancer Registries.
Cancer is a chronic disease, hence, the retrieval of cancer information is a complex process. The information on new cancer
cases comes from voluntary notifications as well as from active finding done by all State Cancer Registries.
In contrast with the previous National Cancer Registry reports, this report provides information not only on cancer
occurrence in Peninsular Malaysia, but cancer occurrence in the whole country which include Peninsular Malaysia, Sabah
and Sarawak.
All care has been taken in the production of this report. The data were deemed to be accurate at the time of analysis and
publication, however, it may be subject to slight changes over time as further notification received. We believe that there
are cancer cases diagnosed in 2007 which have not yet been notified to the cancer registry, and this might have contributed
to the lower incidence rate in this cancer report compared to the previous reports.
The collection on the information of the 2007 new cancer cases was started in January 2007 when new cancer registries
were being established at states other than Penang, Kelantan, Pahang, Johor, Sabah and Sarawak. These new cancer
registries are the Cancer Registry of Federal Territory Kuala Lumpur & Putrajaya, Selangor Cancer Registry, Perak Cancer
Registry, Negeri Sembilan Cancer Registry, Malacca Cancer Registry, Terengganu Cancer Registry, Kedah Cancer Registry
and Perlis Cancer Registry. The Cancer Registry of the Federal Territory of Labuan has only been established in 2009.
For this 2007 data report, the percentage of ill defined (other and unspecified) cases was 2.6% and the
histological/morphological verification was 92.5%. We are aware that the Death Certificate Only notification (DCO) is an
important criteria for quality control, however, it is still a challenge for us as not all the State Cancer Registries have the
capacity to carry out DCO yet. We hope to be able to show improvement on this in the next report.
As of this point, most of the previously established Regional Cancer Registries had produced their cancer reports. Penang
and Sarawak Cancer Registries had each published two (2) five-year cancer reports namely the 1994-1998 and 1999-2003
for Penang; and 1996-2000 and 2001-2005 for Sarawak. The Kelantan and Pahang Cancer Registries had produced their
first five-year report, that is, the 1999-2003 report, while Sabah had produced the 2001-2005 report.
Much time and effort has been put into the process of collecting data and ensuring its accuracy, its completeness and its
good quality by the State Cancer Registries as well as the National Cancer Registry and also into the preparing of this report.
It is hoped that the information derived from this NCR 2007 report can be used as reference in the planning and evaluation
of Cancer Control Programme in Malaysia.
Acknowledgements
The National Cancer Registry (NCR) under the Non-Communicable Disease Section, Disease Control Division, Ministry of
Health, Malaysia would like to express its gratitude to all individual and organisation who have directly or indirectly
contributed to the National Cancer Registry and made this National Cancer Registry Report, Malaysia Cancer Statistics, Data
and Figure 2007 possible.
The NCR would like to thank especially the following:

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
The Honorable Minister of Health Malaysia, Y.B. Dato Sri Liow Tiong Lai.
Director General of Health Malaysia, Tan Sri Dato Seri Dr. Hj. Mohd Ismail Merican.
Deputy Director General of Health Malaysia (Public Health), Dato Dr. Hasan Bin Abdul Rahman.
Deputy Director General of Health Malaysia (Medical), Datuk Dr. Noor Hisham Bin Abdullah.
Deputy Director General of Health Malaysia (Research & Technical Support), Dato Dr. Maimunah Binti A. Hamid.
Deputy Director, Health Informatics Centre, Planning and Development Division, Ministry of Health, Malaysia.
State Directors and Deputy State Directors for their commitment and continuous support.
All State Epidemiologists (NCD) for their commitment and support.
Head of Oncology Department, Hospital Kuala Lumpur, Dr. Gerard Lim Chin Chye for his continuous support.
Oncologists, pathologists, other discipline specialists, palliative care professionals, and all other members of the medical
profession from various government, universities, non-government and private centers, upon whose commitment, hard
work, and timely data submission to State Cancer Registries, that this report ultimately depended on.
Director of National Registration Department for assistance and support.
Medical record departments of all hospitals.
All others whom had contributed directly and indirectly that made this report possible.
We would like to express our appreciation to the State Cancer Registries listed below for their
hard work and continuous data contribution to the National Cancer Registry.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
Penang Cancer Registry

Kelantan Cancer Registry
Pahang Cancer Registry
Johor Cancer Registry
Sarawak Cancer Registry
Sabah Cancer Registry
Selangor Cancer Registry
Perak Cancer Registry
Kedah Cancer Registry
Terengganu Cancer Registry
Malacca Cancer Registry
Negeri Sembilan Cancer Registry
Federal Territory of Kuala Lumpur & Putrajaya Cancer Registry
Perlis Cancer Registry
Federal Territory of Labuan Cancer Registry
Our appreciation also to the following individuals for their contributions:

1.
2.
Dr. Noorhashimah Binti Abdullah, Kelantan State Health Department, for sharing her SHIbzz Tools to help produce
incidence summary tables faster and easier.
Nor Asikin Abd. Kadir, National Cancer Society, Penang Branch for her time and support.
Members of the National Cancer Registry

1.
Dr. Lokman Hakim Bin Sulaiman

Director Disease Control Division, Ministry of Health Malaysia
2.
Dr. Zainal Ariffin Bin Omar

Deputy Director (Non-Communicable Disease), Disease Control Division, Ministry of Health Malaysia
3.
Dr. Nor Saleha Ibrahim Tamin

Cancer Unit, NCD Section, Disease Control Division, MOH Malaysia
4.
Koraiza Binti Mohd Yussof

5.
Raja Rohanira Binti Raja Talib

Technical Committee Members of the National Cancer Registry

1.
Dr. Zainal Ariffin Bin Omar

Deputy Director (NCD), Disease Control Division, Ministry of Health, Malaysia
2.
Dr. Md Khadzir Bin Sheikh Ahmad

Deputy Director, Health Informatics Centre, Planning and Development Division, Ministry of Health, Malaysia
3.
Dato Dr. Norain Karim

Consultant Pathologist & Head of Pathology Services, Hospital Raja Permaisuri Bainon, Ipoh, Perak
4.
Dr. Inderjeet Kaur Gill

Senior Principal Assistant Director, Medical Development Division, Ministry of Health, Malaysia
5.
Dr. Norlida Binti Abdullah

Senior Principal Assistant Director, Oral Health Division, Ministry of Health, Malaysia
6.
Dr. Zubaidah Binti Zakaria

Head of Cancer Research Centre, Institute Medical Research, Ministry of Health, Malaysia
7.
Dr. Azizah Binti Abdul Manan

Public Health Physician & State Epid. Officer (NCD), Penang State Health Department.
8.
Dr. Nor Saleha Ibrahim Tamin

Public Health Physician & Senior Principle Assistant Director, NCD Section, Disease Control Division,
List of Tables
Table 1
Ethnicity and sex status for Malaysia, 2007
17
Table 2
Proportion of citizens and non-citizens in Malaysia, 2007
18
Table 3
Age, sex and major ethnic distribution of Malaysian population 2007
18
Table 4
10 Principle Cause of Deaths in Ministry of Health Malaysia (MOH) Hospitals, 2007
19
Table 5
Percentage of stage III and IV for selected cancer sites, Malaysia 2007
23
Table 6
Cancer Incidence, Malaysia 2007
24
Table 7
Number of new cancer cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
24
Table 8
Ten most frequent cancers, all residence, Malaysia 2007
24
Table 9
Ten most frequent cancers, males, Malaysia 2007
25
Table 10
Ten most frequent cancers, females, Malaysia 2007
26
Table 11
Five most frequent cancers in children, male, Malaysia 2007
28
Table 12
Five most frequent cancers in children, female, Malaysia 2007
28
Table 13
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
29
Table 14
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
30
Table 15
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
30
Table 16
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese female
31
Table 17
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
32
Table 18
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
33
Table 19
Female Breast, number of new cases, percentage, crude rate (CR), age-standardised rate (ASR)
and Cumulative Risk (CumR), Malaysia 2007
34
Table 20
Female Breast. number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative
rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
34
Table 21
Colorectal. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
36
Table 22
Colorectal. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
36
Table 23
Lung. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
38
Table 24
Lung. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate (CR74)
and cumulative risk (CumR) by major ethnic groups and sex, Malaysia 2007
38
Table 25
Nasopharynx. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
40
Table 26
Nasopharynx. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative
40
Table 27
Cervix Uteri. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
42
Table 28
Cervix Uteri. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups, Malaysia 2007
42
Table 29
Lymphoma. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
44
Table 30
Lymphoma. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
44
Table 31
Leukaemia. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
46
Table 32
Leukaemia. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
46
Table 33
Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR), Malaysia 2007
48
Table 34
Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
48
Table 35
Stomach. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
49
Table 36
Stomach. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
49
Table 37
Liver. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
51
Table 38
Liver. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
51
Table 39
Prostate. Number of new cases, percentage, crude rate (CR), age-standardised rate (ASR),
53
Table 40
Prostate. Number of new cases, crude rate (CR), age-standardised rate (ASR), cumulative rate
(CR74) and cumulative risk (CumR) by major ethnic groups, Malaysia 2007
53
Table 41
Oral. Number of new cases, percentage, crude rate (CR) and age-standardised rate (ASR),
Malaysia 2007
54
Table 42
Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Malaysia 2007
54
Table 43
Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR) by site and sex,
Malaysia 2007
54
Table 44
Cancer Incidence, Federal Territory of Kuala Lumpur 2007
56
Table 45
Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR) by major ethnic
groups and sex, Federal Territory of Kuala Lumpur 2007
56
Table 46
Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
56
Table 47
Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
56
Table 48
Cancer Incidence, Selangor 2007
58
Table 49
groups, Selangor 2007
58
Table 50
Five most common cancers, male, Selangor 2007
58
Table 51
Five most common cancers, female, Selangor 2007
58
Table 52
Cancer incidence, Perak 2007
60
Table 53
groups and sex, Perak 2007
60
Table 54
Five most common cancers, male, Perak 2007
60
Table 55
Five most common cancers, female, Perak 2007
60
Table 56
Cancer Incidence, Pahang 2007
62
Table 57
groups and sex, Pahang 2007
62
Table 58
Five most common cancers, male, Pahang 2007
62
Table 59
Five most common cancers, female, Pahang 2007
62
Table 60
Cancer Incidence, Kelantan 2007
64
Table 61
groups and sex, Kelantan 2007
64
Table 62
Five most common cancers, male, Kelantan 2007
64
Table 63
Five most common cancers, female, Kelantan 2007
64
Table 64
Cancer Incidence, Penang 2007
66
Table 65
groups and sex, Penang 2007
66
Table 66
Five most common cancers, male, Penang 2007
66
Table 67
Five most common cancers, female, Penang 2007
66
Table 68
Cancer Incidence, Johor 2007
68
Table 69
groups and sex, Johor 2007
68
Table 70
Five most common cancers, male, Johor 2007
68
Table 71
Five most common cancers, female, Johor 2007
68
Table 72
Cancer Incidence, Kedah 2007
70
Table 73
groups and sex, Kedah, 2007
70
Table 74
Five most common cancers, male, Kedah 2007
70
Table 75
Five most common cancers, female, Kedah 2007
70
Table 76
Cancer Incidence, Terengganu 2007
72
Table 77
groups and sex,Terengganu 2007
72
Table 78
Five most common cancers, male, Terengganu 2007
72
Table 79
Five most common cancers, female, Terengganu 2007
72
Table 80
Cancer Incidence, Malacca 2007
74
Table 81
groups and sex, Malacca, 2007
74
Table 82
Five most common cancers, male, Malacca 2007
74
10
Table 83
Five most common cancers, female, Malacca 2007
74
Table 84
Cancer Incidence, Sabah 2007
76
Table 85
groups and sex, Sabah 2007
76
Table 86
Five most common cancers, male, Sabah 2007
76
Table 87
Five most common cancers, female, Sabah 2007
76
Table 88
Cancer Incidence, Sarawak 2007
78
Table 89
groups and sex, Sarawak 2007
78
Table 90
Five most common cancers, male, Sarawak 2007
78
Table 91
Five most common cancers, female, Sarawak 2007
78
Table 92
Cancer Incidence, Negeri Sembilan 2007
80
Table 93
groups and sex, Negeri Sembilan, 2007
80
Table 94
Five most common cancers, male, Negeri Sembilan 2007
80
Table 95
Five most common cancers, female, Negeri Sembilan 2007
80
Table 96
Cancer Incidence, Perlis 2007
82
Table 97
Five most common cancers, male, Perlis 2007
82
Table 98
Five most common cancers, female, Perlis 2007
82
11
List of Figures
Figure 1
Map of Malaysia
16
Figure 2
Population Pyramid, Malaysia Population, 2007
17
Figure 3
Major ethnic distribution in Malaysia 2007
18
Figure 4
Ten most frequent cancers, all residence, Malaysia 2007
25
Figure 5
Ten most frequent cancers, males, Malaysia 2007
25
Figure 6
Ten most frequent cancers, females, Malaysia 2007
26
Figure 7
Average age-specific incidence rate, all residence, by all sites and sex, Malaysia 2007
27
Figure 8
Average age-specific incidence rate for ten most frequent sites, males, Malaysia 2007
27
Figure 9
Average age-specific incidence rate for ten most frequent sites, females, Malaysia 2007
27
Figure 10
Five most frequent cancers in children, male, Malaysia 2007
28
Figure 11
Five most frequent cancers in children, female, Malaysia 2007
28
Figure 12
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
29
Figure 13
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
30
Figure 14
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
31
Figure 15
Ten most frequent cancers in females by major ethnic groups, Malaysia 2007: Chinese female
31
Figure 16
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
32
Figure 17
Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
33
Figure 18
Female Breast. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
34
Figure 19
Female breast, stage at diagnosis, Malaysia 2007
35
Figure 20
Colorectal. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
36
Figure 21
Colorectal, stage at diagnosis, all residence, Malaysia 2007
37
Figure 22
Lung. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
39
Figure 23
Lung, stage at diagnosis, all residence, Malaysia 2007
39
Figure 24
Nasopharynx. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
41
Figure 25
Nasopharynx, stage at diagnosis, all residence, Malaysia 2007
41
Figure 26
Cervix Uteri. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
42
Figure 27
Cervix Uteri, stage at diagnosis, all residence, Malaysia 2007
43
Figure 28
Lymphoma. Age-specific Cancer Incidence Rate per 100,000 population by sex, Malaysia 2007
44
Figure 29
Lymphoma, stage at diagnosis, all residence, Malaysia, 2007
45
Figure 30
Leukaemia. Age specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
46
Figure 31
Leukaemia, stage at diagnosis, all residence, Malaysia, 2007
47
Figure 32
Ovary. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
48
Figure 33
Ovary, stage at diagnosis, Malaysia, 2007
48
Figure 34
Stomach. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
49
Figure 35
Stomach, stage at diagnosis, all residence, Malaysia 2007
50
Figure 36
Liver. Age specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
51
12
Figure 37
Liver, stage at diagnosis, all residence, Malaysia, 2007
52
Figure 38
Prostate. Age-specific Cancer Incidence per 100,000 population, Malaysia 2007
53
Figure 39
Prostate, Stage at diagnosis, All Residence, Malaysia 2007
53
Figure 40
Oral. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
55
Figure 41
Oral, stage at diagnosis, all residence, Malaysia 2007
55
Figure 42
Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
57
Figure 43
Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
57
Figure 44
Five most frequent cancers, male, Selangor 2007
59
Figure 45
Five most frequent cancers, female, Selangor 2007
59
Figure 46
Five most frequent cancers, male, Perak 2007
61
Figure 47
Five most frequent cancers, female, Perak 2007
61
Figure 48
Five most common cancers, male, Pahang 2007
63
Figure 49
Five most common cancers, female, Pahang 2007
63
Figure 50
Five most common cancers, male, Kelantan 2007
65
Figure 51
Five most common cancers, female, Kelantan 2007
65
Figure 52
Five most frequent cancers, male, Penang 2007
67
Figure 53
Five most frequent cancers, female, Penang 2007
67
Figure 54
Five most frequent cancers, male, Johor 2007
69
Figure 55
Five most frequent cancers, female, Johor 2007
69
Figure 56
Five most frequent cancers, male, Kedah 2007
71
Figure 57
Five most frequent cancers, female, Kedah 2007
71
Figure 57
Five most frequent cancers, female, Terengganu 2007
73
Figure 58
Five most frequent cancers, female, Terengganu 2007
73
Figure 60
Five most common cancers, male, Malacca 2007
75
Figure 61
Five most common cancers, female, Malacca 2007
75
Figure 62
Five most common cancers, male, Sabah 2007
77
Figure 63
Five most common cancers, female, Sabah 2007
77
Figure 64
Five most common cancers, male, Sarawak 2007
79
Figure 65
Five most common cancers, female, Sarawak 2007
79
Figure 66
Five most common cancers, male, Negeri Sembilan 2007
81
Figure 67
Five most common cancers, female, Negeri Sembilan 2007
81
Figure 68
Five most common cancers, male, Perlis 2007
83
Figure 69
Five most common cancers, female, Perlis 2007
83
13
List of Appendices
Appendix 1
Population by sex, ethnic group and age, Malaysia, 2007 (source: Statistic Department)
84
Appendix 2
Staging For All Cancer Types
85
Appendix 3
Incidence Summary Table, All Residence, Male, Malaysia 2007
86
Appendix 4
Incidence Summary Table, All Residence, Female, Malaysia 2007
87
Appendix 5
Incidence Summary Table, All Residence, Malay Male, Malaysia 2007
88
Appendix 6
Incidence Summary Table, All Residence, Malays Female, Malaysia 2007
89
Appendix 7
Incidence Summary Table, All Residence, Chinese Male, Malaysia 2007
90
Appendix 8
Incidence Summary Table, All Residence, Chinese Female, Malaysia 2007
91
Appendix 9
Incidence Summary Table, All Residence, Indian Male, Malaysia 2007
92
Appendix 10
Incidence Summary Table, All Residence, Indian Female, Malaysia 2007
93
Appendix 11
Number of new cancer cases, All Residence, Male, Malaysia 2007
94
Appendix 12
Number of new cancer cases, All Residence, Female, Malaysia 2007
95
Appendix 13
Cancer Incidence Rates, Male, Malaysia 2007
96
Appendix 14
Cancer Incidence Rates, Female, Malaysia 2007
97
Appendix 15
Number of new cancer cases, Malay Male, Malaysia 2007
98
Appendix 16
Number of new cancer cases, Malay Female, Malaysia 2007
99
Appendix 17
Cancer Incidence, Malay Male, Malaysia 2007
100
Appendix 18
Cancer Incidence, Malay Female, Malaysia 2007
101
Appendix 19
Number of new cases, Chinese Male, Malaysia 2007
102
Appendix 20
Number of new cases, Chinese Female, Malaysia 2007
103
Appendix 21
Cancer Incidence, Chinese Male, Malaysia 2007
104
Appendix 22
Cancer Incidence, Chinese Female, Malaysia 2007
105
Appendix 23
Number of new cancer cases, Indian Male, Malaysia 2007
106
Appendix 24
Number of new cancer cases, Indian Female, Malaysia 2007
107
Appendix 25
Cancer Incidence, Indian Male, Malaysia 2007
108
Appendix 26
Cancer Incidence, Indian Female, Malaysia 2007
109
Appendix 27
Morphology of the cancer cases reported and registered at NCR, Malaysia 2007
110
14
National Cancer
Registry Report
2007
Malaysia Cancer Statistics Data and Figure
1.0 INTRODUCTION
Cancer is one of the common caused of death in Malaysia. The data from this report aims to provide an epidemiological
profile of cancer, cancer burden, and high risk group of specific cancer in Malaysia which is very important in the Cancer
Control Programme.
2.0 BACKGROUND
2.1
Geography
Malaysia covers and area of about 329,961 square kilometers, consisting of Peninsular Malaysia and East Malaysia
(Sabah, Sarawak and Federal Territory of Labuan). It is separated by the South East China Sea and has its frontier
with Thailand, Singapore, Indonesia and Brunei.
Peninsular Malaysia covers the area of 35,965 square kilometers and consists of the following states: Selangor Darul
Ehsan, Perak Darul Ridzuan, Kedah Darul Aman, Kelantan Darul Naim, Perlis, Penang, Negeri Terengganu Darul
Iman, Pahang Darul Makmur, Johor Darul Takzim, Malacca, Negeri Sembilan Darul Khusus and Federal Teritory of
Kuala Lumpur and Putrajaya.
Figure 1: Map of Malaysia
2.2
Population
The estimated Malaysian population in 2007 was 25.3 millions. The population pyramid and its distribution of ethnic,
gender and age is as shown in Figure 2 and table 3 respectively. Overall, there were about 50.6 % male and 49.4%
female (Table 1) in the country. The major ethnic contribution was Malay (54.5%), followed by Chinese (24.9%),
Indian (7.5%) and others (13.1%), (Table 1 and Figure 3). In addition there were about more than 900,000 noncitizens in Malaysia (Table 2).
16
Figure 2: Population Pyramid, Malaysia Population, 2007

Male
80+
71.2
99.9
75-79
84.0
101.5
70-74
318.2
328.1
55-59
449.4
464.9
50-54
596.3
612.6
45-49
698.6
706.1
40-44
786.9
778.7
35-39
831.4
817.9
30-34
863.9
848.9
25-29
996.7
1,003.7
20-24
1,151.1
1,189.5
15-19
5-9
242.3
231.2
60-64
10-14
174.4
148.4
65-69
Age group
Female
1,215.6
1,278.1
1,261.5
1,341.8
1,326.6
1,403.9
0-4
1,378.5
1,463.9
2,000.000
1,500.000
1,000.000
500.000
0.000
500.000
1,000.000
1,500.000
2,000.000
Source: Department of Statistics, Malaysia
Table 1: Ethnicity and sex status for Malaysia, 2007

Year
Number
Ethnicity
Malay
Chinese
Indian
Others
Total
13,773.1
6,287.9
1,883.9
326.1
25,265.8
54.5
24.9
7.5
13.1
100.0
Sex
Male
Female
Total
12773.0
12,492.8
25,265.8
50.6
49.4
100.0
17
Figure 3: Major ethnic distribution in Malaysia 2007

7.5%
13.1%
24.9%
54.5%
Malay
Chinese
Indian
Others
Table 2: Proportion of citizens and non-citizens in Malaysia, 2007

Year
Citizenship
Malaysian citizen
Non-citizen
Total
Number
25,265.8
907.8
27,173.6
93.0
7.0
100.0
Table 3: Age, sex and major ethnic distribution of Malaysian population 2007
Age group,
years
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
Total
Malay
Indian
Male
Female
Male
Female
Male
Female
905.1
830.4
783.7
739.2
673.4
542.7
434.8
412.1
389.0
345.4
293.6
217.5
148.7
102.2
64.0
66.5
6,948.4
637,400
846.5
782.5
738.2
706.5
657.1
544.1
448.3
424.6
398.0
347.7
292.3
215.7
148.6
111.4
84.7
6,824.8
271.1
283.6
273.2
267.3
262.8
245.7
231.9
231.7
228.0
220.1
202.6
163.5
123.0
88.7
57.6
58.6
3,209.4
248.6
264.6
251.1
247.8
248.3
235.0
224.3
226.3
223.3
211.5
191.7
152.4
114.5
89.0
65.1
85.0
3,078.5
91.6
94.6
89.8
87.9
86.3
78.4
71.6
69.1
65.1
60.1
52.0
36.4
22.7
15.2
9.4
9,6
939.7
88.2
91.3
86.5
83.9
82.7
78.5
74.0
71.2
66.8
61.8
54.0
38.0
24.1
18.1
13.1
12.1
944.1
18
Chinese
All groups
Male
Female
1,463.9 1,378.5
1,403.9 1,326.6
1,341.8 1,261.5
1,278.1 1,215.6
1,189.5 1,151.1
1,003.7
996.7
848.9
863.9
817.9
831.4
778.7
786.9
706.1
698.6
612.6
596.3
464.9
449.4
328.1
318.2
231.2
242.3
174.4
148.4
155.2
201.4
12,773.0 12,492.8
2.3
Health Status
In 2007, cancer was the third common cause of death in Ministry of Health Malaysia Hospitals after Heart Diseases
& Diseases of Pulmonary Circulation and Septicaemia (Table 4).
Table 4: 10 Principle Cause of Deaths in Ministry of Health Malaysia (MOH) Hospitals, 2007
Diseases
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Percentage (%)
Heart Diseases & Diseases of Pulmonary Circulation

Septicaemia
Malignant Neoplasms
Cerebrovascular Diseases
Pneumonia
Accidents
Diseases of the Digestive System
Certain Conditions Originating in The Perinatal Period
Nephritis, Nephrotic Syndrome & Nephrosis
Ill-define conditions
All causes
16.49
13.38
11.28
8.50
7.43
5.20
4.86
4.11
4.09
2.55
100.0
Source: Health Informatic Centre, Planning and Development Division, Ministry of Health, Malaysia
3.0
OBJECTIVES OF THE NATIONAL CANCER REGISTRY (NCR)
The objectives of the NCR are:

1.
2.
3.
4.
To determine the disease burden attributable to cancer by quantifying the magnitude of cancer morbidity, its
geographic and temporal trends in Malaysia.
To identify the subgroups in population at high risk of cancer to whom specific cancer prevention programme should
be targeted.
To enable evaluation on the effectiveness of the existing cancer control programmes.
To stimulate and facilitate research on cancer.
by ensuring:
1.
2.
3.
Complete enumeration of all incidence cases of cancer in the population.

Validity of the data collected on these cases of cancer.
Correct and reproducible classification and coding.
4.0 METHODS
All cancer data collected by State Cancer Registries using CanReg system were compiled and merged using
CanReg4 system at the National Cancer Registry (NCR).
4.1
List of State Cancer Registries

i.
ii.
iii.
iv.
v.
vi.
Penang Cancer Registry

Kelantan Cancer Registry
Pahang Cancer Registry
Johor Cancer Registry
Sarawak Cancer Registry
Sabah Cancer Registry
19
vii.
viii.
ix.
x.
xi.
xii.
xiii.
xiv.
xv.
4.2
Selangor Cancer Registry

Perak cancer Registry
Kedah Cancer Registry
Terengganu Cancer Registry
Malacca Cancer Registry
Negeri Sembilan Cancer Registry
Kuala Lumpur & Putrajaya Cancer Registry
Perlis Cancer Registry
Federal Territory of Labuan Cancer Registry
Source of data
As cancer is a non-notifiable disease, case registration is based primarily on voluntary notifications. The registry
seek to obtain basic epidemiological and clinical data on all cases of cancer diagnosed in Malaysia from 1st January
until 31st December 2007, regardless of citizenship, place of stay and basis of diagnosis. The registry received
notification from all sections of the medical profession in the whole country using a standardised format. However,
the analysis of data is confined only to Malaysian residents.
Malaysian residents are defined as Malaysian citizens as well as permanent residents living in Malaysia at the time
of diagnosis.
Active case finding and routine checks are done by the State Cancer Registries at the government and private
hospital discharges as well as pathology, heamatology and oncology record listings from the government hospital
to ensure completeness of the data. Any cancer cases picked up from pathology, heamatology, oncology are then
checked against previously registered cases. For the cases that are yet to be notified, reminders will be sent to the
hospital/head of department for more information. Additional missing data for these cases also were sought by
registry staff by searching the relevant hospital records and discharge list.
Multiple sources of data assist in optimising completeness but it can create the problem of multiple notification of
a patient. This issue has been addressed by cross checking names and Identity Card numbers (I/C) through
CanReg4 software. Identification card number is personal to each Malaysian citizen and permanent residents.
4.3
Denominator (population-at-risk estimates)

The population-at-risk refers to the part of population which is susceptible to develop a specific cancer. It is defined
on the basis of demographic data.
The population-at-risk was measured as person years at risk, obtained by summing population estimates by age,
sex, race and state for the calendar year 2007. This information was provided by the Department of Statistics.
4.4
Numerator figures
Invasive cancer cases registered in Malaysian residents, diagnosed in 2007 were counted as Malaysian incidence
cases.
4.5
Reference population
The World Standard Population (modified by Doll et al., 1966) applied in this report is widely used in the published
volumes of the Cancer Incidence in Five Continents. This will facilitate comparison of cancer statistics between
different registries that use the same reference population.
20
4.6
Pathology and morphology

The primary sites and morphology are manually coded according to the International Classification of Diseases for
Oncology (ICD-O 3rd Edition). However during analysis, the CanReg4 software programme (IARC) automatically
converted the codes to that of the WHO 10th revision of the International Classification of Diseases (ICD-10).
4.7
Multiple primaries
Registration of multiple primary cancers is in accordance with the IARC criteria, as specified in the Manual for
Cancer Registry Personnel, IARC Technical Report No. 10, 1995 (Esteban et al., 1995).
4.8
Staging
The stage of cancer at the time of diagnosis is reported based on information provided by the notifying clinicians.
A scale from I to IV was used for reporting clinical stage. While definitive criteria were not provided, clinicians would
have been guided by TNM criteria.
4.9
Quality control
In order to ascertain high coverage and accuracy of data, all State Cancer Registries performed several quality
control checks. These include sourcing out missed cases, identifying multiple notifications and inaccurate
information.
Quality of data can be measured indirectly using percentages of morphologically verified cases (MV%) and death
certificate only cases (DCO%).
4.10 Description of statistical methods

4.10.1 Crude incidence rate (CR)
The number of new cancer cases (incidence cases) observed in the population during a defined period,
divided by the number of population at risk in the same period. It is usually expressed per 100,000.
4.10.2 Age-specific rate (AR)

Incidence rate in a specified age group, that is calculated by dividing the number of cancer cases in a fiveyear age group and sex structure of Malaysian population in the particular age group and multiplying that
by 100,000.
AR = Ni / Pi x 100,000
Ni - Number of new cancer occurring in the ith age group
Pi Person-years at risk in the ith age group in Kelantan State
4.10.3 Age-standardised rate (ASR)

Crude incidence rates are not suitable for use in comparisons between different regions or different
periods. Since the incidence of cancer depends heavily on the age structure of the population, there is a
need for age adjustments. Therefore standardisation is necessary when comparing several populations
that differ with respect to age for it is a powerful influence on the risk of cancer. The age-standardised
incidence rate is a summary measure of a rate that a population would have if it had a standard age
structure.
21
It is calculated by summing the products of the age-specific rates applied to the world standard
population; the calculated incidence rate is then called the World Standardised incidence rate. It is also
expressed per 100,000.
ASR = (ARi x Pi.std) / total world standard population
ARi - Age specific rate in the ith age class
Pi.std - The number in the ith age class of world standard population
4.10.4 Standard error (SE)

As with any measurement of a population, incidence rates have a certain amount of chance variation. The
index measure of this variability is known as the standard error and is computed as follows:
SE = i di(wi/yi)2
di - Number of cases of the cancer of interest in the age class i

wi - Standard world population for age class i
yi - Person-years at risk for age class i.
4.10.5 95% Confidence Limit of ASR (95% CL)

ASRs are subject to random variation around the true underlying rate. 95% confidence limits are
endpoints of a range in which the true rate would be expected to fall 95% of the time. 95%CLs are
computed from the standard error (SE) of the ASR using the following formula:
95% CL = ASR (1.96 x SE)
4.10.6 Cumulative rate (CR74)

Cumulative rate is the weighted sum of age-specific incidence rates until completion of age 74. The
weightage used in this calculation is based simply on the widths of the age groups, i.e. multiplying the
age-sex specific rates per person and summing over age groups from 0-4 to 70-74. CR74 is necessary in
order to ascertain the cumulative risk and is expressed in percentages.
CR74 = (i di /yi ) x 10-5 x 100%
di Number of cases in age class i
yi Person-years at risk of age class i
4.10.7 Cumulative risk (CumR)

The cumulative risk is the probability that an individual will develop the cancer in question during a certain
age period, in the absence of any competing cause of death. The age period over which the risk is
accumulated in this report is in the range of 0-74 years. The precise mathematical relationship between
the cumulative rate and the cumulative risk is:
CumR = 100 x [1 exp (- CR74/100)
exp exponential
22
5.0 REPORT SUMMARY

5.1
Overall Cancer Incidence And Burden

A total of 18,219 new cancer cases were diagnosed in 2007 and registered at the National Cancer Registry. It
comprises of 8,123 (44.6%) males and 10,096 (55.4%) females. Of all the new cases, 18.8% were from Penang,
18.4% Johor, 11.3% Selangor, 8.7% Perak and Sarawak, 8.2% Sabah, 7.1% Federal Territory of Kuala Lumpur,
5.5% Kedah, 4.9% Pahang, 4.7% Kelantan, 3.9% Malacca, 3.5% Terengganu, 3.4% Negeri Sembilan, 0.6% Perlis
and 0.01% Federal Territory of Labuan.
The age-standardised incidence rates (ASR) were 85.1/100.000 males and 94.4/100,000 females while the
cumulative rate (CR74) percent to age 75 was 10.1 and 10.5 for males and females respectively. The cumulative risk
(CumR) was 9.6 for males and 9.9 for males, representing the risks of males and females in Malaysia developing
cancer before the age of 75, in the absence of other causes of death.
The ten leading cancers among population of Malaysia in 2007 were breast, colorectal, lung, nasopharynx, cervix,
lymphoma, leukaemia, ovary, stomach and liver (Table 8 and Figure 4).
The five most frequent cancers among Malaysian males in 2007 were lung, colorectal, nasopharynx, prostate and
lymphoma, while the five most common cancers in females were breast, colorectal, cervix, ovary and lung (Table 9,
Table 10, Figure 5 and Figure 6).
5.2
Variation In Cancer Incidence By Sex And Ethnicity

The Age-standardised Rate (ASR) for all cancers in the year 2007 for males was 85.1 per 100,000 populations and
for females was 94.4 per 100,000 populations. Similar with previous NCR reports, cancer seems to be predominant
among Chinese as compared to Malay and Indian. The ASR for Chinese male was 111.9 per 100,000 and for Chinese
female was 115.0 per 100,000 while for Indian male was 68.2 per 100,000 populations and for female was 99.9 per
100,000 populations. The ASR among Malay male and female were 66.9 per 100,000 and 79.0 per 100,000
populations respectively.
5.3
Staging
Staging was reported for 8,869 from 18,219 (48.7%) new cases reported and registered at NCR. Of these, 17.0%
were reported as stage I, 25.3% as stage II, 25.0% as stage III and 32.7% as stage IV. Therefore, at diagnosis, of
those staged, 57.6% were already at advance stages of cancer.
Similar results were seen for several cancers where it can be easily detected and screening programmes are
available as shown in Table 5
Table 5: Percentage of stage III and IV for selected cancer sites, Malaysia 2007
ICD 10
C00
C01-C02
C03-C06
C11
C18-C21
C50
C53
Sites
Lip
Tongue
Mouth
Nasopharynx
Colorectal
Breast
Cervix Uteri
Stage III (%)

7.7
24.2
19.4
33.3
31.8
24.2
25.6
Stage IV (%)
30.8
40.4
55.9
32.3
31.7
17.7
18.7
23
6.0 CANCER INCIDENCE IN MALAYSIA 2007

6.1
Overall cancer incidence
Table 6: Cancer Incidence, Malaysia 2007

Sex
Male
Female
Both
No.
CR
ASR
CR74
CumR
8123
10096
18219
44.6
55.4
100
63.6
80.9
85.1
94.4
10.1
10.5
9.6
9.9
Table 7: Number of new cancer cases, crude rate (CR), age-standardised rate (ASR), cumulative
MALE
FEMALE
Ethnic
No.
CR
ASR
CR74
CumR
NO.
CR
ASR
CR74
CumR
Malay
Chinese
Indian
3093
3650
462
44.5
113.8
49.2
66.9
111.9
68.2
7.7
13.4
7.9
7.4
12.5
7.6
4238
3990
825
62.1
129.7
87.5
79.0
115.0
99.9
8.6
13.0
11.2
8.2
12.2
10.6
Table 8: Ten most frequent cancers, all residence, Malaysia 2007

ICD-10
C50
C18-C22
C33-C34
C11
C53
C81-C85,C96
C91-C95
C56
C16
C22
24
SITES
Breast
Colorectal
Trachea, Bronchus, Lung
Nasopharynx
Cervix Uteri
Lymphoma
Leukaemia
Ovary
Stomach
Liver
NO
3292
2246
1865
940
847
776
741
656
630
605
18.1
12.3
10.2
5.2
4.6
4.3
4.1
3.6
3.5
3.3
Figure 4: Ten most frequent cancers, all residence, Malaysia 2007

18.1
Breast
12.3
Colorectal
10.2

Nasopharynx
5.2
Cervix Uteri
4.6
4.3
Lymphoma
4.1
leukaemia
Ovary
3.6
Stomach
3.5
Liver
3.3
0
10
15
20
Percentage of all cancers
Table 9: Ten most frequent cancers, males, Malaysia 2007

MALES
ICD-10
SITES
C33-C34
C18-C20
C11
C61
C81-C85,C96
C22
C91-C95
C16
C70-C72
C67

Colorectal
Nasopharynx
Prostate
Lymphoma
Liver
Leukaemia
Stomach
Brain, Nervous system
Bladder
NO
CR
ASR
1320
1185
685
502
448
443
419
351
259
258
16.3
14.6
8.4
6.2
5.5
5.5
5.2
4.3
3.2
3.2
10.3
9.7
5.4
3.9
3.5
3.5
3.3
2.7
2.0
2.0
14.8
13.4
6.4
6.2
4.2
4.7
3.5
3.9
2.3
2.9
Figure 5: Ten most frequent cancers, males, Malaysia 2007

16.3

14.6
Colorectal
Nasopharynx
8.4
6.2
Prostate
Liver
5.5
Lymphoma
5.5
leukaemia
5.2
4.3
Stomach
Bladder
3.2
3.2
0
6
8
10
12
14
16
18
25
Table 10: Ten most frequent cancers, females, Malaysia 2007

FEMALE
ICD-10
SITES
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
Lymphoma
Leukaemia
Thyroid
Stomach
C50
C56 C18-C20
C53
C56
C73 C33-C34
C54
C81-C85,C96
C91-C95
C73
C16
NO
CR
ASR
3242
1011
847
656
545
414
328
322
305
279
32.1
10.0
8.4
6.5
5.4
4.1
3.2
3.2
3.0
2.8
26.0
8.1
6.8
5.3
4.4
3.3
2.6
2.6
2.4
2.2
29.1
10.2
7.8
5.9
5.6
3.9
3.0
2.7
2.7
2.8
Figure 6: Ten most frequent cancers, females, Malaysia 2007

32.1
Breast
Colorectal
10
8.4
Cervix Uteri
6.5
Ovary
5.4
4.1
Corpus Uteri
leukaemia
3.2
3.2
Lymphoma
Thyroid
2.8
Stomach
0
10
15
26
20
25
30
35
Age variations
Cancer occurs at all ages and increases with age. The incidence rate in males exceeded the incidence rate in females
after the age of 60 years (Figure 7).
Figure 7: Average age-specific incidence rate, all residence, by all sites and sex, Malaysia 2007
600
Incidence per 100,000
500
400
300
200
Male
100
Female
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Age group (years)
Figure 8: Average age-specific incidence rate for ten most frequent sites, males, Malaysia 2007
160
140
Colorectal
Nasopharynx
120
Prostate
Lymphoma
100
Liver
Leukaemia
80
Stomach
Bladder
60
40
20
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Age group (years)
Figure 9: Average age-specific incidence rate for ten most frequent sites, females, Malaysia 2007
120
100
Breast
Colorectal
Cervix Uteri
80
6.2
Ovary
Corpus Uteri
Lymphoma
60
Leukaemia
Thyroid
Stomach
40
20
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Age group (years)
27
6.3
Cancer in children
There were 319 male and 220 female cancer cases in children diagnosed in 2007 and registered at NCR. The most
frequent cancer in children (0-14 years old) was leukaemia.
Table 11: Five most frequent cancers in children, male, Malaysia 2007
SITES
ICD-10
C91-C95
C70-C72
C81-C85, C96
C40-C41
C69
Leukaemia
Lymphoma
Bone
Eye
NO
153
48
29
19
12
48.0
15.0
9.1
6.0
3.8
Figure 10: Five most frequent cancers in children, male, Malaysia 2007
48
Leukaemia
15
Lymphoma
9.1
Bone
3.8
Eye
0
10
20
30
40
50
60
Percentage of all Paediatric cancers (0 - 14 y.o)
Table 12: Five most frequent cancers in children, female, Malaysia 2007
ICD-10
SITES
Leukaemia
Lymphoma
Ovary
Bone
C91-C95
C70-C72
C81-C85, C96
C56
C40-C41
NO
98
43
15
13
12
44.5
19.5
6.8
5.9
5.5
Figure 11: Five most frequent cancers in children, female, Malaysia 2007
44.5
Leukaemia
19.5
Lymphoma
6.8
Ovary
5.9
Bone
5.5
28
10
20
30
Percentage of all Paediatric cancers (0 - 14 y.o)
40
50
6.4
Cancer incidence by site

6.4.1
Sex differences in cancer incidence by site and major ethnicity

6.4.1.1 CANCER INCIDENCE IN MALAY, BY SEX AND SITE
Table 13: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
MALE
ICD-10
SITES
C33-C34
C18-21
C91-C95
C81-C85,C96
C61
C11
C22
C70-C72
C67
C44

Colorectal
Leukaemia
Lymphoma
Prostate
Nasopharynx
Liver
Bladder
Other Skin
NO
CR
ASR
501
445
241
221
176
152
152
137
124
83
16.2
14.4
7.8
7.1
5.7
4.9
4.9
4.4
4.0
2.7
7.2
6.4
3.5
3.2
2.5
2.2
2.2
2.0
1.8
1.2
11.8
10.1
3.8
4.3
4.9
3.0
3.4
2.3
3.1
1.9
Figure 12: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay male
16.2
Colorectal
14.4
Leukaemia
7.8
Lymphoma
7.1
Prostate
5.7
Liver
4.9
Nasopharynx
4.9
4.4
4
Bladder
Other Skin
2.7
0
10
12
14
16
18
29
Table 14: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
MALAY FEMALE
ICD-10
SITES
Breast
Colorectal
Ovary
Cervix Uteri
Corpus Uteri
Leukaemia
Lymphoma
Thyroid
C50
C18-C21
C56
C53
C33-C34
C54
C91-C95
C81-C85,C96
C73
C70-C72
NO
CR
ASR
1432
360
336
282
201
195
184
172
169
128
33.8
8.5
7.9
6.7
4.7
4.6
4.3
4.0
4.0
3.0
21
5.3
4.9
4.1
2.9
2.9
2.7
2.5
2.5
1.9
25.4
7.5
6.0
5.3
4.4
3.7
3.0
3.0
3.0
2.1
Figure 13: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Malay female
Breast
33.8
Colorectal
8.5
Ovary
7.9
Cervix Uteri
6.7
4.7
Corpus Uteri
4.6
Leukaemia
4.3
Thyroid
Lymphoma
3
0
10
15
20
25
30
35
40
6.4.1.2 CANCER INCIDENCE IN CHINESE, BY SEX AND SITE
Table 15: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
CHINESE MALE
ICD-10
C33-C34
C18-C21
C11
C61
C22
C16
C81-C85,C96
C44
C91-C95
C32
30
SITES
Colorectal
Nasopharynx
Prostate
Liver
Stomach
Lymphoma
Other Skin
Leukaemia
Larynx
NO
CR
ASR
652
631
389
264
215
179
136
125
103
87
17.9
17.3
10.7
7.2
5.9
4.9
3.7
3.4
2.8
2.4
20.3
19.7
12.1
8.2
6.7
5.6
4.2
3.9
3.2
2.7
20.5
19.4
10.9
8.7
6.4
5.6
4.1
4.0
3.3
2.7
Figure 14: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese male
17.9
Colorectal
17.3
Nasopharynx
10.7
Prostate
7.2
Liver
5.9
Stomach
4.9
Lymphoma
3.7
Other Skin
3.4
Leukaemia
2.8
Larynx
2.4
0
10
12
14
16
18
20
Table 16: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Chinese female
CHINESE FEMALE
ICD-10
SITES
C50
C18-C21
C53
C33-C34
C56
C54
C16
C11
C44
C73
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
Stomach
Nasopharynx
Other Skin
Thyroid
NO
CR
ASR
1343
510
330
273
201
160
138
123
79
76
33.7
12.9
8.3
6.8
5.0
4.0
3.5
3.1
2.0
1.9
43.6
16.6
10.7
8.9
6.5
5.2
4.5
4.0
2.6
2.5
38.1
14.6
9.5
8.0
5.8
4.5
4.0
3.5
2.2
2.2
Figure 15: Ten most frequent cancers in females by major ethnic groups, Malaysia 2007:
Chinese female
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
Stomach
Nasopharynx
Other Skin
Thyroid
0
10
15
20
25
30
35
40
31
6.4.1.3 CANCER INCIDENCE IN INDIAN, BY SEX AND SITE
Table 17: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
INDIAN MALE
ICD-10
SITES
C18-C21
C33-C34
C61
C16
C91-C95
C81-C85,C96
C67
C03-C06
C32
C01-C02
Colorectal
Prostate
Stomach
Leukaemia
Lymphoma
Bladder
Mouth
Larynx
Tongue
NO
CR
ASR
65
46
31
30
29
25
21
21
16
15
14.1
10.0
6.7
6.5
6.3
5.4
4.5
4.5
3.5
3.2
6.9
4.9
3.3
3.2
3.1
2.7
2.2
2.2
1.7
1.6
10.2
7.2
5.8
4.8
3.4
3.1
3.5
3.6
2.6
2.0
Figure 16: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian male
Colorectal
14.1
10
Prostate
6.7
Stomach
6.5
Leukaemia
6.3
Lymphoma
5.4
Mouth
4.5
Bladder
4.5
Larynx
3.5
Tongue
3.2
0
10
32
12
14
16
Table 18: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
INDIAN FEMALE
ICD-10
SITES
Breast
Cervix Uteri
Colorectal
Mouth
Ovary
Corpus Uteri
Leukaemia
Oesophagus
Stomach
Tongue
C50
C53
C18-C21
C03-C06
C56
C54
C91-C95
C15
C16
C01-C02
NO
CR
ASR
297
85
53
49
48
34
28
28
26
20
36.0
10.3
6.5
5.9
5.8
4.1
3.4
3.4
3.2
2.4
31.5
9.0
5.6
5.3
5.1
3.6
3.0
3.0
2.8
2.1
33.7
10.3
6.9
7.4
5.2
4.1
2.9
3.7
3.4
2.6
Figure 17: Ten most frequent cancers by major ethnic groups, Malaysia 2007: Indian female
Breast
36
Cervix Uteri
10.3
Colorectal
6.5
Mouth
5.9
Ovary
5.8
Corpus Uteri
4.1
Oesophagus
3.4
Leukaemia
3.4
Stomach
3.2
Tongue
2.4
0
10
15
20
25
30
35
40
33
7.0 SELECTED CANCER SITES

FEMALE BREAST (ICDO: C50)
Breast cancer was the most common cancer in females and also the first most common cancer among population
regardless of sex in Malaysia. There were 3,242 female breast cancer cases diagnosed in 2007 and reported to NCR,
accounted for 18.1% of all cancer cases reported and 32.1% of all female cases. The age pattern in 2007 showed a
peak ASR at the 50-59 age groups. The incidence of breast cancer was highest among Chinese where the ASR was
38.1 per 100,000 population followed by Indian and Malay with the ASR of 33.7 per 100,000 population and 25.4
per 100,000 populations respectively.
The percentage of breast cancer detected at stage I and II was 58%.
Table 19: Female Breast, number of new cases, percentage, crude rate (CR),
age-standardised rate (ASR) and Cumulative Risk (CumR), Malaysia 2007
SEX
NO.
CR
ASR
CR74
CumR
Female
3,242
100
26.0
29.1
3.1
3.1
Table 20: Female Breast. number of new cases, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and
sex, Malaysia 2007
ETHNIC GROUP
Malay
Chinese
Indian
NO.
CR
ASR
CR74
CumR
1432
1343
297
21.0
43.6
31.5
25.4
38.1
33.7
2.6
4.2
3.7
2.6
4.1
3.6
Figure 18: Female Breast. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
120
100
7.1
80
60
40
20
0-
5-
10-
15-
20-
25-
30-
35-
Age group (years)
34
40-
45-
50-
55-
60-
65-
70-
75+
Figure 19: Female breast, stage at diagnosis, Malaysia 2007
stage 3
24%
stage 4
18%
stage 2
37%
stage 1
21%
35
COLORECTAL (ICDO: C18-C21)

Colorectal cancer was the second most common cancer after breast cancer and the also second most common
cancer in males and females in Malaysia. A total of 2,246 cases were diagnosed in 2007 and reported to NCR,
represent 12.3 % of all cases reported. The incidence of colorectal cancer increases with age.
The incidence of colorectal cancer in 2007 was slightly higher among males (ASR 13.4 per 100,000) compared to
females (ASR 10.2 per 100,000 population). The incidence was highest among Chinese where the ASR for males
and females were 19.4 and 14.6 per 100,000 populations respectively.
The percentage of colorectal cancer detected at stage I and II was only 37%.
Table 21: Colorectal. Number of new cases, percentage, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
Male
Female
Both
No.
CR
ASR
CR74
CumR
1,235
1,011
2,246
55.0
45.0
100
9.7
8.1
13.4
10.2
1.6
1.2
1,6
1.2
Table 22: Colorectal. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups and sex,
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
445
631
65
6.4
19.7
6.9
10.1
19.4
10.2
Female
CR74 CumR
1.2
2.4
1.2
1.2
2.4
1.2
No.
CR
ASR
360
510
53
5.3
16.6
5.6
7.6
14.6
6.9
CR74 CumR
0.9
1.8
0.8
0.9
1.8
0.8
Figure 20: Colorectal. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
140
120
100
7.2
80
60
40
Male
20
Female
0-
5-
10-
15-
20-
25-
30-
35-
40-
Age group (years)
36
45-
50-
55-
60-
65-
70-
75+
Figure 21: Colorectal, stage at diagnosis, all residence, Malaysia 2007

stage 3
31%
stage 4
32%
stage 1
9%
stage 2
28%
37
7.3
LUNG (ICDO: C33-C34)

There were 1,865 cases of lung cancer diagnosed in 2007 and registered at NCR, comprising of 1,320 males and
545 females. Lung cancer is the most common cancer among males and third most common cancer in the general
population.
The ASR for male was 14.7 per 100,000 population and 5.6 per 100,000 for female. The incidence was more than
2 folds higher among males when compared to females. Chinese were found to have higher incidence rate compared
to Malay and Indian.
The incidence of lung cancer increased with age and in 2007 the peak of Age-specific Incidence Rate was at the 7075 age groups.
Most of the lung cancer was detected late where 60% of the cases was detected at stage IV. The percentage of lung
cancer detected at stage I and II was 12%.
Table 23: Lung. Number of new cases, percentage, crude rate (CR), age-standardised rate
Sex
No.
CR
ASR
CR74
CumR
Male
Female
Both
1,320
545
1,865
70.8
29.2
100
10.3
4.4
14.7
5.6
1.9
0.7
1.9
0.7
Table 24: Lung. Number of new cases, crude rate (CR), age-standardised rate (ASR),
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
38
No.
CR
ASR
501
652
46
7.2
20.3
4.9
11.8
20.5
7.2
Female
CR74 CumR
1.5
2.6
0.8
1.5
2.6
0.8
No.
CR
ASR
201
273
15
2.9
8.9
1.6
4.4
8.0
2.0
CR74 CumR
0.6
1.0
0.3
0.6
1.0
0.3
Figure 22: Lung. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
160
140
120
100
Male
80
Female
60
40
20
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Age group (years)
Figure 23: Lung, stage at diagnosis, all residence, Malaysia 2007

stage 1
4%
stage 2
8%
stage 4
60%
stage 3
28%
39
7.4
NASOPHARYNX (ICDO: C11)

There were 900 cases of nasopharyngeal cancer diagnosed in 2007 and registered at NCR, comprising of 685 males
and 255 females. Nasopharyngeal cancer is the fourth most common cancer among Malaysian and the third most
common cancer among males in Malaysia.
The incidence was more than 2 folds higher among males when compared to females. The ASR for male was 6.4
per 100,000 population and 2.3 per 100,000 for female. Chinese were found to have higher incidence rate compared
to Malay and Indian.
The incidence of nasopharyngeal cancer increases with age and the peak of Age-specific Incidence Rate was at the
70-75 age groups.
The majority of nasopharyngeal cancer was detected at stage III and IV. The percentage of the cancer detected at
stage I and II was 34%.
Table 25: Nasopharynx. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR) by sex, Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Male
Female
Both
685
255
900
72.9
27.1
100
5.4
2.0
6.4
2.3
0.7
0.2
0.7
0.2
Table 26: Nasopharynx. Number of new cases, crude rate (CR), age-standardised rate
sex, Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
40
No.
CR
ASR
152
389
9
2.2
12.1
1.0
3.0
10.9
1.1
Female
CR74 CumR
0.3
1.2
0.1
0.3
1.2
0.1
No.
CR
ASR
70
123
6
1.0
4
0.6
1.3
3.5
0.9
CR74 CumR
0.1
0.4
0.1
0.1
0.4
0.1
Figure 24: Nasopharynx. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
35
Male
30
Female
25
20
15
10
5
0
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
75+
Age group (years)
Figure 25: Nasopharynx, stage at diagnosis, all residence, Malaysia 2007

stage 1
11%
stage 4
32%
stage 2
23%
stage 3
34%
41
CERVIX UTERI (ICDO: C53)

Cancer of the cervix was the third most common cancer among women and fifth most common cancer in the entire
general population. There were a total of 847 cases diagnosed in 2007 registered at NCR. Cervical cancer incidence
rate increased after 30 years old and peaks at ages 65-69 years.
Compared among the major races, Indian women had the highest incidence for cervical cancer followed by Chinese
and Malay. The ASR for Indian females was 10.3 per 100,000 populations.
The percentage of breast cancer detected at stage I and II was 55%.
Table 27: Cervix Uteri. Number of new cases, percentage, crude rate (CR), age-standardised
rate (ASR), cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Female
847
100
6.8
7.8
0.9
0.9
Table 28: Cervix Uteri. Number of new cases, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups,
Malaysia 2007
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
CR74
CumR
282
330
85
4.1
10.7
9.0
5.3
9.5
10.3
0.6
1.1
1.1
0.6
1.1
1.1
Figure 26: Cervix Uteri. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
35
7.5
30
25
20
15
10
5
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
Age group (years)
42
50-
55-
60-
65-
70-
75+
Figure 27: Cervix Uteri, stage at diagnosis, all residence, Malaysia 2007
stage 4
19%
stage 3
26%
stage 1
21%
stage 2
34%
43
LYMPHOMA (ICDO: C77)

There were 776 cases of lymphoma diagnosed in 2007 and registered at NCR, comprising of 448 males and 328
females. Lymphoma is the sixth most common cancer among Malaysian regardless of sex, the sixth most common
cancer among males and eighth most common cancer among females in Malaysia.
The incidence of lymphoma was slightly higher among males compared to females. Chinese were found to have
higher incidence rate compared to Malay and Indian.
Table 29: Lymphoma. Number of new cases, percentage, crude rate (CR), age-standardised
Sex
No.
Male
Female
Both
448
328
776
CR
57.7
42.3
100
3.5
2.6
ASR
CR74
CumR
4.2
3.0
0.4
0.3
0.4
0.3
Table 30: Lymphoma. Number of new cases, crude rate (CR), age-standardised rate (ASR),
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
221
136
25
3.2
4.2
2.7
4.3
4.1
3.1
Female
CR74 CumR
0.4
0.4
0.3
0.4
0.4
0.3
No.
CR
ASR
172
101
13
2.5
3.3
1.4
3.0
3.0
1.7
CR74 CumR
0.3
0.3
0.2
0.3
0.3
0.2
Figure 28: Lymphoma. Age-specific Cancer Incidence Rate per 100,000 population by sex,
Malaysia 2007
25
20
7.6
15
10
Male
Female
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
Age group (years)
44
50-
55-
60-
65-
70-
75+
Figure 29: Lymphoma, stage at diagnosis, all residence, Malaysia, 2007
stage 4
28%
stage 1
11%
stage 2
34%
stage 3
23%
45
LEUKAEMIA (ICDO: C42)

There were 741 cases of leukaemia diagnosed in 2007 and registered at NCR, comprising of 419 males and 322
females. Leukaemia is the seventh most common cancer in general population and also seventh in males and
females in Malaysia. It is the most common cancer in children (0-14 years).
Table 31: Leukaemia. Number of new cases, percentage, crude rate (CR), age-standardised
Sex
No.
Male
Female
Both
419
322
741
CR
56.5
43.5
100
3.3
2.6
ASR
CR74
CumR
3.5
2.7
0.3
0.2
0.3
0.2
Table 32: Leukaemia. Number of new cases, crude rate (CR), age-standardised rate (ASR),
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
241
103
29
3.4
3.2
3.1
3.9
3.2
3.4
Female
CR74 CumR
0.3
0.3
0.3
0.3
0.3
0.3
No.
CR
ASR
184
63
28
2.7
2.0
2.9
2.9
2.0
2.9
CR74 CumR
0.3
0.2
0.2
0.3
0.2
0.2
Figure 30: Leukaemia. Age specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
10
9
8
7.7
Male
Female
5
4
3
2
1
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
Age group (years)
46
50-
55-
60-
65-
70-
75+
Figure 31: Leukaemia, stage at diagnosis, all residence, Malaysia, 2007

stage 1
15%
stage 4
33%
stage 3
17%
stage 2
35%
47
OVARY (ICDO: C56-C57)

There were 658 cases of ovarian cancer diagnosed in 2007 and registered at NCR. It is the fourth most common
cancer in Malaysian female. Out of 426 cases reported stage, 48% were diagnosed at stage I and II.
Table 33: Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
Sex
No.
CR
ASR
CR74
CumR
Female
847
100
6.8
7.8
0.9
0.9
Table 34: Ovary. Number of new cases, crude rate (CR), age-standardised rate (ASR),
Malaysia 2007
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
CR74
CumR
336
201
48
4.9
6.5
5.1
6.0
5.8
5.2
0.6
0.6
0.5
0.6
0.6
0.5
Figure 32: Ovary. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
25
20
7.8
15
10
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
Age group (years)
Figure 33: Ovary, stage at diagnosis, Malaysia, 2007

stage 1
33%
stage 4
21%
stage 2
15%
stage 3
31%
48
65-
70-
75+
STOMACH (ICDO: C16)

There were 630 cases of stomach cancer diagnosed in 2007 and registered at NCR, comprising of 351 males and
279 females. Stomach cancer is the ninth most common cancer in the entire general population and the eight most
common cancer in males and tenth in females in Malaysia.
The incidence of stomach cancer increases with age and slightly higher in males compared to females. Chinese were
found to have higher incidence rate compared to Malay and Indian.
Of the cases with reported stage, most of cases were detected at stage III and IV. The percentage of the cancer
detected at stage I and II was only 26.6%.
Table 35: Stomach. Number of new cases, percentage, crude rate (CR), age-standardised
Sex
No.
Male
Female
Both
351
279
630
CR
55.7
54.3
100
2.7
2.2
ASR
CR74
CumR
3.9
2.8
0.5
0.3
0.5
0.3
Table 36: Stomach Cancer. Number of new cases, crude rate (CR), age-standardised rate
sex, Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
152
215
15
2.2
6.7
1.6
3.4
6.4
2.2
Female
CR74 CumR
0.4
0.8
0.2
0.4
0.8
0.2
No.
CR
ASR
69
69
7
1.0
2.2
0.7
1.4
2.0
0.9
CR74 CumR
0.2
0.3
0.1
0.2
0.2
0.1
Figure 34: Stomach. Age-specific Cancer Incidence per 100,000 population by sex,
Malaysia 2007
45
40
7.9
35
30
25
20
male
15
female
10
5
0
0-
10-
20-
30-
40-
50-
60-
70-
Age group (years)
49
Figure 35: Stomach, stage at diagnosis, all residence, Malaysia 2007
stage 1
8.5%
stage 4
48.7%
stage 2
18.1%
stage 3
24.7%
50
7.10 LIVER (ICDO: C22)

There were 605 cases of liver cancer diagnosed in 2007 and reported to NCR, comprising of 443 males and 162
females. Liver cancer is the fifth most common cancer in males and the tenth most common cancer in the entire
general population.
The incidence of liver cancer increases with age and higher in males compared to females. The Chinese were found
to have higher incidence rate compared to Malay and Indian. Of the cases with reported stage, only 19.0% of the
cases were diagnosed at stage I and II.
Table 37: Liver. Number of new cases, percentage, crude rate (CR), age-standardised rate
Sex
No.
Male
Female
Both
443
162
605
CR
73.2
22.8
100
ASR
CR74
CumR
4.7
1.6
0.6
0.2
0.6
0.2
3.5
1.3
Table 38: Liver. Number of new cases, crude rate (CR), age-standardised rate (ASR),
Malaysia 2007
Male
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
152
215
15
2.2
6.7
1.6
3.4
6.4
2.2
Female
CR74 CumR
0.4
0.8
0.2
0.4
0.8
0.2
No.
CR
ASR
69
69
7
1.0
2.2
0.7
1.4
2.0
0.9
CR74 CumR
0.2
0.2
0.1
0.2
0.2
0.1
Figure 36: Liver. Age specific Cancer Incidence per 100,000 population by sex, Malaysia 2007
35
30
25
Male
20
Female
15
10
5
0
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
75+
Age group (years)
51
Figure 37: Liver, stage at diagnosis, all residence, Malaysia, 2007

stage 1
7%
stage 2
12%
stage 3
19%
52
stage 4
62%
7.11 PROSTATE (ICDO: C61)

There were 502 prostate cancer cases diagnosed in 2007 and reported to NCR. It is the fourth most common cancer
in Malaysian males.
The incidence of prostate cancer increases after the age of 45 years and higher in Chinese male compared to Malay
and Indian. Of the cases with reported stage, 40.6% of the cases were diagnosed at stage I and II.
Table 39: Prostate. Number of new cases, percentage, crude rate (CR), age-standardised rate
(ASR), cumulative rate (CR74) and cumulative risk (CumR), Malaysia 2007
Sex
No.
Male
502
CR
100
ASR
3.9
6.2
CR74
CumR
0.8
0.8
Table 40: Prostate. Number of new cases, crude rate (CR), age-standardised rate (ASR),
cumulative rate (CR74) and cumulative risk (CumR) by major ethnic groups, Malaysia 2007
Ethnic
Malay
Chinese
Indian
No.
CR
ASR
CR74
CumR
176
264
31
2.5
8.2
3.3
4.9
8.7
5.8
0.7
1.1
0.5
0.7
1.1
0.5
Figure 38: Prostate. Age-specific Cancer Incidence per 100,000 population, Malaysia 2007
100
90
80
70
60
50
40
30
20
10
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Age group (years)
Figure 39: Prostate, stage at diagnosis, all residence, Malaysia, 2007

stage 1
13.3%
stage 4
39.1%
stage 2
27.3%
stage 3
20.3%
53
7.12 ORAL (ICDO: C00-C06)

There were 353 cases of oral (lip, tongue and mouth) cancer reported to NCR, comprising of 171 males and
182 females. Oral cancer is the 21st most common cancer in the general population and the 17th most common
cancer in males and 16th in females.
The incidence of oral cancer is predominant among the Indian ethnic group where mouth and tongue cancers were
among the 10 most common cancer among both male and female (Table 18, Table 19).
The incidence of oral cancer is highest in Indian females where the ASR was 10.2/100,000 female populations (Table
42). Of those cases reported with staging, only 35.4% of the cases were diagnosed at stage I and II (Figure 41).
Table 41: Oral. Number of new cases, percentage, crude rate (CR) and age-standardised
rate (ASR), by sex, Malaysia 2007
SEX
Male
Female
Both
NO.
CR
ASR
171
182
353
48.4
51.6
100
1.3
1.5
1.8
1.8
Table 42: Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR), by
major ethnic groups and sex, Malaysia 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
52
62
36
0.8
1.9
3.8
1.1
1.8
3.8
57
32
70
0.9
1.1
7.4
1.2
0.8
10.2
Table 43: Oral. Number of new cases, crude rate (CR) and age-standardised rate (ASR),
by site and sex, Malaysia 2007
MALE
FEMALE
SITES
Lip
Tongue
Mouth
All
54
NO.
CR
ASR
NO.
CR
ASR
9
93
69
171
0.1
0.7
0.5
0.1
1.0
0.7
8
78
96
182
0.1
0.6
0.8
0.1
0.7
1.0
Figure 40: Oral. Age-specific Cancer Incidence per 100,000 population by sex, Malaysia
2007
20
18
16
14
12
10
Male
Female
6
4
2
0
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75+
Age group (years)
Figure 41: Oral, stage at diagnosis, all residence, Malaysia 2007

Stage 3
20.0%
Stage 2
23.3%
Stage 4
44.6%
Stage 1
12.1%
55
8.0 CANCER INCIDENCE BY STATE, 2007

8.1
FIVE MOST FREQUENT CANCER IN EACH STATE, MALAYSIA 2007

8.1.1
FEDERAL TERRITORY OF KUALA LUMPUR
Table 44: Cancer incidence, Federal Territory of Kuala Lumpur 2007

SEX
Male
Female
Both
NO.
CR
ASR
550
749
1,299
42.3
57.7
100.0
72.6
99.3
98.8
119.4
Table 45: Number of new cancer cases, crude rate (CR) and age-standardised rate (ASR)
by major ethnic groups and sex, Federal Territory of Kuala Lumpur 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
181
320
45
54.3
98.1
54.4
100.2
103.1
69.9
236
439
68
73
139.9
83.5
109.8
132.5
86.4
Table 46: Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
MALE
ICD-10
C33-C34
C18-C21
C11
C81-C85,C96
C70-C72
SITES
Colorectal
Nasopharynx
Lymphoma
NO
CR
ASR
94
82
45
37
33
17.0
14.8
8.2
6.7
6.0
6.3
5.5
3.0
2.5
2.2
19.2
15.8
6.8
5.5
4.4
Table 47: Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
FEMALE
ICD-10
C50
C18-C21
C53
C33-C34
C56
56
SITES
Breast
Colorectal
Cervix Uteri
Ovary
NO
CR
ASR
292
61
54
46
33
38.9
8.2
7.2
6.1
4.4
38.6
8.1
7.1
6.1
4.4
42.6
10.9
9.0
8.3
5.4
Figure 42: Five most common cancers, male, Federal Territory of Kuala Lumpur 2007
17
Colorectal
14.8
Nasopharynx
8.2
Lymphoma
6.7
6
0
10
15
20
25
Figure 43: Five most common cancers, female, Federal Territory of Kuala Lumpur 2007
Breast
38.9
Colorectal
8.2
Cervix Uteri
7.2
6.1
Ovary
4.4
10
15
20
25
30
35
40
45
57
8.1.2
SELANGOR
Table 48: Cancer incidence, Selangor 2007

SEX
Male
Female
Both
NO.
CR
ASR
775
1326
2101
36.9
63.1
100.0
32.4
57.9
48.5
74.5
by major ethnic groups, Selangor 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
309
353
100
23.9
50.1
30.3
42.0
57.6
38.8
570
534
205
46.2
80.6
62.6
69.6
78.1
74.9
Table 50: Five most common cancers, male, Selangor 2007

MALE
ICD-10
C18-C21
C33-C34
C11
C81-C85,C96
C70-C72
SITES
Colorectal
Nasopharynx
Lymphoma
NO
CR
ASR
117
114
71
54
49
15.1
14.7
9.2
7.0
6.3
4.9
4.8
3.0
2.3
2.1
7.7
8.2
3.4
2.9
2.5
Table 51: Five most common cancers, female, Selangor 2007

FEMALE
ICD-10
C50
C18-C21
C53
C56
C54
58
SITES
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
NO
CR
ASR
541
108
93
92
55
40.8
8.2
7.0
6.9
4.1
23.6
4.7
4.1
4.0
2.4
14.9
7.3
5.7
4.9
4.7
Figure 44: Five most frequent cancers, male, Selangor 2007

Colorectal
15.1
14.7
Nasopharynx
9.2
Lymphoma
6.3
10
15
20
25
Figure 45: Five most frequent cancers, female, Selangor 2007

40.8
Breast
8.2
Colorectal
Cervix Uteri
Ovary
6.9
Corpus Uteri
4.1
0
10
15
20
25
30
35
40
45
59
8.1.3
PERAK
Table 52: Cancer incidence, Perak 2007

SEX
Male
Female
Both
NO.
CR
ASR
711
870
1581
45.0
55.0
100.0
63.3
77.2
69
75.8
by major ethnic groups and sex, Perak 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
198
444
67
31.1
128.8
48.1
4.9
12.0
7.3
311
423
128
48.7
125.3
87.0
6.1
92.9
89.1
Table 54: Five most common cancers, male, Perak 2007

MALE
ICD-10
C33-C34
C18-C21
C11
C61
C44
SITES
Colorectal
Nasopharynx
Prostate
Other Skin
NO
CR
ASR
153
85
74
59
36
21.5
11.9
10.4
8.3
5.1
13.6
7.6
6.6
5.3
3.2
15.1
8.3
7.0
5.9
3.6
Table 55: Five most common cancers, female, Perak 2007

FEMALE
ICD-10
C50
C18-C21
C53
C56
C33-C34
60
SITES
Breast
Colorectal
Cervix Uteri
Ovary
NO
CR
ASR
346
82
61
59
36
39.8
9.4
7.0
6.8
4.1
30.7
7.3
5.4
5.2
3.2
30.3
7.0
5.3
5.2
3.2
Figure 46: Five most frequent cancers, male, Perak 2007

21.5

Colorectal
11.9
10.4
Nasopharynx
8.3
Prostate
Other Skin
5.1
5
10
15
20
25
Figure 47: Five most frequent cancers, female, Perak 2007

39.8
Breast
9.4
Colorectal
Cervix Uteri
Ovary
6.8
4.1
0
10
15
20
25
30
35
40
45
61
8.1.4
PAHANG
Table 56: Cancer incidence, Pahang 2007

SEX
Male
Female
Both
NO.
CR
ASR
407
478
885
46.0
54.0
100.0
56.8
69.5
75
84.8
by major ethnic groups and sex, Pahang 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
226
163
13
43.5
133.6
37.4
61.6
117.6
66.1
293
151
29
58.3
133.7
87.1
76.1
112.4
104.0
Table 58: Five most common cancers, male, Pahang 2007

MALE
ICD-10
C18-C20
C33-C34
C11
C91-C96
C81-C85: C96
SITES
Colorectal
Nasopharnyx
Leukaemia
Lymphoma
NO
CR
ASR
68
56
40
23
22
16.7
13.7
9.8
5.6
5.4
9.4
7.8
5.6
3.2
3.1
12.2
10.8
6.6
3.6
3
Table 59: Five most common cancers, female, Pahang 2007

FEMALE
ICD-10
C50
C53
C18-C20
C56
C33-C34
62
SITES
Breast
Cervix Uteri
Colorectal
Ovary
NO
CR
ASR
133
49
48
27
23
27.8
10.3
10.0
5.6
4.8
19.3
7.1
7.0
3.9
3.3
22
8.6
9.4
4.8
4.6
Figure 48: Five most common cancers, male, Pahang 2007

Colorectal
16.7
13.7
9.8
Nasopharnyx
Leukemia
5.6
Lymphoma
5.4
5
10
15
20
25
Figure 49: Five most common cancers, female, Pahang 2007

Breast
27.8
Cervix Uteri
10.3
10
Colorectal
5.6
Ovary
4.8

0
10
15
20
25
30
63
8.1.5
KELANTAN
Table 60: Cancer incidence, Kelantan 2007

SEX
Male
Female
Both
NO.
CR
ASR
432
428
860
50.2
49.8
100.0
56.4
56.2
77.6
71
by major ethnic groups and sex, Kelantan 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
403
25
0
56.4
91.6
0
78.2
85.9
0
391
31
1
54.3
121.6
0
69.5
102.2
0
Table 62: Five most common cancers, male, Kelantan 2007

MALE
ICD-10
C33-C34
C18-21
C91-C95
c81-c85,c96
C22
SITES
Colorectal
Leukaemia
Lymphoma
Liver
NO
CR
ASR
73
71
39
36
32
16.90
16.44
9.03
8.33
7.41
9.5
9.3
5.1
4.7
4.2
13.7
13.1
5.6
6.0
6.1
Table 63: Five most common cancers, female, Kelantan 2007

FEMALE
ICD-10
C50
C18-21
C56
C73
C53
64
SITES
Breast
Colorectal
Ovary
Thyroid
Cervix Uteri
NO
CR
ASR
102
49
40
31
24
23.8
11.5
9.4
7.2
5.6
13.4
6.4
5.3
4.1
3.2
17.1
8.3
6.6
5.1
4.1
Figure 50: Five most common cancers, male, Kelantan 2007

16.9
Colorectal
16.44
Leukaemia
9.03
8.33
Lymphoma
7.41
Liver
0
10
15
20
25
Figure 51: Five most common cancers, female, Kelantan 2007

Breast
23.8
11.5
Colorectal
Ovary
9.4
7.2
Thyroid
5.6
Cervix Uteri
0
10
15
20
25
65
8.1.6
PENANG
Table 64: Cancer incidence, Penang 2007

SEX
Male
Female
Both
NO.
CR
ASR
904
1059
1963
46.1
53.9
100.0
127.5
147.8
154.1
150
by major ethnic groups and sex, Penang 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
202
625
69
64.6
194.8
94.3
104.0
181.4
138.7
246
696
109
77.1
218.2
144.2
100.3
175.3
165.5
Table 66: Five most common cancers, male, Penang 2007

MALE
ICD-10
C18-C21
C33-C34
C61
C11
C16
SITES
Colorectal
Lung
Prostate
Nasopharynx
Stomach
NO
CR
ASR
147
142
77
56
49
16.3
15.7
8.5
6.2
5.4
20.7
20.0
10.9
7.9
6.9
25.6
24.3
15.0
8.3
8.5
Table 67: Five most common cancers, female, Penang 2007

FEMALE
ICD-10
C50
C18-C21
C53
C33-C34
C56
66
SITES
Breast
Colorectal
Cervix Uteri
Lung
Ovary
NO
CR
ASR
333
127
99
65
62
31.4
12.0
9.3
6.1
5.9
46.5
17.7
13.8
9.1
8.7
46.7
18.3
13.4
9.3
8.5
Figure 52: Five most frequent cancers, male, Penang 2007
Colorectal
16.3
15.7
Lung
8.5
Prostate
6.2
Nasopharynx
5.4
Stomach
5
10
15
20
Figure 53: Five most frequent cancers, female, Penang 2007
Breast
31.4
Colorectal
12
9.3
Cervix Uteri
Lung
6.1
Ovary
5.9
0
10
15
20
25
30
35
67
8.1.7
JOHOR
Table 68: Cancer incidence, Johor 2007

SEX
Male
Female
Both
NO.
CR
ASR
1586
1775
3361
47.2
52.8
100.0
110.4
120.5
179.1
150.3
by major ethnic groups and sex, Johor 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
712
782
76
82.6
150.5
69.5
142.8
175.6
127.6
887
749
130
105.2
151
124.8
140.1
158.3
190.4
Table 70: Five most common cancers, male, Johor 2007

MALE
ICD-10
C33-C34
C18-C21
C61
C11
C91-C95
SITES
Colorectal
Prostate
Nasopharynx
Leukaemia
NO
CR
ASR
282
270
126
99
97
17.8
17.0
7.9
6.2
6.0
19.6
18.8
8.8
6.9
6.7
31.9
32.2
15.8
11.6
9.2
Table 71: Five most common cancers, female, Johor 2007

FEMALE
ICD-10
C50
C18-C21
C33-C34
C53
C56
68
SITES
Breast
Colorectal
Cervix Uteri
Ovary
NO
CR
ASR
608
204
109
105
96
34.3
11.5
6.1
5.9
5.4
41.3
13.8
7.4
7.1
6.5
46.5
19.7
10.2
9.1
7.4
Figure 54: Five most frequent cancers, male, Johor 2007

17.8
Colorectal
17
Prostate
7.9
6.2
Nasopharynx
6
Leukaemia
0
10
15
20
Figure 55: Five most frequent cancers, female, Johor 2007
Breast
34.3
11.5
Colorectal
6.1
Cervix Uteri
5.9
5.4
Ovary
0
10
15
20
25
30
35
40
69
8.1.8
KEDAH
Table 72: Cancer incidence, Kedah 2007

SEX
Male
Female
Both
NO.
CR
ASR
420
589
1009
41.6
58.4
100.0
45.1
62.8
57.2
69.7
Table 73: Number of new cancer cases, crude rate (CR) and age-standardised rate
(ASR) by major ethnic groups and sex, Kedah, 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
210
163
42
29.2
121.9
67.0
37.7
115.0
111.2
312
210
64
42.9
164.0
97.3
48.9
140.1
121.6
Table 74: Five most common cancers, male, Kedah 2007

MALE
ICD-10
C33-C34
C18-C21
C61
C91-C95
C81-C85,C96
SITES
Colorectal
Prostate
Leukaemia
Lymphoma
NO
CR
ASR
60
57
41
27
26
14.3
13.6
9.8
6.4
6.2
6.4
6.1
4.4
3.0
2.8
8.6
8.0
6.3
2.9
3.2
Table 75: Five most common cancers, female, Kedah 2007

FEMALE
ICD-10
C50
C18-C21
C33-C34
C53
C56
70
SITES
Breast
Colorectal
Cervix Uteri
Ovary
NO
CR
ASR
608
204
109
105
96
34.3
11.5
6.1
5.9
5.4
41.3
13.8
7.4
7.1
6.5
4.7
2.0
1.3
1.0
0.8
Figure 56: Five most frequent cancers, male, Kedah 2007

14.3
13.6
Colorectal
Prostate
9.8
6.4
Leukaemia
6.2
Lymphoma
5
10
15
20
Figure 57: Five most frequent cancers, female, Kedah 2007

30.1
Breast
Colorectal
9.8
Cervix Uteri
9.7
5.6
Ovary
0
10
15
20
25
30
35
71
8.1.9
TERENGGANU
Table 76: Cancer incidence, Terengganu 2007

SEX
Male
Female
Both
NO.
CR
ASR
240
391
631
38.0
62.0
100.0
45.7
77.2
67.9
96.1
Table 77: Number of new cancer cases, crude rate (CR) and ag standardised rate (ASR)
by major ethnic groups and sex,Terengganu 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
243
14
0
47.5
105.3
0
71.2
88.0
0
387
19
1
78.0
145.0
0
98.7
116.1
0
Table 78: Five most common cancers, male, Terengganu 2007

MALE
ICD-10
C33-C34
C18-C21
C91,-C95
C22
C61
SITES
Trachea,Bronchus,Lung
Colorectal
Leukaemia
Liver
Prostate
NO
CR
ASR
42
38
18
17
13
16.3
14.8
7.0
6.6
5.1
7.7
7.0
3.2
3.2
2.5
12.2
11.4
3.2
5.1
4.6
Table 79: Five most common cancers, female, Terengganu 2007

FEMALE
ICD-10
C50
C56
C54
C53
C18-C21
72
SITES
Breast
Ovary
Corpus Uteri
Cervix Uteri
Colorectal
NO
CR
ASR
107
41
37
29
26
26.3
10.1
9.1
7.1
6.3
20.9
8.1
7.3
5.5
4.8
25.5
9.6
9.0
7.0
6.8
Figure 57: Five most frequent cancers, female, Terengganu 2007

16.3

14.8
Colorectal
Leukaemia
Liver
6.6
5.1
Prostate
5
10
15
20
Figure 58: Five most frequent cancers, female, Terengganu 2007
Breast
26.3
Ovary
10.1
9.1
Corpus Uteri
7.1
Cervix Uteri
Colorectal
6.3
0
10
15
20
25
30
73
8.1.10 MALACCA
Table 80: Cancer incidence, Malacca 2007

SEX
Male
Female
Both
NO.
CR
ASR
322
389
711
45.3
54.7
100.0
91.2
110.0
113.3
117.8
by major ethnic groups and sex, Malacca, 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
147
155
18
64.8
158.4
86.2
95.3
138.6
123.2
195
167
22
85.9
173.2
94.5
103.0
139.6
110.7
Table 82: Five most common cancers, male, Malacca 2007

MALE
ICD-10
C33-C34
C18-C20
C91,-C95
C22
C81-C85,C96
SITES
Colorectal
Leukaemia
Liver
Lymphoma
NO
CR
ASR
60
58
24
21
17
24.4
23.6
9.8
8.5
6.9
16.8
16.5
6.9
6.0
4.9
21.9
20.9
7.4
7.5
5.6
Table 83: Five most common cancers, female, Malacca 2007

FEMALE
ICD-10
C50
C18-C20
C54
C53
C56
74
SITES
Breast
Colorectal
Corpus Uteri
Cervix Uteri
Ovary
NO
CR
ASR
135
46
30
29
28
34.8
11.9
7.7
7.5
7.2
38.3
13.1
8.5
8.2
7.9
41.6
14.4
9.0
9.0
8.5
Figure 60: Five most common cancers, male, Malacca 2007

24.4
23.6
Colorectal
9.8
Leukemia
Liver
8.5
6.9
Lymphoma
0
10
15
20
25
30
Figure 61: Five most common cancers, female, Malacca 2007
Breast
34.8
Colorectal
11.9
Corpus Uteri
7.7
Cervix Uteri
7.5
Ovary
7.2
10
20
30
40
75
8.1.11 SABAH
Table 84: Cancer incidence, Sabah 2007

SEX
Male
Female
Both
NO.
CR
ASR
735
766
1501
49.0
51.0
100.0
72.1
70.8
104.9
101
by major ethnic groups and sex, Sabah 2007
MALE
FEMALE
ETHNIC
Malay
Kadazan
Bajau
Murut
NO.
CR
ASR
NO.
CR
ASR
26
215
78
20
14.6
82.1
40.3
42.7
25.4
130.3
72.4
86.1
24
246
100
29
14.3
93.1
52.9
62.3
27.3
137.9
79.8
93.9
Table 86: Five most common cancers, male, Sabah 2007

MALE
ICD-10
C33-C34
C18-C21
C11
C16
C22
SITES
Colorectal
Nasopharynx
Stomach
Liver
NO
CR
ASR
89
88
84
59
46
12.1
12.0
11.4
8.0
6.3
8.7
8.6
8.2
5.8
4.5
13.3
12.4
11.4
8.7
6.3
Table 87: Five most common cancers, female, Sabah 2007

FEMALE
ICD-10
C50
C53
C18-C21
C56
C33-C34
76
SITES
Breast
Cervix Uteri
Colorectal
Ovary
NO
CR
ASR
147
82
80
58
46
19.2
10.7
10.4
7.6
6.0
13.6
7.6
7.4
5.4
4.3
17.0
10.0
11.7
6.7
8.1
Figure 62: Five most common cancers, male, Sabah 2007

12.1
12
Colorectal
Nasopharynx
11.4
Stomach
6.3
Liver
0
10
15
20
Percentage off all cancers
Figure 63: Five most common cancers, female, Sabah 2007

19.2
Breast
10.7
Cervix Uteri
Colorectal
10.4
7.6
Ovary

0
10
15
20
25
77
8.1.12 SARAWAK
Table 88: Cancer incidence, Sarawak 2007

SEX
Male
Female
Both
NO.
CR
ASR
729
851
1580
46.1
53.9
100.0
59.8
73.1
86
90.4
by major ethnic groups and sex, Sarawak 2007
MALE
FEMALE
ETHNIC
Bidayuh
Iban
Melanau
Malay
Chinese
NO.
CR
ASR
NO.
CR
ASR
93
177
19
111
282
96.1
50.9
28
41
93.3
143.3
69.5
38
68.9
115.4
84
214
33
184
278
88.3
62.9
50.5
70.4
93.5
111.4
71.9
83.6
96.4
103
Table 90: Five most common cancers, male, Sarawak 2007

MALE
ICD-10
C11
C18-C21
C33-C34
C22
C16
SITES
Nasopharynx
Colorectal
Liver
Stomach
NO
CR
ASR
115
103
97
55
48
15.8
14.2
13.3
07.5
06.6
9.4
8.4
7.9
4.5
3.9
10.7
13.2
12.7
6.6
6.4
Table 91: Five most common cancers, female, Sarawak 2007

FEMALE
ICD-10
C50
C53
C18-C21
C56
C11
78
SITES
Breast
Cervix Uteri
Colorectal
Ovary
Nasopharynx
NO
CR
ASR
190
126
86
51
49
22.3
14.8
10.0
6.0
5.8
16.3
10.8
7.4
4.4
4.2
18.8
12.2
10.8
5.0
4.5
Figure 64: Five most common cancers, male, Sarawak 2007

15.8
Nasopharynx
Colorectal
14.2
13.3
Liver
7.5
Stomach
6.6
5
10
15
20
Figure 65: Five most common cancers, female, Sarawak 2007

Breast
22.3
Cervix Uteri
14.8
Colorectal
10
6
Ovary
Nasopharynx
5.8
0
10
15
20
25
79
8.1.13 NEGERI SEMBILAN
Table 92: Cancer incidence, Negeri Sembilan 2007

SEX
Male
Female
Both
NO.
CR
ASR
277
350
627
44.2
55.8
100.0
55.1
73.7
68.9
78.8
by major ethnic groups and sex, Negeri Sembilan, 2007
MALE
FEMALE
ETHNIC
Malay
Chinese
Indian
NO.
CR
ASR
NO.
CR
ASR
126
168
0
48.6
133.1
0
61.9
119.9
0
178
151
4
69.6
128.2
5.4
75.6
111.3
7.7
Table 94: Five most common cancers, male, Negeri Sembilan 2007
MALE
ICD-10
C33-C34
C18-C21
C11
C61
C81-C85,C96
SITES
Colorectal
Nasopharynx
Prostate
Lymphoma
NO
CR
ASR
54
51
30
21
17
19.5
18.4
10.8
7.6
6.2
10.1
6.0
4.2
3.4
2.8
14.3
13.2
6.6
6.2
3.6
Table 95: Five most common cancers, female, Negeri Sembilan 2007
FEMALE
ICD-10
C50
C18-C21
C56
C53
C54
80
SITES
Breast
Colorectal
Ovary
Cervix Uteri
Corpus Uteri
NO
CR
ASR
126
35
34
32
19
36
10
9.7
9.1
5.4
26.5
7.3
7.2
6.7
4.0
28.0
8.3
7.3
7.0
4.1
Figure 66: Five most common cancers, male, Negeri Sembilan 2007
19.5
Colorectal
18.4
10.8
Nasopharynx
7.6
Prostate
6.2
Lymphoma
0
10
15
20
25
Figure 67: Five most common cancers, female, Negeri Sembilan 2007
Breast
36
Colorectal
10
Ovary
9.7
Cervix Uteri
9.1
Corpus Uteri
5.4
0
10
15
20
25
30
35
40
81
8.1.14 PERLIS
Table 96: Cancer incidence, Perlis 2007

SEX
Male
Female
Both
NO.
CR
ASR
32
75
107
30
70
100
31.5
64.4
38
66.6
Table 97: Five most common cancers, male, Perlis 2007

MALE
ICD-10
C33-C34
C11
C67
C18-C21
C22
SITES
Nasopharynx
Bladder
Colorectal
Liver
NO
CR
ASR
5
4
3
2
2
15.6
12.5
9.4
6.2
6.2
4.9
3.9
2.9
2.0
2.0
0.5
0.6
0.2
0.2
0.3
Table 98: Five most common cancers, female, Perlis 2007

FEMALE
ICD-10
C33-C34
C53
C50
C73
C01-C02
82
SITES
Cervix Uteri
Breast
Thyroid
Tongue
NO
CR
ASR
18
8
7
5
4
24.0
10.7
9.3
6.7
5.3
15.4
6.9
6.0
4.3
3.4
1.9
0.8
0.6
0.6
0.5
Figure 68: Five most common cancers, male, Perlis 2007

15.6
Nasopharynx
12.5
9.4
Bladder
Colorectal
6.2
Liver
6.2
5
10
15
20
Figure 69: Five most common cancers, female, Perlis 2007

24
10.7
Cervix Uteri
9.3
Breast
6.7
Thyroid
Tongue
5.3
0
10
15
20
25
30
83
Appendix 1: Population by sex, ethnic group and age, Malaysia, 2007 (source: Statistic Department)
Age Group
Total
Malay
Chinese
Indian
Others
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80+
Total
2842.400
2730.500
2603.400
2493.700
2340.600
2000.400
1712.800
1649.300
1565.600
1404.700
1208.900
914.300
646.300
473.500
322.900
185.500
171.000
25,265.800
1751.700
1612.900
1521.900
1445.700
1330.500
1086.800
883.100
836.700
786.900
693.100
585.900
433.200
297.300
213.700
142.600
80.100
71.100
13,773.100
519.700
548.300
524.300
515.100
511.100
480.600
456.200
457.900
451.300
431.600
394.300
315.800
237.600
177.800
122.600
73.800
69.800
6,287.900
179.800
185.900
176.300
171.800
169.000
156.800
145.600
140.200
131.900
121.900
106.000
74.400
46.900
33.300
22.500
11.300
10.300
1,883.900
36.600
42.800
43.100
37.800
31.300
24.900
19.500
19.400
17.500
15.400
12.600
8.800
5.700
4.000
2.600
1.700
2.300
326.100
Male
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80+
Total
1463.900
1403.900
1341.800
1278.100
1189.500
1003.700
848.900
817.900
778.700
706.100
612.600
464.900
328.100
231.200
148.400
84.000
71.200
12,773.000
905.100
830.400
783.700
739.200
673.400
542.700
434.800
412.100
389.000
345.400
293.600
217.500
148.700
102.200
64.000
36.000
30.500
6,948.400
271.100
283.600
273.200
267.300
262.800
245.700
231.900
231.700
228.000
220.100
202.600
163.500
123.000
88.700
57.600
32.800
25.800
3,209.400
91.600
94.600
89.800
87.900
86.300
78.400
71.600
69.100
65.100
60.100
52.000
36.400
22.700
15.200
9.400
5.000
4.600
939.700
19.200
22.200
22.200
18.900
15.500
11.800
8.700
9.100
8.400
8.000
7.100
4.800
3.000
2.200
1.400
0.900
1.500
1,64.900
Female
0-4
5-9
10-`4
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80+
Total
1378.500
1326.600
1261.500
1215.600
1151.100
996.700
863.900
831.400
786.900
698.600
596.300
449.400
318.200
242.300
174.400
101.500
99.900
12,492.800
846.500
782.500
738.200
706.500
657.100
544.100
448.300
424.600
398.000
347.700
292.300
215.700
148.600
111.400
78.600
44.000
40.700
6,824.800
248.600
264.600
251.100
247.800
248.300
235.000
224.300
226.300
223.300
211.500
191.700
152.400
114.500
89.000
65.100
41.000
44.000
3,078.500
88.200
91.300
86.500
83.900
82.700
78.500
74.000
71.200
66.800
61.800
54.000
38.000
24.100
18.100
13.100
6.400
5.700
944.100
17.400
20.600
20.900
19.000
15.800
13.000
10.800
10.300
9.200
7.300
5.500
4.000
2.700
1.800
1.200
0.800
0.800
161.100
84
Appendix 2: Staging For All Cancer Types
(ICD-10)
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18-C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81-C85;C96
C90
C91-C95
Sites
Lip
Tongue
Mouth
Salivary Glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx Unspec
Oesophagus
Stomach
Small Intestine
Colorectal
Liver
Gallbladder
Pancreas
Nose, Sinuses
Larynx
Other Thoracic Organs
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi Sarcoma
Connective Soft Tissue
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus Unspec
Ovary
Other Female Genital
Placenta
Penis
Prostate
Testis
Other Male Genital
Kidney
Renal Pelvis
Ureter
Bladder
Other Urinary Organs
Eye
Brain, Nervous System
Thyroid
Adrenal Gland
Other Endocrine
Lymphoma
Multiple Myeloma
Leukaemia
Others
ALL SITES
Number
with
Total
recorded
Stage
17
171
165
143
38
28
940
49
13
206
630
43
2246
605
101
284
79
183
1865
52
173
61
402
5
2
148
3292
21
31
847
414
85
656
3
7
23
502
74
4
201
11
3
331
12
37
471
434
21
53
776
107
741
413
18219
13
99
93
14
26
18
468
15
7
99
259
19
1105
202
19
135
40
108
1083
21
75
20
117
2
1
117
2114
7
14
519
243
33
426
2
1
4
271
44
4
106
9
3
137
7
10
160
139
5
14
235
18
103
66
8869
Stage
%
II
III
IV
76.4
57.0
56.0
16.5
68.4
64.3
49.8
30.6
53.9
48.1
39.7
44.2
49.2
33.4
18.8
47.5
50.6
59.0
58.1
40.4
43.4
33
29.1
20
50
79.1
65.2
33.3
45.2
61.3
58.7
38.3
64.9
66.7
14.3
17.4
44.8
59.5
100
52.7
81.8
100
41.39
58.3
27
34
32
23.8
26.4
30.3
16.8
13.9
19.7
48.7
6
10
10
3
2
1
53
1
1
7
22
3
98
14
2
6
12
27
39
3
11
2
50
0
0
50
447
0
2
109
109
12
140
1
1
1
36
20
2
15
3
1
35
0
4
27
44
2
3
35
1
15
13
1511
46.2
10.1
10.8
21.4
7.7
5.6
11.3
6.7
14.3
7.1
8.5
15.8
8.9
6.9
10.5
4.4
30
25.0
3.6
14.3
14.7
10
42.7
0
0
42.7
21.1
0
14.3
21
44.9
36.4
32.9
50
100
25.0
13.3
45.5
50
14
33.3
33
25.5
0
40
16.9
31.3
40
21.4
14.9
5.6
14.6
33.3
17
2
25
13
5
4
3
108
3
2
19
47
4
305
25
3
19
10
25
86
3
23
3
23
0
0
23
782
3
4
180
54
5
64
1
0
0
74
11
1
19
1
0
44
4
1
37
30
0
5
80
4
37
22
2246
15.4
25.3
14.0
35.7
15.4
16.7
23.1
20.0
28.6
19.2
18.1
21.1
27.6
12.4
15.8
14.1
25
23.1
7.9
14.3
30.7
15
19.7
0
0
19.7
37
43
28.6
34.7
22.2
15.2
15
50
0
0.0
27.3
25
25
18
11.1
0
32.1
57.1
10
23.1
22
0
35.7
34.0
22.2
35.9
33.3
25.3
1
24
18
3
6
5
156
5
2
26
64
3
352
38
3
20
4
31
301
10
6
8
24
1
0
24
510
2
2
133
48
9
133
0
0
0
55
1
0
20
0
2
29
0
0
34
15
1
3
55
3
17
9
2216
7.7
24.2
19.4
21.4
23.1
27.8
33.3
33.3
28.6
26.3
24.7
15.8
31.8
18.8
15.8
14.8
10.0
28.7
27.8
47.6
8.0
40
20.5
50
0
20.5
24.2
28.5
14.3
25.6
19.8
27.3
31.2
0
0
0.0
20.3
2.3
0
19
0
67
21.1
0
0
21.3
10.7
20
21.4
23.4
16.6
16.5
13.6
25
4
40
52
3
14
9
151
6
2
47
126
9
350
125
11
90
14
25
657
5
35
7
20
1
1
20
375
2
6
97
32
7
89
0
0
3
106
12
1
52
5
0
29
3
5
62
50
2
3
65
10
34
22
2896
30.8
40.4
55.9
21.4
53.9
50.0
32.3
40.0
28.6
47.5
48.7
47.4
31.7
61.9
57.9
66.7
35.0
23.1
60.7
23.8
46.7
35
17.1
50
100
17.1
17.7
28.5
42.9
18.7
13.2
21.2
20.9
0
0
75.0
39.1
27.3
25
49
55.6
0
21.1
42.9
50
38.8
36
40
21.4
27.7
55.5
33
33.3
32.7
85
Appendix 3: Incidence Summary Table, All Residence, Male, Malaysia 2007

2007 Male Malaysia
Age Group
C33-C34
C18-C21
C11
C61
C81-C85,C96
C22
C91-C95
C16
C70-C72
C67
C44
C32
C25
C64
C73
C15
C40-C41
C01-C02
C47;C49
C62
C03-C06
C90
C23-C24
C30-C31
C50
C07-C08
C75
C12-C13
C43
C17
C37-C38
C60
C10
C09
C69
C74
C14
C00
C65
C68
C45
C63
C46
C66
C88
Other
All
86
Total
Colorectal
Nasopharynx
Prostate
Lymphoma
Liver
Leukaemia
Stomach
Bladder
Other Skin
Larynx
Pancreas
Kidney
Thyroid
Oesophagus
Bone
Tongue
Connective, Soft tissue
Testis
Mouth
Multiple Myeloma
Gallbladder etc.
Nose, sinuses etc.
Breast
Salivary glands
Other Endocrine
Hypopharynx
Melanoma of Skin
Small intestine
Other Thoracic organs
Penis
Other Oropharynx
Tonsil
Eye
Adrenal gland
Pharynx unspec.
Lip
Renal Pelvis
Other Urinary organs
Mesothelioma
Other male genital
Kaposi sarcoma
Ureter
Immunoproliferative dis.
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
1320
1235
685
502
448
443
419
351
259
258
236
164
151
141
129
125
97
93
76
74
69
60
52
51
50
47
37
36
34
27
27
23
22
20
20
13
10
9
9
8
5
4
2
2
1
279
8123
16.3%
15.3%
8.4%
6.2%
5.5%
5.5%
5.1%
4.3%
3.2%
3.2%
2.9%
2.0%
0.2%
1.7%
1.6%
1.5%
1.2%
1.1%
0.9%
0.9%
0.8%
0.7%
0.6%
0.6%
0.6%
0.6%
0.5%
0.4%
0.4%
0.3%
0.3%
0.3%
0.3%
0.2%
0.2%
0.2%
0.1%
0.1%
0.1%
0.1%
0.4%
0.0%
0.0%
0.0%
0.0%
3.4%
100.0%
10.3
9.7
5.4
3.9
3.5
3.5
3.3
2.7
2.0
2.0
1.8
1.3
1.2
1.1
1.0
1.0
0.8
0.7
0.6
0.6
0.5
0.5
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
2.2
63.6
1.9
1.6
0.7
0.8
0.4
0.6
0.3
0.5
0.2
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
10.1
14.7
13.4
6.4
6.2
4.2
4.7
3.5
3.9
2.3
2.9
2.6
1.9
1.6
1.4
1.3
1.4
0.8
1.0
0.7
0.6
0.7
0.6
0.6
0.5
0.5
0.5
0.3
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
3.0
85.1
13.9
12.6
5.9
5.7
3.8
4.2
3.2
3.5
2.0
2.6
2.3
1.6
1.4
1.2
1.0
1.2
0.7
0.8
0.5
0.4
0.6
0.5
0.4
0.4
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.6
83.1
15.6
14.2
6.9
6.8
4.6
5.1
3.9
4.3
2.6
3.3
3.0
2.1
1.9
1.7
1.5
1.7
1.0
1.2
0.9
0.7
0.9
0.8
0.7
0.6
0.6
0.6
0.4
0.6
0.5
0.4
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.0
0.1
0.0
3.3
86.9
CumR
1.9
1.6
0.7
0.8
0.4
0.6
0.3
0.5
0.2
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
9.6
Appendix 4: Incidence Summary Table, All Residence, Female, Malaysia 2007

2007 Female Malaysia
Age Group
C50
C18-C21
C53
C56
C33-C34
C54
C81-C85,C96
C91-C95
C73
C16
C11
C70-C72
C44
C22
C25
C03-C06
C55
C15
C01-C02
C40-C41
C67
C47;C49
C64
C23-C24
C90
C07-C08
C52
C30-C31
C43
C37-C38
C51
C32
C09
C69
C17
C75
C12-C13
C00
C74
C58
C10
C68
C14
C57
C65
C66
C45
C46
C88
Other
All
Total
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
Lymphoma
Leukaemia
Thyroid
Stomach
Nasopharynx
Other Skin
Liver
Pancreas
Mouth
Uterus unspec.
Oesophagus
Tongue
Bone
Bladder
Kidney
Gallbladder etc.
Multiple Myeloma
Salivary glands
Vagina
Nose, sinuses etc.
Melanoma of Skin
Vulva
Larynx
Tonsil
Eye
Small intestine
Other Endocrine
Hypopharynx
Lip
Adrenal gland
Placenta
Other Oropharynx
Pharynx unspec.
Renal Pelvis
Ureter
Mesothelioma
Kaposi sarcoma
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
3242
1011
847
656
545
414
328
322
305
279
255
212
166
162
133
96
85
81
78
76
73
72
60
49
47
38
31
28
27
25
21
19
18
17
16
16
13
8
8
7
6
4
3
3
2
1
0
0
0
191
10096
32.1
10.0
8.4
6.5
5.4
4.1
3.3
3.2
3.0
2.8
2.5
2.1
1.6
1.6
1.3
1.0
0.8
0.8
0.8
0.8
0.7
0.7
0.6
0.5
0.5
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
100
26.0
8.1
6.8
5.3
4.4
3.3
2.6
2.6
2.4
2.2
2.0
1.7
1.3
1.3
1.1
0.8
0.7
0.6
0.6
0.6
0.6
0.6
0.5
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5
80.9
3.1
1.2
0.9
0.6
0.7
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
10.5
29.1
10.2
7.8
5.9
5.6
3.9
3.0
2.7
2.7
2.8
2.3
1.9
1.7
1.6
1.4
1.0
0.7
0.8
0.7
0.6
0.8
0.7
0.6
0.5
0.5
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
94.4
28.1
9.5
7.3
5.4
5.2
3.5
2.7
2.4
2.4
2.5
2.0
1.6
1.4
1.4
1.1
0.8
0.6
0.7
0.6
0.5
0.6
0.5
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
92.5
CumR
30.1
10.8
8.4
6.3
6.1
4.2
3.3
3.0
3.0
3.2
2.6
2.1
1.9
1.9
1.6
1.2
0.9
1.0
0.9
0.8
0.9
0.8
0.7
0.7
0.6
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
2.1
96.2
3.1
1.2
0.9
0.6
0.7
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
9.9
87
Appendix 5: Incidence Summary Table, All Residence, Malay Male, Malaysia 2007
2007 Malay Male
Age Group
C33-C34
C18-21
C91-C95
C81-C85,C96
C61
C11
C22
C70-C72
C67
C44
C73
C16
C32
C25
C40-C41
C64
C47;C49
C62
C90
C15
C01-C02
C75
C23-C24
C07-C08
C30-C31
C50
C03-C06
C69
C37-C38
C43
C17
C74
C14
C00
C12-C13
C09
C10
C45
C60
C63
C65
C88
C46
C66
C68
Other
All
88
Total
Colorectal
Leukaemia
Lymphoma
Prostate
Nasopharynx
Liver
Bladder
Other Skin
Thyroid
Stomach
Larynx
Pancreas
Bone
Kidney
Testis
Multiple Myeloma
Oesophagus
Tongue
Other Endocrine
Gallbladder etc.
Salivary glands
Nose, sinuses etc.
Breast
Mouth
Eye
Melanoma of Skin
Small intestine
Adrenal gland
Pharynx unspec.
Lip
Hypopharynx
Tonsil
Other Oropharynx
Mesothelioma
Penis
Other male genital
Renal Pelvis
Kaposi sarcoma
Ureter
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
501
445
241
221
176
152
152
137
124
83
69
65
51
50
48
45
43
41
40
36
27
27
25
23
23
23
21
14
12
11
9
6
5
4
4
3
3
3
3
3
3
1
0
0
0
120
3093
16.2
14.4
7.8
7.1
5.7
4.9
4.9
4.4
4
2.7
2.2
2.1
1.6
1.6
1.6
1.5
1.4
1.3
1.3
1.2
0.9
0.9
0.8
0.7
0.7
0.7
0.7
0.5
0.4
0.4
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
3.9
100
7.2
6.4
3.5
3.2
2.5
2.2
2.2
2.0
1.8
1.2
1.0
0.9
0.7
0.7
0.7
0.6
0.6
0.6
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7
44.5
1.5
1.2
0.3
0.4
0.7
0.3
0.4
0.2
0.4
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
7.7
11.8
10.1
3.8
4.3
4.9
3.0
3.4
2.3
3.1
1.9
1.5
1.5
1.2
1.2
0.8
1.0
0.8
0.6
0.9
0.9
0.5
0.4
0.6
0.5
0.5
0.4
0.5
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
2.6
66.9
10.8
9.2
3.3
3.7
4.2
2.5
2.8
1.9
2.6
1.4
1.1
1.1
0.9
0.8
0.6
0.7
0.6
0.4
0.6
0.6
0.3
0.3
0.4
0.3
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
64.4
12.9
11.1
4.3
4.9
5.7
3.5
4.0
2.8
3.7
2.3
1.8
1.9
1.6
1.5
1.0
1.4
1.1
0.8
1.1
1.2
0.8
0.6
0.9
0.7
0.7
0.6
0.7
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.0
0.0
0.0
3.1
69.3
CumR
1.5
1.2
0.3
0.4
0.7
0.3
0.4
0.2
0.4
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
7.4
Appendix 6: Incidence Summary Table, All Residence, Malays Female, Malaysia 2007
2007 Malay Female
Age Group
C50
C18-C21
C56
C53
C33-C34
C54
C91-C95
C81-C85,C96
C73
C70-C72
C11
C22
C16
C44
C25
C55
C40-C41
C01-C02
C47;C49
C90
C15
C64
C67
C03-C06
C23-C24
C07-C08
C43
C30-C31
C52
C69
C75
C32
C58
C09
C37-C38
C00
C74
C12-C13
C17
C51
C57
C10
C14
C65
C68
Other
All
Total
Breast
Colorectal
Ovary
Cervix Uteri
Corpus Uteri
Leukaemia
Lymphoma
Thyroid
Nasopharynx
Liver
Stomach
Other Skin
Pancreas
Uterus unspec.
Bone
Tongue
Multiple Myeloma
Oesophagus
Kidney
Bladder
Mouth
Gallbladder etc.
Salivary glands
Melanoma of Skin
Nose, sinuses etc.
Vagina
Eye
Other Endocrine
Larynx
Placenta
Tonsil
Lip
Adrenal gland
Hypopharynx
Small intestine
Vulva
Other Oropharynx
Pharynx unspec.
Renal Pelvis
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
1432
360
336
282
201
195
184
172
169
128
70
69
55
53
47
47
39
35
35
35
27
25
20
18
18
17
14
12
10
10
9
7
6
5
5
4
4
3
3
3
2
1
1
1
1
68
4238
33.8
8.5
7.9
6.7
4.7
4.6
4.3
4
4
3
1.7
1.6
1.3
1.3
1.1
1.1
0.9
0.8
0.8
0.8
0.6
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
1.6
100
21.0
5.3
4.9
4.1
2.9
2.9
2.7
2.5
2.5
1.9
1.0
1.0
0.8
0.8
0.7
0.7
0.6
0.5
0.5
0.5
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
62.1
2.6
0.9
0.6
0.6
0.6
0.4
0.3
0.3
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
8.6
25.4
7.5
6.0
5.3
4.4
3.7
3.0
3.0
3.0
2.1
1.3
1.4
1.1
1.1
1.0
0.8
0.6
0.7
0.6
0.7
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
1.4
79.0
24.1
6.7
5.4
4.7
3.8
3.1
2.5
2.6
2.5
1.7
1.0
1.1
0.8
0.8
0.7
0.6
0.4
0.5
0.4
0.5
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
76.5
CumR
26.8
8.3
6.7
5.9
5.0
4.2
3.4
3.5
3.5
2.5
1.6
1.8
1.5
1.4
1.3
1.1
0.8
0.9
0.8
0.9
0.9
0.7
0.6
0.6
0.6
0.5
0.4
0.3
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
1.7
81.4
2.6
0.9
0.6
0.6
0.6
0.4
0.3
0.3
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
8.2
89
Appendix 7: Incidence Summary Table, All Residence, Chinese Male, Malaysia 2007
2007 Chinese Male
Age Group
C33-C34
C18-C21
C11
C61
C22
C16
C81-C85,C96
C44
Other
C91-C95
C32
C64
C67
C70-C72
C25
C15
C01-C02
C73
C40-C41
C50
C62
C30-C31
C23-C24
C07-C08
C47;C49
C03-C06
C17
C12-C13
C90
C43
C37-C38
C68
C75
C60
C65
C09
C10
C00
C69
C14
C45
C46
C66
C63
C74
C88
Other
All
90
Total
Colorectal
Nasopharynx
Prostate
Liver
Stomach
Lymphoma
Other Skin
Other & unspecified
Leukaemia
Larynx
Kidney
Bladder
Pancreas
Oesophagus
Tongue
Thyroid
Bone
Breast
Testis
Nose, sinuses etc.
Gallbladder etc.
Salivary glands
Mouth
Small intestine
Hypopharynx
Multiple Myeloma
Melanoma of Skin
Other Endocrine
Penis
Renal Pelvis
Tonsil
Other Oropharynx
Lip
Eye
Pharynx unspec.
Mesothelioma
Kaposi sarcoma
Ureter
Other male genital
Adrenal gland
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
652
631
389
264
215
179
136
125
111
103
87
86
85
84
78
64
41
33
27
23
22
21
20
20
19
17
15
15
13
10
9
8
7
7
6
6
5
4
3
2
2
2
2
1
1
0
111
3650
17.9
17.3
10.7
7.2
5.9
4.9
3.7
3.4
3
2.8
2.4
2.4
2.3
2.3
2.1
1.8
1.1
0.9
0.7
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.4
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
3
100
20.3
19.7
12.1
8.2
6.7
5.6
4.2
3.9
3.5
3.2
2.7
2.7
2.6
2.6
2.4
2
1.3
1
0.8
0.7
0.7
0.7
0.6
0.6
0.6
0.5
0.5
0.5
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
3.5
113.8
2.6
2.4
1.2
1.1
0.8
0.7
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
13.4
20.5
19.4
10.9
8.7
6.4
5.6
4.1
4
3.4
3.3
2.7
2.5
2.7
2.5
2.4
2
1.2
0.9
0.8
0.7
0.6
0.6
0.6
0.6
0.6
0.5
0.4
0.5
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
3.4
111.9
18.9
17.8
9.8
7.6
5.6
4.8
3.4
3.3
2.8
2.6
2.1
2
2.1
2
1.9
1.5
0.9
0.6
0.5
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
2.8
108.2
22.1
20.9
12
9.7
7.3
6.4
4.8
4.7
4.1
3.9
3.3
3
3.3
3
2.9
2.5
1.6
1.3
1.2
0.9
0.9
0.9
0.9
0.8
0.8
0.7
0.7
0.7
0.6
0.5
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0
4.1
115.5
CumR
2.6
2.4
1.2
1.1
0.8
0.7
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
12.5
Appendix 8: Incidence Summary Table, All Residence, Chinese Female, Malaysia 2007
2007 Chinese Female
Age Group
C50
C18-C21
C53
C33-C34
C56
C54
C16
C11
C81-C85,C96
C44
C73
C22
C25
C91-C95
C70-C72
C67
C64
C55
C40-C41
C47;C49
C23-C24
C15
C03-C06
C01-C02
C30-C31
C07-C08
C43
C37-C38
C52
C51
C17
C90
C32
C09
C12-C13
C68
C74
C75
C00
C10
C69
C57
C65
C66
C14
C45
C46
C58
C88
Other
All
Total
Breast
Colorectal
Cervix Uteri
Ovary
Corpus Uteri
Stomach
Nasopharynx
Lymphoma
Other Skin
Thyroid
Liver
Pancreas
Leukaemia
Bladder
Kidney
Uterus unspec.
Bone
Gallbladder etc.
Oesophagus
Mouth
Tongue
Nose, sinuses etc.
Salivary glands
Melanoma of Skin
Vagina
Vulva
Small intestine
Multiple Myeloma
Larynx
Tonsil
Hypopharynx
Adrenal gland
Other Endocrine
Lip
Other Oropharynx
Eye
Renal Pelvis
Ureter
Pharynx unspec.
Mesothelioma
Kaposi sarcoma
Placenta
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
1343
510
330
273
201
160
138
123
101
79
76
69
65
63
58
41
28
26
23
22
21
18
15
15
13
12
11
10
10
9
9
8
6
5
3
3
3
3
2
2
2
1
1
1
0
0
0
0
0
78
3990
33.7
12.9
8.3
6.8
5
4
3.5
3.1
2.5
2
1.9
1.7
1.6
1.6
1.5
1
0.7
0.7
0.6
0.6
0.5
0.5
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
2
100
43.6
16.6
10.7
8.9
6.5
5.2
4.5
4
3.3
2.6
2.5
2.2
2.1
2
1.9
1.3
0.9
0.8
0.7
0.7
0.7
0.6
0.5
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
2.5
129.7
4.2
1.8
1.1
1
0.6
0.5
0.5
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
13
38.1
14.6
9.5
8
5.8
4.5
4
3.5
3
2.2
2.2
2
1.9
2
1.9
1.2
0.8
0.7
0.7
0.7
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0
0
0
0
0
0
0
0
2.3
115
36
13.3
8.5
7
5
3.8
3.3
2.9
2.4
1.7
1.7
1.6
1.5
1.5
1.4
0.8
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.7
111.3
CumR
40.1
15.9
10.5
8.9
6.7
5.3
4.6
4.1
3.6
2.7
2.8
2.5
2.4
2.5
2.3
1.5
1.1
1
0.9
0.9
0.9
0.7
0.6
0.6
0.6
0.5
0.5
0.4
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0
0
0
0
0
2.8
118.5
4.1
1.8
1.1
1
0.6
0.5
0.5
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
12.2
91
Appendix 9: Incidence Summary Table, All Residence, Indian Male, Malaysia 2007
2007 Indian Male
Age Group
C18-C21
C33-C34
C61
C16
C91-C95
C81-C85,C96
C70-C72
C03-C06
C67
C15
C32
C01-C02
C22
C10
C40-C41
C09
C11
C12-C13
C44
C73
C25
C62
C64
C60
C30-C31
C07-C08
C23-C24
C14
C43
C75
C17
C37-C38
C50
C00
C45
C46
C47;C49
C63
C65
C66
C68
C69
C74
C88
C90
Other
All
92
Total
Colorectal
Prostate
Stomach
Leukaemia
Lymphoma
Mouth
Bladder
Oesophagus
Larynx
Tongue
Liver
Other Oropharynx
Bone
Tonsil
Nasopharynx
Hypopharynx
Other Skin
Thyroid
Pancreas
Testis
Kidney
Penis
Nose, sinuses etc.
Salivary glands
Gallbladder etc.
Pharynx unspec.
Melanoma of Skin
Other Endocrine
Small intestine
Breast
Lip
Mesothelioma
Kaposi sarcoma
Other male genital
Renal Pelvis
Ureter
Eye
Adrenal gland
Multiple Myeloma
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
65
46
31
30
29
25
22
21
21
17
16
15
15
12
10
9
9
8
7
7
6
5
5
4
3
3
2
2
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
10
462
14.1
10
6.7
6.5
6.3
5.4
4.8
4.5
4.5
3.7
3.5
3.2
3.2
2.6
2.2
1.9
1.9
1.7
1.5
1.5
1.3
1.1
1.1
0.9
0.6
0.6
0.4
0.4
0.4
0.4
0.2
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
2.2
100
6.9
4.9
3.3
3.2
3.1
2.7
2.3
2.2
2.2
1.8
1.7
1.6
1.6
1.3
1.1
1
1
0.9
0.7
0.7
0.6
0.5
0.5
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
1.1
49.2
1.2
0.8
0.5
0.6
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.2
0.2
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
7.9
10.2
7.2
5.8
4.8
3.4
3.1
2.5
3.6
3.5
2.8
2.6
2
2.2
1.8
1.1
1.4
1.1
1.1
0.8
0.9
0.9
0.6
0.7
0.6
0.3
0.4
0.3
0.4
0.3
0.2
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
1.5
68.2
7.6
5
3.7
3
2.1
1.8
1.4
2
1.9
1.4
1.3
0.9
1
0.7
0.4
0.4
0.3
0.3
0.2
0.2
0.1
0
0
0
0
-0.1
-0.1
-0.2
-0.2
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0.5
61.6
12.8
9.4
7.9
6.6
4.7
4.3
3.7
5.1
5.1
4.1
3.9
3.1
3.3
2.9
1.7
2.3
1.9
1.9
1.4
1.7
1.6
1.2
1.3
1.2
0.7
0.8
0.7
1
0.8
0.5
0.3
0.3
0.3
0
0
0
0
0
0
0
0
0
0
0
0
2.5
74.7
CumR
1.2
0.8
0.5
0.6
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.2
0.2
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
7.6
Appendix 10: Incidence Summary Table, All Residence, Indian Female, Malaysia 2007
2007 Indian Female
Age Group
C50
C53
C18-C21
C03-C06
C56
C54
C15
C91-C95
C16
C01-C02
C33-C34
C70-C72
C81-C85,C96
C73
C25
C22
C11
C52
C23-C24
C32
C44
C09
C40-C41
C47;C49
C67
C75
C12-C13
C30-C31
C51
C10
C14
C37-C38
C55
C64
C90
C00
C07-C08
C43
C69
C17
C45
C46
C57
C58
C65
C66
C68
C74
C88
Other
All
Total
Breast
Cervix Uteri
Colorectal
Mouth
Ovary
Corpus Uteri
Oesophagus
Leukaemia
Stomach
Tongue
Lymphoma
Thyroid
Pancreas
Liver
Nasopharynx
Vagina
Gallbladder etc.
Larynx
Other Skin
Tonsil
Bone
Bladder
Other Endocrine
Hypopharynx
Nose, sinuses etc.
Vulva
Other Oropharynx
Pharynx unspec.
Uterus unspec.
Kidney
Multiple Myeloma
Lip
Salivary glands
Melanoma of Skin
Eye
Small intestine
Mesothelioma
Kaposi sarcoma
Placenta
Renal Pelvis
Ureter
Adrenal gland
Other & unspecified
All sites Total
NO.
CR
CR74
ASR
ASR(95%CL)
297
85
53
49
48
34
28
28
26
20
15
13
13
11
8
7
6
6
5
5
5
4
4
4
4
4
3
3
3
2
2
2
2
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
18
825
36
10.3
6.5
5.9
5.8
4.1
3.4
3.4
3.2
2.4
1.8
1.6
1.6
1.3
1
0.8
0.7
0.7
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.5
0.4
0.4
0.4
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
2.2
100
31.5
9
5.6
5.2
5.1
3.6
3
3
2.8
2.1
1.6
1.4
1.4
1.2
0.8
0.7
0.6
0.6
0.5
0.5
0.5
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
1.9
87.5
3.7
1.1
0.8
1
0.5
0.4
0.5
0.2
0.4
0.3
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
11.2
33.7
10.3
6.9
7.4
5.2
4.1
3.7
2.9
3.4
2.6
2
1.4
1.7
1.2
1
0.9
0.9
0.8
0.7
0.7
0.8
0.5
0.4
0.5
0.6
0.5
0.3
0.4
0.4
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0
0
0
0
0
0
0
0
0
0
2.2
99.9
29.7
8
5
5.3
3.7
2.6
2.3
1.8
2.1
1.4
0.9
0.6
0.7
0.4
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.2
-0.1
-0.2
-0.1
0
0
0
0
0
0
0
0
0
0
1.1
92.8
CumR
37.6
12.6
8.9
9.5
6.7
5.5
5.1
4
4.8
3.8
3
2.2
2.6
1.9
1.7
1.6
1.5
1.4
1.4
1.3
1.4
0.9
0.8
1
1.3
0.9
0.7
0.9
0.8
0.8
0.6
0.6
0.7
0.5
0.5
0.5
0.3
0.5
0.3
0
0
0
0
0
0
0
0
0
0
3.2
106.9
3.6
1.1
0.8
1
0.5
0.4
0.5
0.2
0.4
0.3
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
10.6
93
94
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Connective,Soft tissue
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Non-Hodgkin lymphoma
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
9
93
69
47
20
22
685
36
10
125
351
27
589
631
15
443
52
151
51
164
1320
27
97
34
236
5
2
76
50
23
502
74
4
141
9
2
258
8
20
259
129
13
37
38
410
1
60
130
223
66
279
8123
7887
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
-4
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
3
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
5
0
3
1
0
0
0
11
19
0
6
0
0
6
0
0
35
24
16
3
135
135
0-
0
0
0
0
0
0
2
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
3
0
0
0
0
0
0
2
0
1
0
0
0
0
1
19
1
1
1
1
8
0
0
17
11
12
1
84
81
5-
-9
-14
0
0
1
0
0
0
4
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
17
0
1
0
0
2
0
0
0
2
0
0
0
0
0
0
0
10
3
0
3
3
11
0
1
15
17
6
2
100
99
10-19
0
1
0
0
0
0
11
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
14
2
2
0
0
4
0
0
0
7
1
0
0
0
1
0
0
7
5
0
5
5
16
0
0
8
7
4
6
108
106
15-24
0
2
0
1
0
1
6
0
0
0
0
1
2
2
1
1
0
1
0
0
3
2
10
2
2
0
0
5
1
0
0
15
0
0
0
0
0
0
0
9
4
0
3
5
21
0
0
11
26
0
2
139
137
20-29
0
1
1
2
0
0
21
0
0
0
3
1
3
5
0
3
0
0
1
0
9
2
7
0
5
0
0
5
0
0
0
11
1
0
0
0
2
0
0
9
5
1
1
1
21
0
0
4
17
4
6
152
147
25-34
0
6
1
4
1
0
37
0
0
1
6
1
6
16
0
12
0
2
0
1
17
0
2
0
5
0
0
6
4
1
0
6
0
2
0
0
3
0
1
16
5
0
2
2
15
0
0
3
6
0
7
197
192
30-39
0
4
2
3
0
0
53
0
1
1
12
1
15
16
0
7
0
2
5
2
22
2
2
3
10
0
0
4
3
1
0
6
0
7
0
0
4
0
0
20
9
0
3
2
20
0
2
3
17
3
9
276
266
35-44
1
3
4
3
0
2
65
0
0
1
14
2
32
29
1
22
4
6
4
5
42
1
4
1
8
0
2
7
6
3
2
7
0
9
0
0
9
0
1
20
7
1
3
5
28
0
4
6
12
3
12
401
393
40-
Number Of Cases - Male
-49
2
10
12
4
4
0
109
3
0
9
27
3
41
53
1
44
5
13
7
10
84
3
5
1
13
0
0
5
10
2
6
2
0
14
1
0
19
1
2
18
15
0
2
2
38
0
6
4
11
3
23
647
634
45-54
0
15
7
7
3
1
104
2
1
7
28
2
69
62
3
55
5
18
8
16
139
4
4
6
23
1
0
9
9
2
21
7
0
25
1
0
20
0
0
24
12
0
4
4
27
0
8
5
19
5
22
814
791
50-59
0
7
6
5
1
4
87
2
1
20
43
6
85
87
1
76
10
17
6
24
173
1
9
4
16
0
0
4
4
6
35
1
0
20
1
0
31
0
0
30
16
0
4
4
55
0
13
9
13
1
41
979
963
55-64
0
14
7
8
4
3
75
7
4
18
37
4
71
111
2
68
3
35
9
19
193
4
7
3
26
0
0
8
4
2
72
0
0
28
0
0
34
3
0
12
13
2
2
0
45
0
9
1
17
2
36
1022
996
60-69
1
16
11
3
1
1
72
9
1
21
62
4
86
105
2
61
10
30
7
32
220
4
3
5
34
1
0
12
4
3
105
2
1
13
3
1
38
2
0
14
20
1
2
1
46
0
9
4
9
1
43
1136
1102
65-
Appendix 11: Number of new cancer cases, All Residence, Male, Malaysia 2007
-74
2
6
5
4
4
6
22
6
1
22
55
2
81
58
3
44
9
5
2
28
204
1
5
3
38
1
0
2
2
0
120
1
0
10
2
1
47
0
0
20
7
1
2
1
20
0
3
4
10
0
31
901
863
70-
3
8
12
3
2
3
17
6
0
25
64
0
97
86
1
47
6
21
2
27
213
3
6
4
50
2
0
2
3
3
141
0
1
9
0
0
50
2
4
12
7
0
0
2
33
1
5
1
7
6
35
1032
982
75+
0.10%
1.10%
0.80%
0.60%
0.20%
0.30%
8.40%
0.40%
0.10%
1.50%
4.30%
0.30%
7.30%
7.80%
0.20%
5.50%
0.60%
1.90%
0.60%
2.00%
16.30%
0.30%
1.20%
0.40%
2.90%
0.10%
0.00%
0.90%
0.60%
0.30%
6.20%
0.90%
0.00%
1.70%
0.10%
0.00%
3.20%
0.10%
0.20%
3.20%
1.60%
0.20%
0.50%
0.50%
5.00%
0.00%
0.70%
1.60%
2.70%
0.80%
3.40%
100.00%
97.10%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
8
78
96
38
18
6
255
13
3
81
279
16
555
433
23
162
49
133
28
19
545
25
76
27
166
0
0
72
3242
21
31
847
414
85
656
3
7
60
2
1
73
4
17
212
305
8
16
29
299
0
47
91
178
53
191
10096
9930
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
1
0
2
0
0
0
0
3
0
0
0
0
0
0
1
0
0
6
0
0
0
0
5
12
0
2
0
0
2
0
0
24
11
15
2
88
88
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
0
0
0
0
2
0
0
0
0
0
0
2
0
0
1
0
0
0
0
0
19
0
0
0
0
7
0
0
14
3
4
3
59
59
5-
-9
-14
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
7
0
1
0
0
2
1
0
0
0
0
0
10
0
0
1
0
0
0
0
1
12
0
1
0
0
6
0
0
11
8
8
2
73
72
10-19
0
0
0
1
0
0
6
0
0
0
4
0
1
2
0
0
0
1
0
0
0
0
16
1
3
0
0
7
6
0
0
0
1
0
21
0
0
1
0
0
0
0
2
13
12
0
1
6
12
0
0
8
9
3
3
140
137
15-24
0
0
2
4
0
0
14
0
0
0
0
2
3
3
1
1
0
1
2
0
3
0
4
0
5
0
0
1
18
0
0
2
0
2
22
0
0
2
0
0
1
0
0
11
15
0
0
7
17
0
0
3
12
2
5
165
160
20-29
0
1
2
1
0
0
9
0
0
0
5
0
7
4
0
2
0
2
0
0
6
0
1
0
3
0
0
3
57
0
0
12
6
3
27
0
0
0
1
0
0
0
1
10
33
0
0
8
16
0
0
3
7
2
5
237
234
25-34
0
5
3
1
0
0
18
0
1
0
6
0
9
9
0
3
1
2
1
0
5
2
3
0
2
0
0
3
138
0
0
27
15
2
21
1
0
2
0
0
0
0
2
9
19
1
0
0
15
0
0
2
13
1
3
345
343
30-39
0
2
2
2
0
0
19
0
0
1
9
0
19
9
1
6
0
2
5
0
12
0
1
1
3
0
0
4
246
2
2
82
23
5
36
0
2
3
0
0
2
0
1
16
32
0
2
1
12
0
1
2
13
3
2
586
583
35-44
0
6
3
3
1
0
33
0
0
4
14
1
31
27
0
6
1
5
1
0
23
2
6
6
7
0
0
9
432
0
4
110
39
11
74
0
1
1
0
0
4
0
0
17
31
0
3
2
20
0
5
5
14
4
15
981
974
40-
Number Of Cases - Female
-49
0
6
0
3
1
1
30
2
1
1
18
1
42
37
2
18
1
11
2
3
50
3
8
1
10
0
0
8
664
3
3
119
58
17
110
1
2
4
0
0
3
0
0
15
40
0
2
0
24
0
2
5
16
2
18
1368
1358
45-54
1
13
8
5
2
0
36
2
0
10
22
4
52
43
2
8
5
15
3
1
58
2
5
0
8
0
0
4
540
1
3
111
71
18
117
0
1
5
0
0
5
1
0
22
34
2
3
1
32
0
10
4
17
2
20
1329
1321
50-59
1
11
7
7
5
0
32
1
0
13
25
2
79
51
6
28
7
17
4
3
58
4
5
4
16
0
0
7
451
2
5
122
81
12
68
0
0
8
0
0
7
0
1
9
30
0
3
2
24
0
10
1
27
1
28
1285
1269
55-64
1
10
14
1
2
1
24
3
1
15
29
0
57
45
2
29
12
26
1
0
86
3
2
3
14
0
0
5
272
2
1
82
49
6
51
1
1
6
0
0
12
3
1
17
21
1
2
0
28
0
6
4
11
2
22
987
973
60-69
0
6
17
0
1
1
19
0
0
12
49
1
76
66
1
18
5
20
3
3
89
2
6
4
22
0
0
10
199
2
5
73
27
1
52
0
0
4
0
1
11
0
2
17
20
0
0
1
31
0
5
1
7
3
25
918
896
65-
Appendix 12: Number of new cancer cases, All Residence, Female, Malaysia 2007
-74
1
6
16
4
2
2
9
3
0
8
37
1
81
61
2
17
8
14
3
6
79
1
2
3
22
0
0
3
110
2
3
52
20
3
25
0
0
8
0
0
10
0
1
9
12
0
0
0
25
0
5
2
5
1
13
697
675
70-
3
12
22
6
4
1
6
2
0
17
61
4
97
76
6
24
9
17
3
3
75
5
5
4
50
0
0
1
108
7
5
55
24
5
19
0
0
8
1
0
18
0
0
4
6
1
0
1
28
0
3
2
5
0
25
838
788
75+
0.10%
0.80%
1.00%
0.40%
0.20%
0.10%
2.50%
0.10%
0.00%
0.80%
2.80%
0.20%
5.50%
4.30%
0.20%
1.60%
0.50%
1.30%
0.30%
0.20%
5.40%
0.20%
0.80%
0.30%
1.60%
0.00%
0.00%
0.70%
32.10%
0.20%
0.30%
8.40%
4.10%
0.80%
6.50%
0.00%
0.10%
0.60%
0.00%
0.00%
0.70%
0.00%
0.20%
2.10%
3.00%
0.10%
0.20%
0.30%
3.00%
0.00%
0.50%
0.90%
1.80%
0.50%
1.90%
100.00%
98.40%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
95
96
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
9
93
69
47
20
22
685
36
10
125
351
27
589
631
15
443
52
151
51
164
1320
27
97
34
236
5
2
76
50
23
502
74
4
141
9
2
258
8
20
259
129
13
37
38
410
1
60
130
223
66
279
8123
7887
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0.2
0
0.1
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0.3
0
0.2
0.1
0
0
0
0.8
1.3
0
0.4
0
0
0.4
0
0
2.4
1.6
1.1
0.2
9
9
0-
-4
0
0
0
0
0
0
0.1
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0.2
0
0
0
0
0
0
0.1
0
0.1
0
0
0
0
0.1
1.4
0.1
0.1
0.1
0.1
0.6
0
0
1.2
0.8
0.9
0.1
6
6
5-
-9
-14
0
0
0.1
0
0
0
0.3
0
0
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
1.3
0
0.1
0
0
0.1
0
0
0
0.1
0
0
0
0
0
0
0
0.7
0.2
0
0.2
0.2
0.8
0
0.1
1.1
1.3
0.4
0.1
7
7
10-19
0
0.1
0
0
0
0
0.9
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
1.1
0.2
0.2
0
0
0.3
0
0
0
0.5
0.1
0
0
0
0.1
0
0
0.5
0.4
0
0.4
0.4
1.3
0
0
0.6
0.5
0.3
0.5
8
8
15-24
0
0.2
0
0.1
0
0.1
0.5
0
0
0
0
0.1
0.2
0.2
0.1
0.1
0
0.1
0
0
0.3
0.2
0.8
0.2
0.2
0
0
0.4
0.1
0
0
1.3
0
0
0
0
0
0
0
0.8
0.3
0
0.3
0.4
1.8
0
0
0.9
2.2
0
0.2
12
12
20-29
0
0.1
0.1
0.2
0
0
2.1
0
0
0
0.3
0.1
0.3
0.5
0
0.3
0
0
0.1
0
0.9
0.2
0.7
0
0.5
0
0
0.5
0
0
0
1.1
0.1
0
0
0
0.2
0
0
0.9
0.5
0.1
0.1
0.1
2.1
0
0
0.4
1.7
0.4
0.6
15
15
25-34
0
0.7
0.1
0.5
0.1
0
4.4
0
0
0.1
0.7
0.1
0.7
1.9
0
1.4
0
0.2
0
0.1
2
0
0.2
0
0.6
0
0
0.7
0.5
0.1
0
0.7
0
0.2
0
0
0.4
0
0.1
1.9
0.6
0
0.2
0.2
1.8
0
0
0.4
0.7
0
0.8
23
23
30-39
0
0.5
0.2
0.4
0
0
6.5
0
0.1
0.1
1.5
0.1
1.8
2
0
0.9
0
0.2
0.6
0.2
2.7
0.2
0.2
0.4
1.2
0
0
0.5
0.4
0.1
0
0.7
0
0.9
0
0
0.5
0
0
2.4
1.1
0
0.4
0.2
2.4
0
0.2
0.4
2.1
0.4
1.1
34
33
35-44
0.1
0.4
0.5
0.4
0
0.3
8.4
0
0
0.1
1.8
0.3
4.1
3.7
0.1
2.8
0.5
0.8
0.5
0.6
5.4
0.1
0.5
0.1
1
0
0.3
0.9
0.8
0.4
0.3
0.9
0
1.2
0
0
1.2
0
0.1
2.6
0.9
0.1
0.4
0.6
3.6
0
0.5
0.8
1.5
0.4
1.5
52
51
40-
Incidence Rates - Male
-49
0.3
1.4
1.7
0.6
0.6
0
15.4
0.4
0
1.3
3.8
0.4
5.8
7.5
0.1
6.2
0.7
1.8
1
1.4
11.9
0.4
0.7
0.1
1.8
0
0
0.7
1.4
0.3
0.9
0.3
0
2
0.1
0
2.7
0.1
0.3
2.6
2.1
0
0.3
0.3
5.4
0
0.9
0.6
1.6
0.4
3.3
92
90
45-54
0
2.5
1.1
1.1
0.5
0.2
17
0.3
0.2
1.1
4.6
0.3
11.3
10.1
0.5
9
0.8
2.9
1.3
2.6
22.7
0.7
0.7
1
3.8
0.2
0
1.5
1.5
0.3
3.4
1.1
0
4.1
0.2
0
3.3
0
0
3.9
2
0
0.7
0.7
4.4
0
1.3
0.8
3.1
0.8
3.6
133
129
50-59
0
1.5
1.3
1.1
0.2
0.9
18.7
0.4
0.2
4.3
9.3
1.3
18.3
18.7
0.2
16.4
2.2
3.7
1.3
5.2
37.2
0.2
1.9
0.9
3.4
0
0
0.9
0.9
1.3
7.5
0.2
0
4.3
0.2
0
6.7
0
0
6.5
3.4
0
0.9
0.9
11.8
0
2.8
1.9
2.8
0.2
8.8
211
207
55-64
0
4.3
2.1
2.4
1.2
0.9
22.9
2.1
1.2
5.5
11.3
1.2
21.7
33.9
0.6
20.7
0.9
10.7
2.7
5.8
58.9
1.2
2.1
0.9
7.9
0
0
2.4
1.2
0.6
22
0
0
8.5
0
0
10.4
0.9
0
3.7
4
0.6
0.6
0
13.7
0
2.7
0.3
5.2
0.6
11
312
304
60-
Appendix 13: Cancer Incidence Rates, Male, Malaysia 2007
-69
0.4
6.9
4.8
1.3
0.4
0.4
31.2
3.9
0.4
9.1
26.8
1.7
37.2
45.4
0.9
26.4
4.3
13
3
13.9
95.2
1.7
1.3
2.2
14.7
0.4
0
5.2
1.7
1.3
45.4
0.9
0.4
5.6
1.3
0.4
16.4
0.9
0
6.1
8.7
0.4
0.9
0.4
19.9
0
3.9
1.7
3.9
0.4
18.6
492
477
65-74
1.3
4
3.4
2.7
2.7
4
14.8
4
0.7
14.8
37.1
1.3
54.6
39.1
2
29.7
6.1
3.4
1.3
18.9
137.6
0.7
3.4
2
25.6
0.7
0
1.3
1.3
0
80.9
0.7
0
6.7
1.3
0.7
31.7
0
0
13.5
4.7
0.7
1.3
0.7
13.5
0
2
2.7
6.7
0
20.9
608
582
70-
1.9
5.2
7.7
1.9
1.3
1.9
11
3.9
0
16.1
41.3
0
62.5
55.5
0.6
30.3
3.9
13.5
1.3
17.4
137.3
1.9
3.9
2.6
32.2
1.3
0
1.3
1.9
1.9
90.9
0
0.6
5.8
0
0
32.2
1.3
2.6
7.7
4.5
0
0
1.3
21.3
0.6
3.2
0.6
4.5
3.9
22.6
665
633
75+
0.1
0.7
0.5
0.4
0.2
0.2
5.4
0.3
0.1
1
2.7
0.2
4.6
4.9
0.1
3.5
0.4
1.2
0.4
1.3
10.3
0.2
0.8
0.3
1.8
0
0
0.6
0.4
0.2
3.9
0.6
0
1.1
0.1
0
2
0.1
0.2
2
1
0.1
0.3
0.3
3.2
0
0.5
1
1.7
0.5
2.2
63.6
61.8
Total
% of
0.1
1
0.7
0.5
0.2
0.2
6.4
0.4
0.1
1.4
3.9
0.3
6.4
6.8
0.2
4.7
0.6
1.6
0.5
1.9
14.8
0.3
0.8
0.3
2.6
0.1
0
0.7
0.5
0.2
6.2
0.6
0
1.4
0.1
0
2.9
0.1
0.2
2.3
1.3
0.1
0.3
0.3
3.9
0
0.6
1
1.9
0.6
3
85.1
82.4
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
8
78
96
38
18
6
255
13
3
81
279
16
555
433
23
162
49
133
28
19
545
25
76
27
166
0
0
72
3242
21
31
847
414
85
656
3
7
60
2
1
73
4
17
212
305
8
16
29
299
0
47
91
178
53
191
10096
9930
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0.1
0
0.1
0
0
0
0
0.2
0
0
0
0
0
0
0.1
0
0
0.4
0
0
0
0
0.4
0.9
0
0.1
0
0
0.1
0
0
1.7
0.8
1.1
0.1
6
6
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.2
0
0
0
0
0.2
0
0
0
0
0
0
0.2
0
0
0.1
0
0
0
0
0
1.4
0
0
0
0
0.5
0
0
1.1
0.2
0.3
0.2
4
4
5-
-9
-14
0.1
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0.6
0
0.1
0
0
0.2
0.1
0
0
0
0
0
0.8
0
0
0.1
0
0
0
0
0.1
1
0
0.1
0
0
0.5
0
0
0.9
0.6
0.6
0.2
6
6
10-19
0
0
0
0.1
0
0
0.5
0
0
0
0.3
0
0.1
0.2
0
0
0
0.1
0
0
0
0
1.3
0.1
0.2
0
0
0.6
0.5
0
0
0
0.1
0
1.7
0
0
0.1
0
0
0
0
0.2
1.1
1
0
0.1
0.5
1
0
0
0.7
0.7
0.2
0.2
12
11
15-24
0
0
0.2
0.3
0
0
1.2
0
0
0
0
0.2
0.3
0.3
0.1
0.1
0
0.1
0.2
0
0.3
0
0.3
0
0.4
0
0
0.1
1.6
0
0
0.2
0
0.2
1.9
0
0
0.2
0
0
0.1
0
0
1
1.3
0
0
0.6
1.5
0
0
0.3
1
0.2
0.4
14
14
20-29
0
0.1
0.2
0.1
0
0
0.9
0
0
0
0.5
0
0.7
0.4
0
0.2
0
0.2
0
0
0.6
0
0.1
0
0.3
0
0
0.3
5.7
0
0
1.2
0.6
0.3
2.7
0
0
0
0.1
0
0
0
0.1
1
3.3
0
0
0.8
1.6
0
0
0.3
0.7
0.2
0.5
24
23
25-34
0
0.6
0.3
0.1
0
0
2.1
0
0.1
0
0.7
0
1
1
0
0.3
0.1
0.2
0.1
0
0.6
0.2
0.3
0
0.2
0
0
0.3
16
0
0
3.1
1.7
0.2
2.4
0.1
0
0.2
0
0
0
0
0.2
1
2.2
0.1
0
0
1.7
0
0
0.2
1.5
0.1
0.3
40
40
30-39
0
0.2
0.2
0.2
0
0
2.3
0
0
0.1
1.1
0
2.3
1.1
0.1
0.7
0
0.2
0.6
0
1.4
0
0.1
0.1
0.4
0
0
0.5
29.6
0.2
0.2
9.9
2.8
0.6
4.3
0
0.2
0.4
0
0
0.2
0
0.1
1.9
3.9
0
0.2
0.1
1.4
0
0.1
0.2
1.6
0.4
0.2
71
70
35-44
0
0.8
0.4
0.4
0.1
0
4.2
0
0
0.5
1.8
0.1
3.9
3.4
0
0.8
0.1
0.6
0.1
0
2.9
0.3
0.8
0.8
0.9
0
0
1.1
54.9
0
0.5
14
5
1.4
9.4
0
0.1
0.1
0
0
0.5
0
0
2.2
3.9
0
0.4
0.3
2.5
0
0.6
0.6
1.8
0.5
1.9
125
124
40-
Incidence Rates - Female
-49
0
0.9
0
0.4
0.1
0.1
4.3
0.3
0.1
0.1
2.6
0.1
6
5.3
0.3
2.6
0.1
1.6
0.3
0.4
7.2
0.4
1.1
0.1
1.4
0
0
1.1
95.1
0.4
0.4
17
8.3
2.4
15.8
0.1
0.3
0.6
0
0
0.4
0
0
2.1
5.7
0
0.3
0
3.4
0
0.3
0.7
2.3
0.3
2.6
196
195
45-54
0.2
2.2
1.3
0.8
0.3
0
6
0.3
0
1.7
3.7
0.7
8.7
7.2
0.3
1.3
0.8
2.5
0.5
0.2
9.7
0.3
0.8
0
1.3
0
0
0.7
90.6
0.2
0.5
18.6
11.9
3
19.6
0
0.2
0.8
0
0
0.8
0.2
0
3.7
5.7
0.3
0.5
0.2
5.4
0
1.7
0.7
2.9
0.3
3.4
223
222
50-59
0.2
2.4
1.6
1.6
1.1
0
7.1
0.2
0
2.9
5.6
0.4
17.6
11.4
1.3
6.2
1.6
3.8
0.9
0.7
12.9
0.9
1.1
0.9
3.6
0
0
1.6
100.4
0.4
1.1
27.2
18
2.7
15.1
0
0
1.8
0
0
1.6
0
0.2
2
6.7
0
0.7
0.4
5.3
0
2.2
0.2
6
0.2
6.2
286
283
55-64
0.3
3.1
4.4
0.3
0.6
0.3
7.5
0.9
0.3
4.7
9.1
0
17.9
14.2
0.6
9.1
3.8
8.2
0.3
0
27
0.9
0.6
0.9
4.4
0
0
1.6
85.5
0.6
0.3
25.8
15.4
1.9
16
0.3
0.3
1.9
0
0
3.8
0.9
0.3
5.3
6.6
0.3
0.6
0
8.8
0
1.9
1.3
3.5
0.6
6.9
310
306
60-
Appendix 14: Cancer Incidence Rates, Female, Malaysia 2007
-69
0
2.5
7
0
0.4
0.4
7.8
0
0
5
20.2
0.4
31.4
27.3
0.4
7.4
2.1
8.3
1.2
1.2
36.8
0.8
2.5
1.7
9.1
0
0
4.1
82.2
0.8
2.1
30.1
11.2
0.4
21.5
0
0
1.7
0
0.4
4.5
0
0.8
7
8.3
0
0
0.4
12.8
0
2.1
0.4
2.9
1.2
10.3
379
370
65-74
0.6
3.4
9.2
2.3
1.1
1.1
5.2
1.7
0
4.6
21.2
0.6
46.5
35
1.1
9.8
4.6
8
1.7
3.4
45.3
0.6
1.1
1.7
12.6
0
0
1.7
63.1
1.1
1.7
29.8
11.5
1.7
14.3
0
0
4.6
0
0
5.7
0
0.6
5.2
6.9
0
0
0
14.3
0
2.9
1.1
2.9
0.6
7.5
400
387
70-
1.5
6
10.9
3
2
0.5
3
1
0
8.4
30.3
2
48.2
37.8
3
11.9
4.5
8.4
1.5
1.5
37.3
2.5
2.5
2
24.8
0
0
0.5
53.7
3.5
2.5
27.3
11.9
2.5
9.4
0
0
4
0.5
0
8.9
0
0
2
3
0.5
0
0.5
13.9
0
1.5
1
2.5
0
12.4
416
392
75+
0.1
0.6
0.8
0.3
0.1
0
2
0.1
0
0.6
2.2
0.1
4.4
3.5
0.2
1.3
0.4
1.1
0.2
0.2
4.4
0.2
0.6
0.2
1.3
0
0
0.6
26
0.2
0.2
6.8
3.3
0.7
5.3
0
0.1
0.5
0
0
0.6
0
0.1
1.7
2.4
0.1
0.1
0.2
2.4
0
0.4
0.7
1.4
0.4
1.5
80.9
79.5
Total
% of
0.1
0.7
1
0.3
0.2
0.1
2.3
0.1
0
0.8
2.8
0.1
5.6
4.4
0.2
1.6
0.5
1.4
0.3
0.2
5.6
0.2
0.6
0.3
1.7
0
0
0.7
29.1
0.2
0.3
7.8
3.9
0.7
5.9
0
0.1
0.6
0
0
0.8
0
0.2
1.9
2.7
0.1
0.1
0.2
2.8
0
0.5
0.8
1.5
0.4
1.9
94.4
92.7
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
97
98
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
27
21
23
3
3
152
4
5
36
65
9
185
253
7
152
25
50
23
51
501
12
48
11
83
3
0
43
23
3
176
41
3
45
3
0
124
0
14
137
69
6
27
23
198
1
40
65
126
50
120
3093
3010
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
3
0
0
1
0
0
0
8
14
0
3
0
0
2
0
0
17
18
12
0
82
82
-4
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
1
13
0
0
1
0
4
0
0
8
8
11
1
53
51
5-
-9
-14
0
0
1
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
1
0
0
2
0
0
0
2
0
0
0
0
0
0
0
6
1
0
3
3
6
0
1
7
5
6
2
59
58
10-19
0
1
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
1
2
0
0
1
0
0
0
5
1
0
0
0
0
0
0
5
4
0
5
3
9
0
0
3
6
4
3
64
62
15-24
0
0
0
1
0
1
1
0
0
0
0
0
0
1
1
1
0
0
0
0
2
2
4
2
1
0
0
5
1
0
0
10
0
0
0
0
0
0
0
5
2
0
2
4
14
0
0
6
16
0
2
84
83
20-29
0
0
1
1
0
0
4
0
0
0
1
0
1
4
0
2
0
0
0
0
7
2
5
0
3
0
0
3
0
0
0
5
0
0
0
0
1
0
0
4
3
0
1
0
10
0
0
4
11
3
4
80
77
25-34
0
2
1
2
1
0
8
0
0
0
2
1
4
10
0
7
0
1
0
0
9
0
0
0
2
0
0
5
4
0
0
4
0
0
0
0
0
0
1
11
3
0
2
2
8
0
0
0
3
0
3
96
94
30-39
0
0
1
2
0
0
11
0
1
0
2
0
10
8
0
3
0
0
4
1
15
1
1
2
5
0
0
0
0
0
0
3
0
2
0
0
1
0
0
12
4
0
2
1
7
0
1
1
10
1
5
117
112
35-44
0
3
2
2
0
0
16
0
0
1
3
1
14
13
1
7
1
4
2
1
22
0
1
0
5
0
0
4
2
0
1
3
0
3
0
0
4
0
1
8
6
0
2
2
19
0
4
5
9
2
8
182
177
40-49
1
4
2
1
1
0
24
0
0
1
11
1
20
24
1
19
3
4
2
3
47
1
0
0
7
0
0
4
6
0
3
2
0
4
0
0
11
0
1
12
4
0
1
2
16
0
6
3
8
1
15
276
269
45-
Number Of Cases Male (Malay)
-54
0
7
4
3
1
0
20
0
1
6
8
0
28
24
2
20
3
8
3
7
62
2
4
3
9
0
0
1
3
1
10
1
0
8
1
0
9
0
0
10
5
0
3
2
14
0
5
2
6
5
10
321
312
50-59
0
2
0
1
0
0
14
0
1
4
6
4
28
34
0
24
4
3
2
11
69
0
5
2
6
0
0
3
3
0
14
1
0
3
0
0
18
0
0
16
9
0
2
2
24
0
7
4
7
0
15
348
342
55-64
0
3
2
5
0
0
23
1
1
7
2
1
24
46
1
24
1
11
6
5
68
1
4
0
8
0
0
5
1
1
21
0
0
12
0
0
20
0
0
4
5
1
2
0
24
0
6
1
8
0
14
369
361
60-
Appendix 15: Number of new cancer cases, Malay Male, Malaysia 2007
-69
1
2
1
1
0
0
11
1
0
3
10
0
15
41
0
11
5
12
2
7
65
1
0
1
11
1
0
5
1
1
33
1
1
7
0
0
14
0
0
2
13
1
1
1
16
0
6
3
4
0
9
321
310
65-74
0
1
2
2
0
0
7
1
0
7
6
1
16
19
0
13
5
0
2
8
71
0
3
0
10
1
0
2
1
0
52
0
0
1
1
0
22
0
0
11
5
1
0
0
7
0
1
0
3
0
18
300
290
70-
2
2
4
2
0
1
6
1
0
7
14
0
25
29
1
20
3
6
0
8
64
2
2
0
11
1
0
2
1
0
42
0
1
5
0
0
24
0
2
4
5
0
0
1
18
1
3
1
4
5
11
341
330
75+
0.10%
0.90%
0.70%
0.70%
0.10%
0.10%
4.90%
0.10%
0.20%
1.20%
2.10%
0.30%
6.00%
8.20%
0.20%
4.90%
0.80%
1.60%
0.70%
1.60%
16.20%
0.40%
1.60%
0.40%
2.70%
0.10%
0.00%
1.40%
0.70%
0.10%
5.70%
1.30%
0.10%
1.50%
0.10%
0.00%
4.00%
0.00%
0.50%
4.40%
2.20%
0.20%
0.90%
0.70%
6.40%
0.00%
1.30%
2.10%
4.10%
1.60%
3.90%
100.00%
97.30%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
35
18
17
5
1
70
3
1
27
55
3
174
178
8
69
18
47
12
7
201
5
39
14
53
0
0
35
1432
3
10
282
195
47
336
2
6
25
1
0
20
1
10
128
169
4
9
14
158
0
35
42
103
39
68
4238
4185
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
3
0
0
0
0
0
0
0
0
0
6
0
0
0
0
1
8
0
1
0
0
2
0
0
10
6
12
0
51
51
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
12
0
0
0
0
2
0
0
4
1
3
1
29
29
5-
-9
-14
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
4
0
0
0
0
1
1
0
0
0
0
0
7
0
0
1
0
0
0
0
1
10
0
0
0
0
4
0
0
6
5
8
1
51
51
10-19
0
0
0
1
0
0
4
0
0
0
3
0
0
1
0
0
0
0
0
0
0
0
10
0
3
0
0
4
6
0
0
0
1
0
13
0
0
0
0
0
0
0
1
8
6
0
0
3
6
0
0
8
6
1
1
86
83
15-24
0
0
0
1
0
0
3
0
0
0
0
0
3
2
0
0
0
1
1
0
3
0
4
0
1
0
0
1
12
0
0
0
0
1
12
0
0
1
0
0
0
0
0
6
10
0
0
4
13
0
0
2
9
2
3
95
94
20-29
0
1
0
1
0
0
2
0
0
0
0
0
3
2
0
1
0
0
0
0
0
0
1
0
2
0
0
1
38
0
0
3
2
2
18
0
0
0
1
0
0
0
1
6
19
0
0
3
12
0
0
0
4
2
3
128
126
25-34
0
4
2
1
0
0
3
0
1
0
1
0
5
6
0
2
0
1
0
0
4
1
2
0
1
0
0
2
72
0
0
9
11
1
12
1
0
1
0
0
0
0
2
6
8
0
0
0
11
0
0
0
6
0
2
178
177
30-39
0
1
0
1
0
0
5
0
0
1
2
0
7
4
1
3
0
2
4
0
6
0
1
0
1
0
0
1
140
1
0
25
10
4
19
0
2
1
0
0
1
0
1
13
21
0
1
0
4
0
1
1
8
3
0
296
295
35-44
0
2
0
1
0
0
8
0
0
0
6
1
14
13
0
2
0
4
0
0
7
0
3
5
5
0
0
7
232
0
3
45
25
6
32
0
1
0
0
0
2
0
0
9
14
0
3
1
13
0
5
4
6
1
4
484
479
40-49
0
5
0
1
0
0
7
0
0
0
6
0
17
15
1
10
1
4
0
1
22
0
3
1
3
0
0
2
322
0
1
40
29
9
56
0
1
1
0
0
2
0
0
9
24
0
2
0
18
0
2
0
12
2
8
637
634
45-
Number Of Cases Female (Malay)
-54
0
3
2
2
0
0
8
1
0
4
5
1
25
22
0
5
3
2
1
0
26
0
2
0
2
0
0
4
220
0
2
41
37
10
64
0
1
4
0
0
3
0
0
14
18
1
1
1
18
0
7
3
7
1
5
576
574
50-59
1
4
1
2
1
0
14
0
0
2
7
0
25
21
1
17
2
6
3
0
23
0
2
1
6
0
0
1
174
0
2
51
35
8
37
0
0
2
0
0
3
0
0
4
14
0
2
2
14
0
7
0
17
0
8
520
514
55-64
0
4
1
0
0
0
7
0
0
5
4
0
24
18
2
8
4
12
0
0
27
0
1
1
6
0
0
0
94
0
1
27
22
2
21
1
1
2
0
0
2
1
1
8
13
1
0
0
9
0
3
1
7
2
9
352
346
60-69
0
4
4
0
0
0
6
0
0
5
13
1
12
28
0
9
2
6
1
2
36
2
1
3
6
0
0
4
64
0
1
16
9
1
23
0
0
2
0
0
3
0
1
6
14
0
0
0
11
0
4
1
4
2
10
317
311
65-
Appendix 16: Number of new cancer cases, Malay Female, Malaysia 2007
-74
1
1
3
1
1
0
1
0
0
4
3
0
24
19
0
6
2
4
0
2
28
1
1
1
6
0
0
1
31
1
0
13
8
2
13
0
0
2
0
0
2
0
1
6
7
0
0
0
11
0
3
1
1
0
5
217
211
70-
1
6
5
5
3
1
2
2
0
6
5
0
14
27
3
6
4
5
2
2
19
0
0
2
11
0
0
1
26
1
0
12
6
1
8
0
0
2
0
0
2
0
0
3
1
1
0
0
10
0
3
1
4
0
8
221
210
75+
0.10%
0.80%
0.40%
0.40%
0.10%
0.00%
1.70%
0.10%
0.00%
0.60%
1.30%
0.10%
4.10%
4.20%
0.20%
1.60%
0.40%
1.10%
0.30%
0.20%
4.70%
0.10%
0.90%
0.30%
1.30%
0.00%
0.00%
0.80%
33.80%
0.10%
0.20%
6.70%
4.60%
1.10%
7.90%
0.00%
0.10%
0.60%
0.00%
0.00%
0.50%
0.00%
0.20%
3.00%
4.00%
0.10%
0.20%
0.30%
3.70%
0.00%
0.80%
1.00%
2.40%
0.90%
1.60%
100.00%
98.70%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
99
100
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
27
21
23
3
3
152
4
5
36
65
9
185
253
7
152
25
50
23
51
501
12
48
11
83
3
0
43
23
3
176
41
3
45
3
0
124
0
14
137
69
6
27
23
198
1
40
65
126
50
120
3093
3010
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
3
0
0
1
0
0
0
8
14
0
3
0
0
2
0
0
17
18
12
0
82
82
-4
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
1
13
0
0
1
0
4
0
0
8
8
11
1
53
51
5-
-9
-14
0
0
1
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
1
0
0
2
0
0
0
2
0
0
0
0
0
0
0
6
1
0
3
3
6
0
1
7
5
6
2
59
58
10-19
0
1
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
1
2
0
0
1
0
0
0
5
1
0
0
0
0
0
0
5
4
0
5
3
9
0
0
3
6
4
3
64
62
15-24
0
0
0
1
0
1
1
0
0
0
0
0
0
1
1
1
0
0
0
0
2
2
4
2
1
0
0
5
1
0
0
10
0
0
0
0
0
0
0
5
2
0
2
4
14
0
0
6
16
0
2
84
83
20-29
0
0
1
1
0
0
4
0
0
0
1
0
1
4
0
2
0
0
0
0
7
2
5
0
3
0
0
3
0
0
0
5
0
0
0
0
1
0
0
4
3
0
1
0
10
0
0
4
11
3
4
80
77
25-34
0
2
1
2
1
0
8
0
0
0
2
1
4
10
0
7
0
1
0
0
9
0
0
0
2
0
0
5
4
0
0
4
0
0
0
0
0
0
1
11
3
0
2
2
8
0
0
0
3
0
3
96
94
30-39
0
0
1
2
0
0
11
0
1
0
2
0
10
8
0
3
0
0
4
1
15
1
1
2
5
0
0
0
0
0
0
3
0
2
0
0
1
0
0
12
4
0
2
1
7
0
1
1
10
1
5
117
112
35-44
0
3
2
2
0
0
16
0
0
1
3
1
14
13
1
7
1
4
2
1
22
0
1
0
5
0
0
4
2
0
1
3
0
3
0
0
4
0
1
8
6
0
2
2
19
0
4
5
9
2
8
182
177
40-49
1
4
2
1
1
0
24
0
0
1
11
1
20
24
1
19
3
4
2
3
47
1
0
0
7
0
0
4
6
0
3
2
0
4
0
0
11
0
1
12
4
0
1
2
16
0
6
3
8
1
15
276
269
45-
Incidence Rates Male (Malay)
-54
0
7
4
3
1
0
20
0
1
6
8
0
28
24
2
20
3
8
3
7
62
2
4
3
9
0
0
1
3
1
10
1
0
8
1
0
9
0
0
10
5
0
3
2
14
0
5
2
6
5
10
321
312
50-59
0
2
0
1
0
0
14
0
1
4
6
4
28
34
0
24
4
3
2
11
69
0
5
2
6
0
0
3
3
0
14
1
0
3
0
0
18
0
0
16
9
0
2
2
24
0
7
4
7
0
15
348
342
55-64
0
3
2
5
0
0
23
1
1
7
2
1
24
46
1
24
1
11
6
5
68
1
4
0
8
0
0
5
1
1
21
0
0
12
0
0
20
0
0
4
5
1
2
0
24
0
6
1
8
0
14
369
361
60-
Appendix 17: Cancer Incidence, Malay Male, Malaysia 2007
-69
1
2
1
1
0
0
11
1
0
3
10
0
15
41
0
11
5
12
2
7
65
1
0
1
11
1
0
5
1
1
33
1
1
7
0
0
14
0
0
2
13
1
1
1
16
0
6
3
4
0
9
321
310
65-74
0
1
2
2
0
0
7
1
0
7
6
1
16
19
0
13
5
0
2
8
71
0
3
0
10
1
0
2
1
0
52
0
0
1
1
0
22
0
0
11
5
1
0
0
7
0
1
0
3
0
18
300
290
70-
2
2
4
2
0
1
6
1
0
7
14
0
25
29
1
20
3
6
0
8
64
2
2
0
11
1
0
2
1
0
42
0
1
5
0
0
24
0
2
4
5
0
0
1
18
1
3
1
4
5
11
341
330
75+
0.10%
0.90%
0.70%
0.70%
0.10%
0.10%
4.90%
0.10%
0.20%
1.20%
2.10%
0.30%
6.00%
8.20%
0.20%
4.90%
0.80%
1.60%
0.70%
1.60%
16.20%
0.40%
1.60%
0.40%
2.70%
0.10%
0.00%
1.40%
0.70%
0.10%
5.70%
1.30%
0.10%
1.50%
0.10%
0.00%
4.00%
0.00%
0.50%
4.40%
2.20%
0.20%
0.90%
0.70%
6.40%
0.00%
1.30%
2.10%
4.10%
1.60%
3.90%
100.00%
97.30%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
35
18
17
5
1
70
3
1
27
55
3
174
178
8
69
18
47
12
7
201
5
39
14
53
0
0
35
1432
3
10
282
195
47
336
2
6
25
1
0
20
1
10
128
169
4
9
14
158
0
35
42
103
39
68
4238
4185
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0.7
0
0
0
0
0.1
0.9
0
0.1
0
0
0.2
0
0
1.2
0.7
1.4
0
6
6
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.3
0
0
0
0
0.3
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
1.5
0
0
0
0
0.3
0
0
0.5
0.1
0.4
0.1
4
4
5-
-9
-14
0.1
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0.5
0
0
0
0
0.1
0.1
0
0
0
0
0
0.9
0
0
0.1
0
0
0
0
0.1
1.4
0
0
0
0
0.5
0
0
0.8
0.7
1.1
0.1
7
7
10-19
0
0
0
0.1
0
0
0.6
0
0
0
0.4
0
0
0.1
0
0
0
0
0
0
0
0
1.4
0
0.4
0
0
0.6
0.8
0
0
0
0.1
0
1.8
0
0
0
0
0
0
0
0.1
1.1
0.8
0
0
0.4
0.8
0
0
1.1
0.8
0.1
0.1
12
12
15-24
0
0
0
0.2
0
0
0.5
0
0
0
0
0
0.5
0.3
0
0
0
0.2
0.2
0
0.5
0
0.6
0
0.2
0
0
0.2
1.8
0
0
0
0
0.2
1.8
0
0
0.2
0
0
0
0
0
0.9
1.5
0
0
0.6
2
0
0
0.3
1.4
0.3
0.5
14
14
20-29
0
0.2
0
0.2
0
0
0.4
0
0
0
0
0
0.6
0.4
0
0.2
0
0
0
0
0
0
0.2
0
0.4
0
0
0.2
7
0
0
0.6
0.4
0.4
3.3
0
0
0
0.2
0
0
0
0.2
1.1
3.5
0
0
0.6
2.2
0
0
0
0.7
0.4
0.6
24
23
25-34
0
0.9
0.4
0.2
0
0
0.7
0
0.2
0
0.2
0
1.1
1.3
0
0.4
0
0.2
0
0
0.9
0.2
0.4
0
0.2
0
0
0.4
16.1
0
0
2
2.5
0.2
2.7
0.2
0
0.2
0
0
0
0
0.4
1.3
1.8
0
0
0
2.5
0
0
0
1.3
0
0.4
40
40
30-39
0
0.2
0
0.2
0
0
1.2
0
0
0.2
0.5
0
1.6
0.9
0.2
0.7
0
0.5
0.9
0
1.4
0
0.2
0
0.2
0
0
0.2
33
0.2
0
5.9
2.4
0.9
4.5
0
0.5
0.2
0
0
0.2
0
0.2
3.1
4.9
0
0.2
0
0.9
0
0.2
0.2
1.9
0.7
0
70
70
35-44
0
0.5
0
0.3
0
0
2
0
0
0
1.5
0.3
3.5
3.3
0
0.5
0
1
0
0
1.8
0
0.8
1.3
1.3
0
0
1.8
58.3
0
0.8
11.3
6.3
1.5
8
0
0.3
0
0
0
0.5
0
0
2.3
3.5
0
0.8
0.3
3.3
0
1.3
1
1.5
0.3
1
122
120
40-49
0
1.4
0
0.3
0
0
2
0
0
0
1.7
0
4.9
4.3
0.3
2.9
0.3
1.2
0
0.3
6.3
0
0.9
0.3
0.9
0
0
0.6
92.7
0
0.3
11.5
8.3
2.6
16.1
0
0.3
0.3
0
0
0.6
0
0
2.6
6.9
0
0.6
0
5.2
0
0.6
0
3.5
0.6
2.3
183
182
45-
Incidence Rates Malay Female
-54
0
1
0.7
0.7
0
0
2.7
0.3
0
1.4
1.7
0.3
8.6
7.5
0
1.7
1
0.7
0.3
0
8.9
0
0.7
0
0.7
0
0
1.4
75.3
0
0.7
14
12.7
3.4
21.9
0
0.3
1.4
0
0
1
0
0
4.8
6.2
0.3
0.3
0.3
6.2
0
2.4
1
2.4
0.3
1.7
197
197
50-59
0.5
1.9
0.5
0.9
0.5
0
6.5
0
0
0.9
3.2
0
11.6
9.7
0.5
7.9
0.9
2.8
1.4
0
10.7
0
0.9
0.5
2.8
0
0
0.5
80.7
0
0.9
23.7
16.2
3.7
17.2
0
0
0.9
0
0
1.4
0
0
1.9
6.5
0
0.9
0.9
6.5
0
3.2
0
7.9
0
3.7
241
238
55-64
0
2.7
0.7
0
0
0
4.7
0
0
3.4
2.7
0
16.2
12.1
1.3
5.4
2.7
8.1
0
0
18.2
0
0.7
0.7
4
0
0
0
63.3
0
0.7
18.2
14.8
1.3
14.1
0.7
0.7
1.3
0
0
1.3
0.7
0.7
5.4
8.8
0.7
0
0
6.1
0
2
0.7
4.7
1.3
6.1
237
233
60-
Appendix 18: Cancer Incidence, Malay Female, Malaysia 2007
-69
0
3.6
3.6
0
0
0
5.4
0
0
4.5
11.7
0.9
10.8
25.2
0
8.1
1.8
5.4
0.9
1.8
32.3
1.8
0.9
2.7
5.4
0
0
3.6
57.5
0
0.9
14.4
8.1
0.9
20.7
0
0
1.8
0
0
2.7
0
0.9
5.4
12.6
0
0
0
9.9
0
3.6
0.9
3.6
1.8
9
285
279
65-74
1.3
1.3
3.8
1.3
1.3
0
1.3
0
0
5.1
3.8
0
30.6
24.2
0
7.6
2.5
5.1
0
2.5
35.6
1.3
1.3
1.3
7.6
0
0
1.3
39.5
1.3
0
16.6
10.2
2.5
16.6
0
0
2.5
0
0
2.5
0
1.3
7.6
8.9
0
0
0
14
0
3.8
1.3
1.3
0
6.4
276
269
70-
1.2
7.1
5.9
5.9
3.5
1.2
2.4
2.4
0
7.1
5.9
0
16.5
31.9
3.5
7.1
4.7
5.9
2.4
2.4
22.4
0
0
2.4
13
0
0
1.2
30.7
1.2
0
14.2
7.1
1.2
9.5
0
0
2.4
0
0
2.4
0
0
3.5
1.2
1.2
0
0
11.8
0
3.5
1.2
4.7
0
9.5
261
248
75+
0.1
0.5
0.3
0.2
0.1
0
1
0
0
0.4
0.8
0
2.6
2.6
0.1
1
0.3
0.7
0.2
0.1
2.9
0.1
0.6
0.2
0.8
0
0
0.5
21
0
0.1
4.1
2.9
0.7
4.9
0
0.1
0.4
0
0
0.3
0
0.1
1.9
2.5
0.1
0.1
0.2
2.3
0
0.5
0.6
1.5
0.6
1
62.1
61.4
Total
% of
0.1
0.7
0.4
0.3
0.1
0
1.3
0.1
0
0.6
1.1
0.1
3.6
3.8
0.2
1.4
0.4
1
0.2
0.2
4.4
0.1
0.6
0.3
1.1
0
0
0.6
25.5
0.1
0.2
5.3
3.7
0.8
6
0
0.1
0.5
0
0
0.4
0
0.2
2.1
3
0.1
0.1
0.2
2.8
0
0.7
0.6
1.7
0.6
1.4
79
77.9
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
101
102
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
41
17
20
6
5
389
15
2
64
179
15
337
287
7
215
20
78
21
87
652
9
27
10
125
2
2
19
23
7
264
22
1
86
6
2
85
8
3
84
33
1
7
9
127
0
13
34
59
10
111
3650
3525
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
1
3
0
0
0
0
1
0
0
8
1
3
2
23
23
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
1
0
1
0
0
0
0
0
2
1
1
0
1
0
0
0
1
2
1
0
13
12
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
3
0
0
7
7
0
0
24
24
10-19
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
1
0
0
0
2
0
0
0
1
0
0
0
0
1
0
0
1
0
0
0
1
2
0
0
2
1
0
2
19
19
15-24
0
1
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
3
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
2
2
0
1
0
4
0
0
2
2
0
0
22
21
20-29
0
0
0
1
0
0
7
0
0
0
1
1
0
1
0
0
0
0
0
0
2
0
1
0
2
0
0
1
0
0
0
5
1
0
0
0
1
0
0
2
0
0
0
1
7
0
0
0
3
1
1
39
37
25-34
0
4
0
1
0
0
20
0
0
1
2
0
2
2
0
3
0
0
0
1
5
0
2
0
2
0
0
1
0
0
0
2
0
2
0
0
3
0
0
5
2
0
0
0
3
0
0
3
3
0
2
71
69
30-39
0
1
0
0
0
0
30
0
0
1
4
1
4
5
0
4
0
2
0
1
3
0
1
0
4
0
0
1
3
0
0
3
0
5
0
0
1
0
0
3
3
0
0
1
7
0
1
1
5
0
3
98
94
35-44
1
0
1
1
0
0
35
0
0
0
7
1
13
9
0
12
2
2
2
4
13
1
0
1
1
0
2
2
3
0
0
3
0
4
0
0
3
0
0
6
1
0
0
3
6
0
0
1
1
1
3
145
144
40-49
1
3
5
3
0
0
60
0
0
3
10
2
15
19
0
18
1
6
4
7
27
0
2
1
5
0
0
1
2
0
2
0
0
9
1
0
4
1
0
3
6
0
0
0
12
0
0
0
2
1
5
241
236
45-
Number Of Cases Male Chinese
-54
0
5
1
3
1
0
69
2
0
1
10
1
32
29
1
23
1
5
5
4
60
1
0
2
10
1
0
4
6
1
7
4
0
13
0
0
5
0
0
12
4
0
1
1
8
0
2
0
9
0
9
353
343
50-59
0
3
3
4
1
0
60
0
0
13
24
2
50
46
1
40
4
11
2
11
72
1
3
1
5
0
0
1
1
2
19
0
0
17
1
0
8
0
0
13
4
0
2
0
21
0
4
4
5
1
16
476
471
55-64
0
8
2
2
0
1
39
4
2
7
22
2
42
54
1
30
1
20
3
9
97
2
1
0
17
0
0
1
3
1
41
0
0
15
0
0
11
3
0
7
3
0
0
0
13
0
1
0
5
0
11
481
464
60-
Appendix 19: Number of new cases, Chinese Male, Malaysia 2007
-69
0
9
2
2
1
0
45
3
0
12
31
4
63
48
2
42
5
15
3
22
132
2
2
3
20
0
0
5
2
1
65
1
0
5
3
1
11
2
0
9
6
0
1
0
21
0
3
1
5
1
28
639
619
65-74
2
4
0
2
3
2
12
2
0
12
33
1
57
29
2
23
3
4
0
13
112
1
2
0
22
0
0
0
1
0
56
0
0
9
1
1
17
0
0
6
0
0
2
1
7
0
1
4
6
0
11
464
442
70-
0
3
3
1
0
2
9
4
0
14
35
0
59
44
0
19
3
13
2
15
127
1
3
1
35
1
0
0
2
2
74
0
0
4
0
0
20
2
2
7
1
0
0
0
12
0
1
0
2
1
18
542
507
75+
0.10%
1.10%
0.50%
0.50%
0.20%
0.10%
10.70%
0.40%
0.10%
1.80%
4.90%
0.40%
9.20%
7.90%
0.20%
5.90%
0.50%
2.10%
0.60%
2.40%
17.90%
0.20%
0.70%
0.30%
3.40%
0.10%
0.10%
0.50%
0.60%
0.20%
7.20%
0.60%
0.00%
2.40%
0.20%
0.10%
2.30%
0.20%
0.10%
2.30%
0.90%
0.00%
0.20%
0.20%
3.50%
0.00%
0.40%
0.90%
1.60%
0.30%
3.00%
100.00%
96.60%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
2
15
15
12
5
2
123
3
0
18
138
9
322
182
6
69
21
65
13
6
273
10
23
11
79
0
0
22
1343
9
10
330
160
26
201
1
0
28
1
1
41
3
2
58
76
3
3
8
93
0
8
21
35
7
78
3990
3911
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
3
0
1
0
0
0
0
0
4
2
0
2
16
16
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
0
0
2
0
0
3
0
0
0
11
11
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
0
0
1
0
0
1
2
0
1
9
8
10-19
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
1
0
0
0
0
0
0
6
0
0
0
0
0
0
0
0
3
5
0
1
1
5
0
0
0
0
1
1
29
29
15-24
0
0
1
1
0
0
4
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
3
0
0
0
2
0
0
1
0
0
2
0
0
0
0
0
0
0
0
3
2
0
0
2
2
0
0
1
2
0
1
29
26
20-29
0
0
0
0
0
0
5
0
0
0
2
0
3
1
0
0
0
2
0
0
4
0
0
0
0
0
0
2
14
0
0
4
2
0
4
0
0
0
0
0
0
0
0
1
12
0
0
2
3
0
0
1
2
0
1
65
65
25-34
0
0
0
0
0
0
8
0
0
0
1
0
4
1
0
1
0
1
1
0
1
0
1
0
1
0
0
1
46
0
0
7
2
0
6
0
0
1
0
0
0
0
0
0
5
0
0
0
0
0
0
1
2
0
0
91
90
30-39
0
1
1
1
0
0
7
0
0
0
4
0
11
1
0
2
0
0
1
0
6
0
0
1
2
0
0
1
81
0
0
24
8
0
11
0
0
1
0
0
1
0
0
3
3
0
1
0
7
0
0
1
3
0
1
184
182
35-44
0
1
0
1
0
0
19
0
0
0
5
0
12
9
0
2
1
1
1
0
13
0
1
1
1
0
0
2
137
0
0
29
8
1
22
0
0
1
0
0
2
0
0
5
9
0
0
1
4
0
0
1
2
3
6
301
300
40-49
0
0
0
1
0
0
15
0
0
1
8
1
18
14
0
6
0
4
2
2
21
1
4
0
5
0
0
2
245
2
0
51
21
8
36
1
0
2
0
0
1
0
0
3
8
0
0
0
3
0
0
4
1
0
5
496
491
45-
Number Of Cases Chinese Female
-54
1
4
2
1
2
0
21
1
0
2
7
3
20
15
1
2
1
8
2
1
25
2
2
0
4
0
0
0
230
0
1
34
25
8
35
0
0
1
0
0
2
1
0
6
6
1
0
0
10
0
1
0
6
0
8
502
498
50-59
0
2
1
3
1
0
17
0
0
3
11
2
44
17
1
7
3
9
1
0
27
3
3
3
5
0
0
5
215
0
1
45
35
2
21
0
0
4
0
0
3
0
0
5
12
0
0
0
5
0
2
0
4
1
15
538
533
55-64
0
0
1
0
1
0
10
2
0
2
17
0
27
21
0
14
5
11
1
0
44
2
1
1
6
0
0
3
133
1
0
36
19
4
20
0
0
4
0
0
5
2
0
8
3
0
1
0
12
0
2
3
3
0
9
434
428
60-
Appendix 20: Number of new cases, Chinese Female, Malaysia 2007
-69
0
1
1
0
1
0
8
0
0
2
17
0
56
29
1
7
2
13
2
1
40
0
3
1
13
0
0
3
115
1
2
38
16
0
19
0
0
2
0
1
8
0
1
7
5
0
0
1
12
0
1
0
2
1
7
440
427
65-74
0
3
2
3
0
2
4
0
0
0
26
0
50
35
1
9
4
7
1
2
41
0
1
2
11
0
0
2
60
1
3
31
9
0
11
0
0
6
0
0
7
0
0
3
3
0
0
0
11
0
2
1
3
1
6
364
353
70-
1
3
6
1
0
0
4
0
0
8
39
2
77
39
2
16
5
8
1
0
51
2
5
1
27
0
0
0
65
4
3
30
15
3
7
0
0
6
1
0
12
0
0
1
3
0
0
1
16
0
0
0
1
0
15
481
454
75+
0.10%
0.40%
0.40%
0.30%
0.10%
0.10%
3.10%
0.10%
0.00%
0.50%
3.50%
0.20%
8.10%
4.60%
0.20%
1.70%
0.50%
1.60%
0.30%
0.20%
6.80%
0.30%
0.60%
0.30%
2.00%
0.00%
0.00%
0.60%
33.70%
0.20%
0.30%
8.30%
4.00%
0.70%
5.00%
0.00%
0.00%
0.70%
0.00%
0.00%
1.00%
0.10%
0.10%
1.50%
1.90%
0.10%
0.10%
0.20%
2.30%
0.00%
0.20%
0.50%
0.90%
0.20%
2.00%
100.00%
98.00%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
103
104
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
4
41
17
20
6
5
389
15
2
64
179
15
337
287
7
215
20
78
21
87
652
9
27
10
125
2
2
19
23
7
264
22
1
86
6
2
85
8
3
84
33
1
7
9
127
0
13
34
59
10
111
3650
3525
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0.7
0
0
0
0
0.4
1.1
0
0
0
0
0.4
0
0
3
0.4
1.1
0.7
8
8
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0.4
0
0
0
0
0
0
0.4
0
0.4
0
0
0
0
0
0.7
0.4
0.4
0
0.4
0
0
0
0.4
0.7
0.4
0
5
4
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
1.1
0
0
2.6
2.6
0
0
9
9
10-19
0
0
0
0
0
0
0.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0.7
0.4
0
0
0
0.7
0
0
0
0.4
0
0
0
0
0.4
0
0
0.4
0
0
0
0.4
0.7
0
0
0.7
0.4
0
0.7
7
7
15-24
0
0.4
0
0
0
0
0.4
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0.4
0
1.1
0
0.4
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0.8
0.8
0
0.4
0
1.5
0
0
0.8
0.8
0
0
8
8
20-29
0
0
0
0.4
0
0
2.9
0
0
0
0.4
0.4
0
0.4
0
0
0
0
0
0
0.8
0
0.4
0
0.8
0
0
0.4
0
0
0
2
0.4
0
0
0
0.4
0
0
0.8
0
0
0
0.4
2.9
0
0
0
1.2
0.4
0.4
16
15
25-34
0
1.7
0
0.4
0
0
8.6
0
0
0.4
0.9
0
0.9
0.9
0
1.3
0
0
0
0.4
2.2
0
0.9
0
0.9
0
0
0.4
0
0
0
0.9
0
0.9
0
0
1.3
0
0
2.2
0.9
0
0
0
1.3
0
0
1.3
1.3
0
0.9
31
30
30-39
0
0.4
0
0
0
0
13
0
0
0.4
1.7
0.4
1.7
2.2
0
1.7
0
0.9
0
0.4
1.3
0
0.4
0
1.7
0
0
0.4
1.3
0
0
1.3
0
2.2
0
0
0.4
0
0
1.3
1.3
0
0
0.4
3
0
0.4
0.4
2.2
0
1.3
42
41
35-44
0.4
0
0.4
0.4
0
0
15.4
0
0
0
3.1
0.4
5.7
4
0
5.3
0.9
0.9
0.9
1.8
5.7
0.4
0
0.4
0.4
0
0.9
0.9
1.3
0
0
1.3
0
1.8
0
0
1.3
0
0
2.6
0.4
0
0
1.3
2.6
0
0
0.4
0.4
0.4
1.3
64
63
40-49
0.5
1.4
2.3
1.4
0
0
27.3
0
0
1.4
4.5
0.9
6.8
8.6
0
8.2
0.5
2.7
1.8
3.2
12.3
0
0.9
0.5
2.3
0
0
0.5
0.9
0
0.9
0
0
4.1
0.5
0
1.8
0.5
0
1.4
2.7
0
0
0
5.5
0
0
0
0.9
0.5
2.3
110
107
45-
Incidence Rates Chinese Male
-54
0
2.5
0.5
1.5
0.5
0
34.1
1
0
0.5
4.9
0.5
15.8
14.3
0.5
11.4
0.5
2.5
2.5
2
29.6
0.5
0
1
4.9
0.5
0
2
3
0.5
3.5
2
0
6.4
0
0
2.5
0
0
5.9
2
0
0.5
0.5
4
0
1
0
4.4
0
4.4
174
169
50-59
0
1.8
1.8
2.4
0.6
0
36.7
0
0
8
14.7
1.2
30.6
28.2
0.6
24.5
2.4
6.7
1.2
6.7
44.1
0.6
1.8
0.6
3.1
0
0
0.6
0.6
1.2
11.6
0
0
10.4
0.6
0
4.9
0
0
8
2.4
0
1.2
0
12.9
0
2.4
2.4
3.1
0.6
9.8
291
288
55-64
0
6.5
1.6
1.6
0
0.8
31.7
3.3
1.6
5.7
17.9
1.6
34.2
43.9
0.8
24.4
0.8
16.3
2.4
7.3
78.9
1.6
0.8
0
13.8
0
0
0.8
2.4
0.8
33.4
0
0
12.2
0
0
8.9
2.4
0
5.7
2.4
0
0
0
10.6
0
0.8
0
4.1
0
8.9
391
377
60-
Appendix 21: Cancer Incidence, Chinese Male, Malaysia 2007
-69
0
10.2
2.3
2.3
1.1
0
50.8
3.4
0
13.5
35
4.5
71.1
54.2
2.3
47.4
5.6
16.9
3.4
24.8
148.9
2.3
2.3
3.4
22.6
0
0
5.6
2.3
1.1
73.3
1.1
0
5.6
3.4
1.1
12.4
2.3
0
10.2
6.8
0
1.1
0
23.7
0
3.4
1.1
5.6
1.1
31.6
721
698
65-74
3.5
6.9
0
3.5
5.2
3.5
20.8
3.5
0
20.8
57.3
1.7
99
50.4
3.5
40
5.2
6.9
0
22.6
194.6
1.7
3.5
0
38.2
0
0
0
1.7
0
97.3
0
0
15.6
1.7
1.7
29.5
0
0
10.4
0
0
3.5
1.7
12.2
0
1.7
6.9
10.4
0
19.1
806
768
70-
0
5.1
5.1
1.7
0
3.4
15.4
6.8
0
23.9
59.8
0
100.8
75.1
0
32.4
5.1
22.2
3.4
25.6
216.9
1.7
5.1
1.7
59.8
1.7
0
0
3.4
3.4
126.4
0
0
6.8
0
0
34.2
3.4
3.4
12
1.7
0
0
0
20.5
0
1.7
0
3.4
1.7
30.7
926
866
75+
0.1
1.3
0.5
0.6
0.2
0.2
12.1
0.5
0.1
2
5.6
0.5
10.5
8.9
0.2
6.7
0.6
2.4
0.7
2.7
20.3
0.3
0.8
0.3
3.9
0.1
0.1
0.6
0.7
0.2
8.2
0.7
0
2.7
0.2
0.1
2.7
0.2
0.1
2.6
1
0
0.2
0.3
4
0
0.4
1.1
1.8
0.3
3.5
113.8
109.9
Total
% of
0.1
1.2
0.5
0.6
0.2
0.2
10.9
0.5
0.1
2
5.6
0.4
10.4
8.7
0.2
6.4
0.6
2.4
0.6
2.7
20.5
0.3
0.8
0.3
4
0.1
0.1
0.6
0.7
0.2
8.7
0.6
0
2.5
0.2
0.1
2.7
0.3
0.1
2.5
0.9
0
0.2
0.3
3.8
0
0.4
1.1
1.8
0.3
3.5
111.9
107.9
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
2
15
15
12
5
2
123
3
0
18
138
9
322
182
6
69
21
65
13
6
273
10
23
11
79
0
0
22
1343
9
10
330
160
26
201
1
0
28
1
1
41
3
2
58
76
3
3
8
93
0
8
21
35
7
78
3990
3911
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0.4
1.2
0
0.4
0
0
0
0
0
1.6
0.8
0
0.8
6
6
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.9
0
0
0
0
0.8
0
0
1.1
0
0
0
4
4
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.8
0
0.4
0
0
0.4
0
0
0.4
0.8
0
0.4
4
3
10-19
0
0
0
0
0
0
0.4
0
0
0
0.4
0
0
0
0
0
0
0.4
0
0
0
0
0.4
0.4
0
0
0
0.4
0
0
0
0
0
0
2.4
0
0
0
0
0
0
0
0
1.2
2
0
0.4
0.4
2
0
0
0
0
0.4
0.4
12
12
15-24
0
0
0.4
0.4
0
0
1.6
0
0
0
0
0.4
0
0
0
0.4
0
0
0
0
0
0
0
0
1.2
0
0
0
0.8
0
0
0.4
0
0
0.8
0
0
0
0
0
0
0
0
1.2
0.8
0
0
0.8
0.8
0
0
0.4
0.8
0
0.4
12
10
20-29
0
0
0
0
0
0
2.1
0
0
0
0.9
0
1.3
0.4
0
0
0
0.9
0
0
1.7
0
0
0
0
0
0
0.9
6
0
0
1.7
0.9
0
1.7
0
0
0
0
0
0
0
0
0.4
5.1
0
0
0.9
1.3
0
0
0.4
0.9
0
0.4
28
28
25-34
0
0
0
0
0
0
3.6
0
0
0
0.4
0
1.8
0.4
0
0.4
0
0.4
0.4
0
0.4
0
0.4
0
0.4
0
0
0.4
20.5
0
0
3.1
0.9
0
2.7
0
0
0.4
0
0
0
0
0
0
2.2
0
0
0
0
0
0
0.4
0.9
0
0
41
40
30-39
0
0.4
0.4
0.4
0
0
3.1
0
0
0
1.8
0
4.9
0.4
0
0.9
0
0
0.4
0
2.7
0
0
0.4
0.9
0
0
0.4
35.8
0
0
10.6
3.5
0
4.9
0
0
0.4
0
0
0.4
0
0
1.3
1.3
0
0.4
0
3.1
0
0
0.4
1.3
0
0.4
81
80
35-44
0
0.4
0
0.4
0
0
8.5
0
0
0
2.2
0
5.4
4
0
0.9
0.4
0.4
0.4
0
5.8
0
0.4
0.4
0.4
0
0
0.9
61.4
0
0
13
3.6
0.4
9.9
0
0
0.4
0
0
0.9
0
0
2.2
4
0
0
0.4
1.8
0
0
0.4
0.9
1.3
2.7
135
134
40-49
0
0
0
0.5
0
0
7.1
0
0
0.5
3.8
0.5
8.5
6.6
0
2.8
0
1.9
0.9
0.9
9.9
0.5
1.9
0
2.4
0
0
0.9
115.9
0.9
0
24.1
9.9
3.8
17
0.5
0
0.9
0
0
0.5
0
0
1.4
3.8
0
0
0
1.4
0
0
1.9
0.5
0
2.4
235
232
45-
Incidence Rates Chinese Female
-54
0.5
2.1
1
0.5
1
0
11
0.5
0
1
3.7
1.6
10.4
7.8
0.5
1
0.5
4.2
1
0.5
13.1
1
1
0
2.1
0
0
0
120.1
0
0.5
17.7
13.1
4.2
18.3
0
0
0.5
0
0
1
0.5
0
3.1
3.1
0.5
0
0
5.2
0
0.5
0
3.1
0
4.2
262
260
50-59
0
1.3
0.7
2
0.7
0
11.2
0
0
2
7.2
1.3
28.9
11.2
0.7
4.6
2
5.9
0.7
0
17.7
2
2
2
3.3
0
0
3.3
141.2
0
0.7
29.5
23
1.3
13.8
0
0
2.6
0
0
2
0
0
3.3
7.9
0
0
0
3.3
0
1.3
0
2.6
0.7
9.8
353
350
55-64
0
0
0.9
0
0.9
0
8.7
1.7
0
1.7
14.9
0
23.6
18.4
0
12.2
4.4
9.6
0.9
0
38.5
1.7
0.9
0.9
5.2
0
0
2.6
116.2
0.9
0
31.5
16.6
3.5
17.5
0
0
3.5
0
0
4.4
1.7
0
7
2.6
0
0.9
0
10.5
0
1.7
2.6
2.6
0
7.9
379
374
60-
Appendix 22: Cancer Incidence, Chinese Female, Malaysia 2007
-69
0
1.1
1.1
0
1.1
0
9
0
0
2.2
19.1
0
63
32.6
1.1
7.9
2.2
14.6
2.2
1.1
45
0
3.4
1.1
14.6
0
0
3.4
129.3
1.1
2.2
42.7
18
0
21.4
0
0
2.2
0
1.1
9
0
1.1
7.9
5.6
0
0
1.1
13.5
0
1.1
0
2.2
1.1
7.9
495
480
65-74
0
4.6
3.1
4.6
0
3.1
6.1
0
0
0
40
0
76.9
53.8
1.5
13.8
6.1
10.8
1.5
3.1
63
0
1.5
3.1
16.9
0
0
3.1
92.2
1.5
4.6
47.7
13.8
0
16.9
0
0
9.2
0
0
10.8
0
0
4.6
4.6
0
0
0
16.9
0
3.1
1.5
4.6
1.5
9.2
560
543
70-
1.2
3.5
7.1
1.2
0
0
4.7
0
0
9.4
45.9
2.4
90.7
45.9
2.4
18.8
5.9
9.4
1.2
0
60
2.4
5.9
1.2
31.8
0
0
0
76.5
4.7
3.5
35.3
17.7
3.5
8.2
0
0
7.1
1.2
0
14.1
0
0
1.2
3.5
0
0
1.2
18.8
0
0
0
1.2
0
17.7
566
534
75+
0.1
0.5
0.5
0.4
0.2
0.1
4
0.1
0
0.6
4.5
0.3
10.5
5.9
0.2
2.2
0.7
2.1
0.4
0.2
8.9
0.3
0.7
0.4
2.6
0
0
0.7
43.7
0.3
0.3
10.7
5.2
0.8
6.5
0
0
0.9
0
0
1.3
0.1
0.1
1.9
2.5
0.1
0.1
0.3
3
0
0.3
0.7
1.1
0.2
2.5
129.7
127.1
Total
% of
0
0.4
0.4
0.3
0.1
0.1
3.5
0.1
0
0.5
4
0.2
9.2
5.3
0.2
2
0.6
1.9
0.4
0.2
8
0.3
0.7
0.3
2.2
0
0
0.7
38.1
0.3
0.3
9.5
4.6
0.7
5.8
0
0
0.8
0
0
1.2
0.1
0.1
1.9
2.2
0.1
0.1
0.3
2.8
0
0.2
0.7
1.1
0.2
2.3
115
112.7
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
105
106
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
0
15
21
3
9
12
9
8
2
17
30
1
30
34
1
15
2
6
3
16
46
1
10
2
7
0
0
0
1
4
31
5
0
5
0
0
21
0
0
22
7
0
2
1
24
0
0
9
16
4
10
462
455
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
1
0
5
5
-4
5-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
1
0
0
0
3
3
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
3
3
10-19
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
3
0
0
1
0
0
1
9
9
15-24
0
1
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
1
2
0
0
11
11
20-29
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
1
0
0
0
1
0
0
0
1
0
1
9
9
25-34
0
0
0
0
0
0
1
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
7
6
30-39
0
2
0
1
0
0
2
0
0
0
0
0
0
1
0
0
0
0
1
0
1
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
5
0
0
0
0
4
0
0
0
1
0
0
21
21
35-44
0
0
0
0
0
2
0
0
0
0
0
0
0
3
0
0
0
0
0
0
1
0
2
0
2
0
0
0
0
0
1
1
0
1
0
0
0
0
0
3
0
0
1
0
0
0
0
0
2
0
0
19
17
40-49
0
2
4
0
3
0
0
2
0
3
2
0
4
1
0
3
0
1
0
0
4
1
2
0
0
0
0
0
1
0
1
0
0
0
0
0
2
0
0
3
2
0
1
0
1
0
0
1
1
1
0
46
46
45-
Number Of Cases Indian Male
-54
0
2
1
1
1
1
1
0
0
0
3
0
4
4
0
0
1
2
0
4
3
0
0
0
2
0
0
0
0
0
2
0
0
2
0
0
4
0
0
2
0
0
0
1
0
0
0
1
3
0
0
45
43
50-59
0
2
2
0
0
3
1
2
0
3
6
0
3
6
0
4
0
0
2
2
10
0
1
0
1
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
2
0
0
0
3
0
0
1
1
0
3
61
60
55-64
0
3
0
1
2
2
2
1
0
3
4
0
3
2
0
2
1
2
0
3
9
0
1
0
0
0
0
0
0
0
4
0
0
1
0
0
1
0
0
1
0
0
0
0
3
0
0
0
2
2
2
57
57
60-
Appendix 23: Number of new cancer cases, Indian Male, Malaysia 2007
-69
0
0
7
0
0
1
1
0
1
5
6
0
5
6
0
0
0
0
0
2
8
0
0
0
0
0
0
0
0
1
2
0
0
1
0
0
6
0
0
0
1
0
0
0
4
0
0
0
0
0
1
58
58
65-74
0
1
2
0
1
3
0
2
1
2
4
0
5
3
1
1
0
1
0
2
3
0
0
1
1
0
0
0
0
0
6
1
0
0
0
0
3
0
0
3
1
0
0
0
0
0
0
0
0
0
0
48
47
70-
0
2
5
0
2
0
0
0
0
1
4
0
4
7
0
3
0
0
0
3
7
0
0
0
0
0
0
0
0
1
14
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
1
0
2
60
60
75+
0.00%
3.20%
4.50%
0.60%
1.90%
2.60%
1.90%
1.70%
0.40%
3.70%
6.50%
0.20%
6.50%
7.40%
0.20%
3.20%
0.40%
1.30%
0.60%
3.50%
10.00%
0.20%
2.20%
0.40%
1.50%
0.00%
0.00%
0.00%
0.20%
0.90%
6.70%
1.10%
0.00%
1.10%
0.00%
0.00%
4.50%
0.00%
0.00%
4.80%
1.50%
0.00%
0.40%
0.20%
5.20%
0.00%
0.00%
1.90%
3.50%
0.90%
2.20%
100.00%
98.50%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
1
20
49
1
4
2
6
3
2
28
26
0
22
26
5
7
5
8
3
5
15
2
4
1
5
0
0
4
297
3
6
85
34
2
48
0
0
2
0
0
4
0
1
13
11
0
4
3
10
0
2
6
17
5
18
825
820
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
2
0
3
3
-4
5-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
2
1
1
2
7
7
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
4
4
10-19
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
3
3
15-24
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
4
0
0
0
0
0
0
0
0
1
0
0
0
1
2
0
0
0
0
0
1
13
13
20-29
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
1
0
1
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
1
1
0
1
11
11
25-34
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
10
0
0
3
1
0
1
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
1
3
1
1
26
26
30-39
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
15
0
1
3
4
0
3
0
0
0
0
0
0
0
0
0
2
0
0
1
0
0
0
0
0
0
0
32
32
35-44
0
2
1
0
1
0
0
0
0
4
2
0
0
3
0
0
0
0
0
0
1
0
2
0
0
0
0
0
34
0
0
6
3
0
9
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
1
0
3
76
76
40-49
0
0
0
0
0
0
0
2
1
0
2
0
0
1
1
1
0
1
0
0
1
0
1
0
0
0
0
1
54
0
1
14
4
0
6
0
0
0
0
0
0
0
0
1
2
0
0
0
0
0
0
0
1
0
0
95
95
45-
Number Of Cases Indian Female
-54
0
4
3
0
0
0
0
0
0
3
4
0
3
5
0
0
0
3
0
0
3
0
0
0
1
0
0
0
55
1
0
13
2
0
10
0
0
0
0
0
0
0
0
1
3
0
2
0
0
0
1
1
3
0
3
124
123
50-59
0
4
4
1
2
0
1
0
0
7
2
0
5
5
3
2
1
1
0
2
2
0
0
0
0
0
0
0
45
1
1
13
7
1
3
0
0
2
0
0
0
0
1
0
0
0
1
0
1
0
1
1
4
0
0
124
124
55-64
0
6
10
0
1
1
2
0
1
4
0
0
4
3
0
0
2
1
0
0
3
0
0
0
0
0
0
1
36
0
0
12
5
0
4
0
0
0
0
0
1
0
0
1
1
0
1
0
0
0
0
0
1
0
0
101
101
60-69
0
1
10
0
0
1
1
0
0
4
6
0
4
3
0
2
0
0
0
0
3
0
0
0
1
0
0
1
14
0
2
7
2
0
4
0
0
0
0
0
0
0
0
1
0
0
0
0
5
0
0
0
0
0
6
78
77
65-
Appendix 24: Number of new cancer cases, Indian Female, Malaysia 2007
-74
0
1
10
0
0
0
1
1
0
3
3
0
2
2
0
0
2
1
2
2
1
0
0
0
0
0
0
0
15
0
0
5
2
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
1
56
56
70-
1
2
10
0
0
0
0
0
0
3
5
0
3
4
1
1
0
1
0
1
1
1
0
1
3
0
0
0
15
1
1
8
3
1
2
0
0
0
0
0
2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
72
69
75+
0.10%
2.40%
5.90%
0.10%
0.50%
0.20%
0.70%
0.40%
0.20%
3.40%
3.20%
0.00%
2.70%
3.20%
0.60%
0.80%
0.60%
1.00%
0.40%
0.60%
1.80%
0.20%
0.50%
0.10%
0.60%
0.00%
0.00%
0.50%
36.00%
0.40%
0.70%
10.30%
4.10%
0.20%
5.80%
0.00%
0.00%
0.20%
0.00%
0.00%
0.50%
0.00%
0.10%
1.60%
1.30%
0.00%
0.50%
0.40%
1.20%
0.00%
0.20%
0.70%
2.10%
0.60%
2.20%
100.00%
99.40%
Total
% of
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
107
108
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Penis
Prostate
Testis
Other male genital
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
0
15
21
3
9
12
9
8
2
17
30
1
30
34
1
15
2
6
3
16
46
1
10
2
7
0
0
0
1
4
31
5
0
5
0
0
21
0
0
22
7
0
2
1
24
0
0
9
16
4
10
462
455
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3.3
0
1.1
0
5
5
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
1.1
0
0
1.1
0
0
0
3
3
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2.2
0
0
3
3
10-19
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
3.4
0
0
1.1
0
0
1.1
10
10
15-24
0
1.2
0
0
0
0
0
0
0
0
0
1.2
1.2
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
2.3
0
0
0
0
0
0
0
1.2
0
0
0
0
1.2
0
0
1.2
2.3
0
0
13
13
20-29
0
0
0
0
0
0
1.3
0
0
0
0
0
1.3
0
0
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.3
0
0
0
0
0
0
0
1.3
1.3
0
0
0
1.3
0
0
0
1.3
0
1.3
11
11
25-34
0
0
0
0
0
0
1.4
0
0
0
1.4
0
0
1.4
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4.2
0
0
0
0
0
0
10
8
30-39
0
2.9
0
1.4
0
0
2.9
0
0
0
0
0
0
1.4
0
0
0
0
1.4
0
1.4
0
0
1.4
0
0
0
0
0
1.4
0
0
0
0
0
0
1.4
0
0
7.2
0
0
0
0
5.8
0
0
0
1.4
0
0
30
30
35-44
0
0
0
0
0
3.1
0
0
0
0
0
0
0
4.6
0
0
0
0
0
0
1.5
0
3.1
0
3.1
0
0
0
0
0
1.5
1.5
0
1.5
0
0
0
0
0
4.6
0
0
1.5
0
0
0
0
0
3.1
0
0
29
26
40-49
0
3.3
6.7
0
5
0
0
3.3
0
5
3.3
0
6.7
1.7
0
5
0
1.7
0
0
6.7
1.7
3.3
0
0
0
0
0
1.7
0
1.7
0
0
0
0
0
3.3
0
0
5
3.3
0
1.7
0
1.7
0
0
1.7
1.7
1.7
0
77
77
45-
Incidence Rates Indian Male
-54
0
3.8
1.9
1.9
1.9
1.9
1.9
0
0
0
5.8
0
7.7
7.7
0
0
1.9
3.8
0
7.7
5.8
0
0
0
3.8
0
0
0
0
0
3.8
0
0
3.8
0
0
7.7
0
0
3.8
0
0
0
1.9
0
0
0
1.9
5.8
0
0
87
83
50-59
0
5.5
5.5
0
0
8.2
2.7
5.5
0
8.2
16.5
0
8.2
16.5
0
11
0
0
5.5
5.5
27.5
0
2.7
0
2.7
0
0
0
0
2.7
2.7
0
0
0
0
0
0
0
0
2.7
5.5
0
0
0
8.2
0
0
2.7
2.7
0
8.2
168
165
55-64
0
13.2
0
4.4
8.8
8.8
8.8
4.4
0
13.2
17.6
0
13.2
8.8
0
8.8
4.4
8.8
0
13.2
39.7
0
4.4
0
0
0
0
0
0
0
17.6
0
0
4.4
0
0
4.4
0
0
4.4
0
0
0
0
13.2
0
0
0
8.8
8.8
8.8
251
251
60-
Appendix 25: Cancer Incidence, Indian Male, Malaysia 2007
-69
0
0
46.1
0
0
6.6
6.6
0
6.6
32.9
39.5
0
32.9
39.5
0
0
0
0
0
13.2
52.7
0
0
0
0
0
0
0
0
6.6
13.2
0
0
6.6
0
0
39.5
0
0
0
6.6
0
0
0
26.3
0
0
0
0
0
6.6
382
382
65-74
0
10.6
21.3
0
10.6
31.9
0
21.3
10.6
21.3
42.6
0
53.2
31.9
10.6
10.6
0
10.6
0
21.3
31.9
0
0
10.6
10.6
0
0
0
0
0
63.9
10.6
0
0
0
0
31.9
0
0
31.9
10.6
0
0
0
0
0
0
0
0
0
0
511
500
70-
0
20.8
52.1
0
20.8
0
0
0
0
10.4
41.7
0
41.7
73
0
31.3
0
0
0
31.3
73
0
0
0
0
0
0
0
0
10.4
145.9
0
0
0
0
0
41.7
0
0
0
0
0
0
0
0
0
0
0
10.4
0
20.8
625
625
75+
0
1.6
2.2
0.3
1
1.3
1
0.9
0.2
1.8
3.2
0.1
3.2
3.6
0.1
1.6
0.2
0.6
0.3
1.7
4.9
0.1
1.1
0.2
0.7
0
0
0
0.1
0.4
3.3
0.5
0
0.5
0
0
2.2
0
0
2.3
0.7
0
0.2
0.1
2.6
0
0
1
1.7
0.4
1.1
49.2
48.4
Total
% of
0
2
3.6
0.4
1.4
1.8
1.1
1.1
0.4
2.8
4.8
0.1
4.7
5.2
0.2
2.2
0.3
0.9
0.3
2.6
7.2
0.1
1.1
0.3
0.8
0
0
0
0.1
0.6
5.8
0.6
0
0.7
0
0
3.5
0
0
2.5
0.9
0
0.2
0.1
3
0
0
1
1.8
0.6
1.5
68.2
67.4
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
Lip
Tongue
Mouth
Salivary glands
Tonsil
Other Oropharynx
Nasopharynx
Hypopharynx
Pharynx unspec.
Oesophagus
Stomach
Small intestine
Colon
Rectum
Anus
Liver
Gallbladder etc.
Pancreas
Nose, sinuses etc.
Larynx
Bone
Melanoma of Skin
Other Skin
Mesothelioma
Kaposi sarcoma
Breast
Vulva
Vagina
Cervix Uteri
Corpus Uteri
Uterus unspec.
Ovary
Placenta
Kidney
Renal Pelvis
Ureter
Bladder
Eye
Thyroid
Adrenal gland
Other Endocrine
Hodgkin disease
Multiple Myeloma
Lymphoid Leukaemia
Myeloid Leukaemia
Leukaemia unspec.
Other & unspecified
All sites Total
All sites but C44
Site
All
1
20
49
1
4
2
6
3
2
28
26
0
22
26
5
7
5
8
3
5
15
2
4
1
5
0
0
4
297
3
6
85
34
2
48
0
0
2
0
0
4
0
1
13
11
0
4
3
10
0
2
6
17
5
18
825
820
Ages
Age
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Unk.
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
0
0
2.3
0
3
3
0-
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.1
0
0
0
0
0
0
0
2.2
1.1
1.1
2.2
8
8
5-
-9
-14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
1.2
0
0
5
5
10-19
0
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.2
1.2
0
4
4
15-24
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0
0
1.2
0
0
1.2
0
0
4.8
0
0
0
0
0
0
0
0
1.2
0
0
0
1.2
2.4
0
0
0
0
0
1.2
16
16
20-29
0
0
0
0
0
0
0
0
0
0
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3.8
0
0
0
1.3
0
1.3
0
0
0
0
0
0
0
0
1.3
0
0
0
1.3
0
0
0
1.3
1.3
0
1.3
14
14
25-34
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
13.5
0
0
4.1
1.4
0
1.4
0
0
0
0
0
0
0
0
4.1
0
0
0
0
0
0
0
1.4
4.1
1.4
1.4
35
35
30-39
0
0
1.4
0
0
0
0
0
0
0
0
0
0
0
0
1.4
0
0
0
0
0
0
0
0
0
0
0
1.4
21.1
0
1.4
4.2
5.6
0
4.2
0
0
0
0
0
0
0
0
0
2.8
0
0
1.4
0
0
0
0
0
0
0
45
45
35-44
0
3
1.5
0
1.5
0
0
0
0
6
3
0
0
4.5
0
0
0
0
0
0
1.5
0
3
0
0
0
0
0
50.9
0
0
9
4.5
0
13.5
0
0
0
0
0
0
0
0
3
3
0
0
0
0
0
0
0
1.5
0
4.5
114
114
40-49
0
0
0
0
0
0
0
3.2
1.6
0
3.2
0
0
1.6
1.6
1.6
0
1.6
0
0
1.6
0
1.6
0
0
0
0
1.6
87.4
0
1.6
22.7
6.5
0
9.7
0
0
0
0
0
0
0
0
1.6
3.2
0
0
0
0
0
0
0
1.6
0
0
154
154
45-
Number Of Cases Indian Female
-54
0
7.4
5.6
0
0
0
0
0
0
5.6
7.4
0
5.6
9.3
0
0
0
5.6
0
0
5.6
0
0
0
1.9
0
0
0
101.9
1.9
0
24.1
3.7
0
18.5
0
0
0
0
0
0
0
0
1.9
5.6
0
3.7
0
0
0
1.9
1.9
5.6
0
5.6
230
228
50-59
0
10.5
10.5
2.6
5.3
0
2.6
0
0
18.4
5.3
0
13.2
13.2
7.9
5.3
2.6
2.6
0
5.3
5.3
0
0
0
0
0
0
0
118.5
2.6
2.6
34.2
18.4
2.6
7.9
0
0
5.3
0
0
0
0
2.6
0
0
0
2.6
0
2.6
0
2.6
2.6
10.5
0
0
327
327
55-64
0
24.9
41.5
0
4.2
4.2
8.3
0
4.2
16.6
0
0
16.6
12.5
0
0
8.3
4.2
0
0
12.5
0
0
0
0
0
0
4.2
149.5
0
0
49.8
20.8
0
16.6
0
0
0
0
0
4.2
0
0
4.2
4.2
0
4.2
0
0
0
0
0
4.2
0
0
419
419
60-
Appendix 26: Cancer Incidence, Indian Female, Malaysia 2007
-69
0
5.5
55.3
0
0
5.5
5.5
0
0
22.1
33.2
0
22.1
16.6
0
11.1
0
0
0
0
16.6
0
0
0
5.5
0
0
5.5
77.4
0
11.1
38.7
11.1
0
22.1
0
0
0
0
0
0
0
0
5.5
0
0
0
0
27.6
0
0
0
0
0
33.2
431
426
65-74
0
7.6
76.4
0
0
0
7.6
7.6
0
22.9
22.9
0
15.3
15.3
0
0
15.3
7.6
15.3
15.3
7.6
0
0
0
0
0
0
0
114.6
0
0
38.2
15.3
0
0
0
0
0
0
0
7.6
0
0
0
0
0
0
0
7.6
0
0
0
0
0
7.6
428
428
70-
8.3
16.5
82.7
0
0
0
0
0
0
24.8
41.4
0
24.8
33.1
8.3
8.3
0
8.3
0
8.3
8.3
8.3
0
8.3
24.8
0
0
0
124.1
8.3
8.3
66.2
24.8
8.3
16.5
0
0
0
0
0
16.5
0
0
0
8.3
0
0
0
0
0
0
0
0
0
0
595
571
75+
0.1
2.1
5.2
0.1
0.4
0.2
0.6
0.3
0.2
3
2.8
0
2.3
2.8
0.5
0.7
0.5
0.8
0.3
0.5
1.6
0.2
0.4
0.1
0.5
0
0
0.4
31.5
0.3
0.6
9
3.6
0.2
5.1
0
0
0.2
0
0
0.4
0
0.1
1.4
1.2
0
0.4
0.3
1.1
0
0.2
0.6
1.8
0.5
1.9
87.5
87
Total
% of
0.2
2.6
7.4
0.1
0.5
0.3
0.9
0.3
0.3
3.7
3.4
0
3
3.3
0.6
0.9
0.7
1
0.4
0.7
2
0.2
0.4
0.2
0.8
0
0
0.5
33.7
0.4
0.8
10.3
4.1
0.3
5.2
0
0
0.2
0
0
0.6
0
0.1
1.4
1.2
0
0.5
0.3
1.4
0
0.2
0.6
1.7
0.6
2.2
99.9
99.1
ICD
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18
C19-C20
C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51
C52
C53
C54
C55
C56
C57
C58
C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81
C82-C85;C96
C88
C90
C91
C92-C94
C95
Other
All
Not C44
(10th)
109
Appendix 27: Morphology of the cancer cases reported and registered at NCR, Malaysia 2007
ICD
Histology
No.
C00 LIP
8000
8070
8010
8020
8200
Neoplasm, malignant
Squamous cell carcinoma, NOS
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Adenoid cystic carcinoma
1
13
1
1
1
17
5.88
76.47
5.88
5.88
5.88
100.00
8020
8000
8001
8032
8051
8073
8075
8140
8560
8980
8810
8010
8070
8071

Neoplasm, malignant
Tumor cells, malignant
Spindle cell carcinoma, NOS
Verrucous carcinoma, NOS
Squamous cell carc.small cell,nonkeratinizing
Squamous cell carcinoma, adenoid
Adenocarcinoma, NOS
Adenosquamous carcinoma
Carcinosarcoma, NOS
Fibrosarcoma, NOS
Carcinoma, NOS
Squamous cell carcinoma, keratinizing, NOS
9
7
2
1
1
1
1
5
1
1
1
14
126
1
171
5.3
4.1
1.2
0.6
0.6
0.6
0.6
2.9
0.6
0.6
0.6
8.2
73.7
0.6
100.0
8000
8010
8020
8041
8070
8071
8072
8076
8200
8140
8430
8480
8720
8920
8550
Neoplasm, malignant
Carcinoma, NOS
Small cell carcinoma, NOS
Squamous cell carc.large cell,nonkeratinizing, NOS
Squamous cell carcinoma, microinvasive
Adenocarcinoma, NOS
Mucoepidermoid carcinoma
Mucinous adenocarcinoma
Malignant melanoma, NOS (except juvenile melanoma)
Oxyphilic adenocarcinoma
Acinar cell carcinoma
5
11
8
1
119
1
1
1
4
7
3
1
1
1
1
165
3.0
6.7
4.8
0.6
72.1
0.6
0.6
0.6
2.4
4.2
1.8
0.6
0.6
0.6
0.6
100.0
8000
8001
8010
8020
8021
8070
8082
8140
8200
8430
8480
8500
8550
8561
8562
8830
Neoplasm, malignant
Carcinoma, NOS
Carcinoma, anaplastic, NOS
Lymphoepithelial carcinoma
Adenocarcinoma, NOS
Infiltrating duct carcinoma, NOS
Adenolymphoma
Epithelial-myoepithelial carcinoma
Malignant fibrous histiocytoma
9
2
9
4
1
11
3
14
6
10
1
1
2
1
1
1
10.6
2.4
10.6
4.7
1.2
12.9
3.5
16.5
7.1
11.8
1.2
1.2
2.4
1.2
1.2
1.2
C01-C02 TONGUE
C03- 06 MOUTH
C07-C08 SALIVARY GLANDS
110
ICD
Histology
No.
8940
8941
8980
8982
Mixed tumor, malignant, NOS

Carcinoma in pleomorphic adenoma
Carcinosarcoma, NOS
Malignant myoepithelioma
2
5
1
1
85
2.4
5.9
1.2
1.2
100.0
8000
8010
8012
8020
8070
8200
Neoplasm, malignant
Carcinoma, NOS
Large cell carcinoma, NOS
1
8
1
5
22
1
38
2.63
21.05
2.63
13.16
57.89
2.63
100.00
8000
8001
8010
8041
8070
8076
8140
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
4
1
5
1
14
1
2
28
14.3
3.6
17.9
3.6
50.0
3.6
7.1
100.0
8000
8001
8010
8020
8032
8050
8070
8071
8072
8073
8075
8082
8120
8121
8140
8200
8230
8260
8800
8851
8900
8980
Neoplasm, malignant
Carcinoma, NOS
Papillary carcinoma, NOS
Transitional cell carcinoma, NOS
Schneiderian carcinoma
Adenocarcinoma, NOS
Solid carcinoma, NOS
Papillary adenocarcinoma, NOS
Sarcoma, NOS
Liposarcoma, well differentiated
Rhabdomyosarcoma, NOS
Carcinosarcoma, NOS
80
2
254
337
1
1
85
18
107
8
1
2
1
1
31
2
1
1
1
2
1
3
940
8.5
0.2
27.0
35.9
0.1
0.1
9.0
1.9
11.4
0.9
0.1
0.2
0.1
0.1
3.3
0.2
0.1
0.1
0.1
0.2
0.1
0.3
100.0
8000
8010
8020
8070
8071
8140
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
1
10
2
34
1
1
49
2.0
20.4
4.1
69.4
2.0
2.0
100.0
C09 TONSIL
C10 OTHER OROPHARYNX
C11 NASOPHARYNX
C12-C13 HYPOPHARYNX
111
ICD
Histology
No.
C14 PHARYNX UNSPEC

8000
8010
8020
8070
8140
8810
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
Fibrosarcoma, NOS
1
1
3
5
2
1
13
7.7
7.7
23.1
38.5
15.4
7.7
100.0
8490
8260
8144
8140
8070
8020
8010
8000
8001
8071
8072
Signet ring cell carcinoma

Adenocarcinoma, intestinal type
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
1
2
1
50
86
10
31
19
2
1
3
206
0.5
1.0
0.5
24.3
41.7
4.9
15.0
9.2
1.0
0.5
1.5
100.0
8153
8890
8800
8440
8490
8480
8260
8145
8144
8140
8050
8020
8010
8000
8001
8002
8003
8012
8042
8500
8936
8941
8510
8070
Gastrinoma, malignant
Leiomyosarcoma, NOS
Sarcoma, NOS
Myxosarcoma
Carcinoma, diffuse type
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Malignant tumor, small cell type
Malignant tumor, giant cell type
Oat cell carcinoma
Gastrointestinal stromal sarcoma
Medullary carcinoma, NOS
2
1
1
1
30
5
1
9
19
364
1
20
75
68
6
2
1
1
1
1
6
1
1
13
630
0.3
0.2
0.2
0.2
4.8
0.8
0.2
1.4
3.0
57.8
0.2
3.2
11.9
10.8
1.0
0.3
0.2
0.2
0.2
0.2
1.0
0.2
0.2
2.1
100.0
8936
8890
8240
8140
8010
8000
8144
8800

Leiomyosarcoma, NOS
Carcinoid tumor, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Sarcoma, NOS
6
1
3
27
3
1
1
1
43
14.0
2.3
7.0
62.8
7.0
2.3
2.3
2.3
100.0
C15 OESOPHAGUS
C16 STOMACH
C17 SMALL INTESTINE
112
ICD
Histology
No.
C18-C21 COLORECTAL
8890
8800
8490
8481
8480
8263
8262
8261
8260
8240
8210
8144
8140
8120
8070
8020
8010
8000
8001
8050
8071
8075
8076
8145
8084
8211
8221
8245
8440
8470
8500
8560
8574
8270
8851
8936
8941
8980
8123
Leiomyosarcoma, NOS
Sarcoma, NOS
Mucin-producing adenocarcinoma
Adenocarcinoma in tubulovillous adenoma
Villous adenocarcinoma
Adenocarcinoma in villous adenoma
Adenocarcinoma in adenomatous polyp
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Carcinoma, diffuse type
Squamous cell carcinoma, clear cell type
Tubular adenocarcinoma
Adenocarcinoma in multiple adenomatous polyps
Adenocarcinoid tumor
Cystadenocarcinoma, NOS
Mucinous cystadenocarcinoma, NOS
Adenocarcinoma,neuroendocrine differentiation
Chromophobe carcinoma
Carcinosarcoma, NOS
Basaloid carcinoma
4
1
4
3
31
3
2
1
12
9
4
4
1627
1
36
80
196
183
7
1
1
1
1
1
2
7
1
1
3
1
1
1
1
4
2
1
1
6
1
2246
0.2
0.0
0.2
0.1
1.4
0.1
0.1
0.0
0.5
0.4
0.2
0.2
72.4
0.0
1.6
3.6
8.7
8.1
0.3
0.0
0.0
0.0
0.0
0.0
0.1
0.3
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.0
0.3
0.0
100.0
9170
8805
8936
8970
8171
8170
8162
8160
8140
8070
8010
8000
8001
8020
8033
8050
8082
8091
Lymphangiosarcoma
Undifferentiated sarcoma
Hepatoblastoma
Hepatocellular carcinoma, fibrolamellar
Hepatocellular carcinoma, NOS
Klatskin tumor
Cholangiocarcinoma
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Pseudosarcomatous carcinoma
Multifocal superficial basal cell carcinoma
1
1
1
4
6
405
8
39
25
2
41
38
4
12
1
2
1
1
0.2
0.2
0.2
0.7
1.0
66.9
1.3
6.4
4.1
0.3
6.8
6.3
0.7
2.0
0.2
0.3
0.2
0.2
C22 LIVER
113
ICD
Histology
No.
8172
8180
8260
8500
8800
Hepatocellular carcinoma, scirrhous

Combined hepatocellular carcinoma / cholangiocarcinoma
Sarcoma, NOS
1
8
2
1
1
605
0.2
1.3
0.3
0.2
0.2
100.0
8000
8001
8010
8020
8140
8160
8260
8480
8500
8560
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
Cholangiocarcinoma
14
1
10
15
36
18
3
2
1
1
101
13.9
1.0
9.9
14.9
35.6
17.8
3.0
2.0
1.0
1.0
100.0
8452
8500
8480
8440
8260
8140
8010
8000
8001
8020
8033
8070
8150
8152
8154
8200
8240
8246
8261
Solid pseudopapillary carcinoma

Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Pseudosarcomatous carcinoma
Islet cell carcinoma
Glucagonoma, malignant
Mixed islet cell and exocrine adenocarcinoma
Neuroendocrine carcinoma, NOS
Adenocarcinoma in villous adenoma
3
5
1
1
2
84
68
80
3
20
2
5
1
1
1
3
1
2
1
284
1.1
1.8
0.4
0.4
0.7
29.6
23.9
28.2
1.1
7.0
0.7
1.8
0.4
0.4
0.4
1.1
0.4
0.7
0.4
100.0
8246
8260
9371
8720
9473
8070
8200
8020
8000
8001
8010
8071
8072
8076
8121
8140
8147
9522

Chondroid chordoma
Primitive neuroectodermal tumor, NOS
Neoplasm, malignant
Carcinoma, NOS
Schneiderian carcinoma
Adenocarcinoma, NOS
Basal cell adenocarcinoma
Olfactory neuroblastoma
2
1
1
1
1
31
3
11
5
1
3
2
1
1
3
9
1
2
79
2.53
1.27
1.27
1.27
1.27
39.24
3.80
13.92
6.33
1.27
3.80
2.53
1.27
1.27
3.80
11.39
1.27
2.53
100.00
C23-C24 GALLBLADDER ETC.
C25 PANCREAS
C30-C31 NOSE, SINUSES ETC.
114
ICD
Histology
No.
Neoplsm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
Sarcoma, NOS
Seminoma, NOS
14
27
7
1
124
1
1
5
1
1
1
183
7.7
14.8
3.8
0.5
67.8
0.5
0.5
2.7
0.5
0.5
0.5
100.0
C33-C34 TRACHEA, BRONCHUS, LUNG

8972
8900
8890
8980
8851
9133
8430
8260
8250
8246
8249
8140
8072
8071
8070
8046
8042
8041
8020
8012
8010
8000
8001
8002
8003
8013
8032
8043
8045
8050
8073
8141
8147
8200
8500
8560
8574
8800
8803
8850
8480
Pulmonary blastoma
Leiomyosarcoma, NOS
Carcinosarcoma, NOS
Epithelioid hemangioendothelioma, malignant
Bronchiolo-alveolar adenocarcinoma, NOS
8A typical carcinoid tumor
Adenocarcinoma, NOS
Non-small cell carcinoma
Oat cell carcinoma
Carcinoma, NOS
Neoplsm, malignant
Large cell neuroendocrine carcinoma
Small cell carcinoma, fusiform cell
Combined small cell carcinoma
Scirrhous adenocarcinoma
Basal cell adenocarcinoma
Adenocarcinoma, neuroendocrine differentiation
Sarcoma, NOS
Small cell sarcoma
Liposarcoma, NOS
1
2
2
4
1
2
3
4
23
3
1
541
8
5
298
85
3
126
83
18
318
293
11
1
2
1
1
1
3
4
3
1
1
1
2
1
1
2
1
1
3
1865
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
1.2
0.2
0.1
29.0
0.4
0.3
16.0
4.6
0.2
6.8
4.5
1.0
17.1
15.7
0.6
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
100.0
C37-C38 OTHER THORACIC ORGANS

9064
9080
8580
Germinoma
Teratoma, malignant, NOS
Thymoma, malignant, NOS
1
1
7
1.9
1.9
13.5
C32 LARYNX
8000
8010
8020
8050
8070
8071
8072
8140
8073
8800
9061
115
ICD
Histology
No.
8070
8000
8010
8013
8020
8041
8052
8140
8260
8560

Neoplsm, malignant
Carcinoma, NOS
Large cell neuroendocrine carcinoma
Papillary squamous cell carcinoma
Adenocarcinoma, NOS
5
5
2
1
1
1
1
24
2
1
52
9.6
9.6
3.8
1.9
1.9
1.9
1.9
46.2
3.8
1.9
100.0
9364
9310
9260
9250
9220
9181
9180
8003
8000
8001
8002
8004
8010
8021
8070
8140
8500
8800
8810
8812
8830
8852
8890
9040
9120
9185
9194
9200
9231
9243
9270
9380
9400
Peripheral neuroectodermal tumor

Ameloblastoma, malignant
Ewing sarcoma
Giant cell tumor of bone, malignant
Chondrosarcoma, NOS
Chondroblastic osteosarcoma
Osteosarcoma, NOS
Neoplsm, malignant
Malignant tumor, spindle cell type
Carcinoma, NOS
Adenocarcinoma, NOS
Sarcoma, NOS
Fibrosarcoma, NOS
Periosteal fibrosarcoma
Myxoid liposarcoma
Leiomyosarcoma, NOS
Synovial sarcoma, NOS
Hemangiosarcoma
Small cell osteosarcoma
High grade surface osteosarcoma
Aggressive osteoblastoma
Myxoid chondrosarcoma
Dedifferentiated chondrosarcoma
Odontogenic tumor, malignant
Glioma, malignant
Astrocytoma, NOS
1
1
13
5
7
1
63
1
27
2
1
1
3
1
5
4
1
3
1
3
2
1
1
1
1
1
1
11
1
1
6
1
1
173
0.6
0.6
7.5
2.9
4.0
0.6
36.4
0.6
15.6
1.2
0.6
0.6
1.7
0.6
2.9
2.3
0.6
1.7
0.6
1.7
1.2
0.6
0.6
0.6
0.6
0.6
0.6
6.4
0.6
0.6
3.5
0.6
0.6
100.0
8772
8720
8744
8770
Spindle cell melanoma, NOS

Acral lentiginous melanoma, malignant
Mixed epithelioid and spindle cell melanoma
1
57
1
2
61
1.6
93.4
1.6
3.3
100.0
8832
8410
8830
8800
8140
Dermatofibrosarcoma, NOS
Sebaceous adenocarcinoma
Sarcoma, NOS
Adenocarcinoma, NOS
17
5
2
1
7
4.2
1.2
0.5
0.2
1.7
C40-C41 BONE
C43 MELANOMA OF SKIN
C44 OTHER SKIN
116
ICD
Histology
No.
1
1
205
2
3
116
1
1
10
1
7
2
8
2
2
2
4
1
1
402
0.2
0.2
51.0
0.5
0.7
28.9
0.2
0.2
2.5
0.2
1.7
0.5
2.0
0.5
0.5
0.5
1.0
0.2
0.2
100.0
9050
5
5
100
100
9140
2
2
100
100
1
10
2
7
3
1
1
1
2
7
12
8
10
7
9
1
2
35
6
2
1
2
4
3
1
1
1
1
1
2
1
0.7
6.8
1.4
4.7
2.0
0.7
0.7
0.7
1.4
4.7
8.1
5.4
6.8
4.7
6.1
0.7
1.4
23.6
4.1
1.4
0.7
1.4
2.7
2.0
0.7
0.7
0.7
0.7
0.7
1.4
0.7
8102
8402
8090
8247
8071
8070
8430
8032
8010
8390
8000
8001
8020
8022
8050
8072
8081
8110
8560
Trichilemmocarcinoma
Nodular hidradenoma, malignant
Basal cell carcinoma, NOS
Merkel cell carcinoma
Carcinoma, NOS
Skin appendage carcinoma
Neoplsm, malignant
Pleomorphic carcinoma
Bowen disease
Pilomatrix carcinoma
C45 MESOTHELIOMA
C46 KAPOSI SARCOMA
C47;C49 CONNECTIVE, SOFT TISSUE

9560
9540
9150
9120
9040
9473
8920
9044
8901
8900
8890
8852
8850
8830
8810
8802
8801
8800
8000
8001
8010
8020
8070
8140
8246
8470
8803
8804
8806
8811
8814
Neurilemoma, malignant
Malignant peripheral nerve sheath tumor
Hemangiopericytoma, malignant
Hemangiosarcoma
Synovial sarcoma, NOS
Primitive neuroectodermal tumor, NOS
Alveolar rhabdomysarcoma
Clear cell sarcoma, NOS (except of kidney)
pleomorphic rhabdomysarcoma, adult type
Rhabdomysarcoma, NOS
Leiomyosarcoma, NOS
Myxoid liposarcoma
Liposarcoma, NOS
Fibrosarcoma, NOS
Giant cell sarcoma (except of bone)
Spindle cell sarcoma
Sarcoma, NOS
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
Small cell sarcoma
Epithelioid sarcoma
Desmoplastic small round cell tumor
Fibromyxosarcoma
Infantile fibrosarcoma
117
ICD
Histology
No.
8821
8822
8851
Aggressive fibromatosis
Abdominal fibromatosis
1
1
1
148
0.7
0.7
0.7
100.0
9020
9010
8980
8540
8530
8522
8521
8520
8510
8501
8500
8480
8140
8070
8050
8935
8890
8010
8000
8001
8004
8020
8032
8034
8071
8200
8201
8211
8310
8315
8503
8513
8523
8541
8543
8573
8800
8810
8850
8851
8852
Phyllodes tumor, malignant

Fibroadenoma, NOS
Carcinosarcoma, NOS
Paget disease, mammary
Inflammatory carcinoma
Infiltrating duct and lobular carcinoma
Infiltrating ductular carcinoma
Lobular carcinoma, NOS
Comedocarcinoma, NOS
Adenocarcinoma, NOS
Stromal sarcoma, NOS
Leiomyosarcoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Malignant tumor, spindle cell type
Polygonal cell carcinoma
Cribriform carcinoma, NOS
Tubular adenocarcinoma
Clear cell adenocarcinoma, NOS
Glycogen-rich carcinoma
Intraductal papillary adenocarcinoma with invasion
Atypical medullary carcinoma
Infiltrating duct mixed with other carcinoma
Paget disease and infilt. duct carcinoma of breast
Paget disease and intraductal carcinoma of breast
Adenocarcinoma, apocrine metaplasia
sarcoma, NOS
Fibrosarcoma, NOS
Liposarcoma, NOS
Myxoid liposarcoma
18
2
16
3
1
9
185
50
20
2
2457
40
69
20
9
2
1
232
77
6
1
40
1
1
1
1
1
3
1
1
6
1
2
3
1
1
2
2
1
2
1
3292
0.5
0.1
0.5
0.1
0.0
0.3
5.6
1.5
0.6
0.1
74.6
1.2
2.1
0.6
0.3
0.1
0.0
7.0
2.3
0.2
0.0
1.2
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
100.0
8070
8010
8140
8542
8000
8720

Carcinoma, NOS
Adenocarcinoma, NOS
Paget disease, extramammary (ex. Paget dis.of bone)
Neoplasm, malignant
14
3
1
1
1
1
21
66.7
14.3
4.8
4.8
4.8
4.8
100.0
8072
8071
8070
Squamous cell carc.large cell, nonkerating

Squamous cell carcinoma, keratinizing,NOS
1
2
13
3.2
6.5
41.9
C50 BREAST
C51 VULVA
C52 VAGINA
118
ICD
Histology
No.
8010
8000
8020
8140
8980
Carcinoma, NOS
Neoplasm, malignant
Adenocarcinoma, NOS
Carcinosarcoma, NOS
2
3
2
7
1
31
6.5
9.7
6.5
22.6
3.2
100.0
8560
8481
8310
8260
8140
8076
8072
8071
8070
8052
8980
8020
8010
8000
8003
8001
8012
8050
8041
8073
8077
8246
8262
8263
8380
8384
8460
8890
Adenocarcinoma, NOS
Adenocarcinoma, NOS
Squamous cell carc. large cell, nonkeratinizing
Squamous cell carcinoma, keratinizing,NOS
Carcinosarcoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Squamous intraepithelial neoplasia, grade III
Villous adenocarcinoma
Adenocarcinoma in tubulovillous adenoma
Endometrioid adenocarcinoma, NOS
Adenocarcinoma, endocervical type
Papillary serous cystadenocarcinoma
Carcinosarcoma, NOS
10
1
3
5
145
10
159
42
252
1
4
41
79
53
1
3
2
6
2
5
1
3
1
1
7
7
1
2
847
1.2
0.1
0.4
0.6
17.1
1.2
18.8
5.0
29.8
0.1
0.5
4.8
9.3
6.3
0.1
0.4
0.2
0.7
0.2
0.6
0.1
0.4
0.1
0.1
0.8
0.8
0.1
0.2
100.0
8950
8930
8890
8800
8931
8560
8310
8260
8810
8140
8070
8010
8000
8001
8020
8050
8052
8073
8380
8072
8381
8480
Mullersian mixed tumor

Endometrial stromal sarcoma, NOS
Leiomyosarcoma, NOS
Sarcoma, NOS
Endometrial stromal sarcoma, low grade
Fibrosarcoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Endometrioid adenofibroma, malignant
3
16
4
1
5
5
3
4
3
169
3
36
26
1
24
2
1
1
102
2
2
1
414
0.7
3.9
1.0
0.2
1.2
1.2
0.7
1.0
0.7
40.8
0.7
8.7
6.3
0.2
5.8
0.5
0.2
0.2
24.6
0.5
0.5
0.2
100.0
C53 CERVIX UTERI
C54 CORPUS UTERI
119
ICD
Histology
No.
C55 UTERUS UNSPECIFIED

8890
8140
8070
8000
8001
8002
8010
8020
8246
8260
8380
8381
8480
8900
8950
9100
Leiomyosarcoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Carcinoma, NOS
Mullerian mixed tumor
Choriocarcinoma, NOS
14
24
3
8
1
1
6
10
1
1
10
1
1
1
2
1
85
16.5
28.2
3.5
9.4
1.2
1.2
7.1
11.8
1.2
1.2
11.8
1.2
1.2
1.2
2.4
1.2
100.0
9085
9080
9071
9060
9100
9580
8620
8480
8471
8470
8461
8460
8450
8441
8440
8380
8310
8260
8140
8070
8020
8010
8000
8001
8003
8002
8011
8041
8050
8072
8076
8246
8320
8323
8381
8472
8481
8490
8621
8631
8640
Mixed germ cell tumor

Teratoma,malignant, NOS
Yolk sac tumor
Dysgerminoma
Granular cell tumor, malignant
Granulosa cell tumor, malignant
Papillary mucinous cystadenocarcinoma
Serous surface papillary carcinoma
Papillary serous cystadenocarcinoma
Papillary cystadenocarcinoma, NOS
Serous cystadenocarcinoma , NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Epithelioma, malignant
Granular cell carcinoma
Mixed cell adenocarcinoma
Mucinous cystic tumor of borderline malignancy
Granulosa cell-theca cell tumor
Sertoli-Leydig cell tumor, poorly differentiated
Sertoli cell carcinoma
2
20
4
3
1
1
10
9
5
35
2
33
10
33
17
43
30
10
162
11
30
73
60
13
1
1
2
2
4
1
1
1
1
1
1
1
1
1
1
1
1
0.3
3.0
0.6
0.5
0.2
0.2
1.5
1.4
0.8
5.3
0.3
5.0
1.5
5.0
2.6
6.6
4.6
1.5
24.7
1.7
4.6
11.1
9.1
2.0
0.2
0.2
0.3
0.3
0.6
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
10.2
0.2
0.2
0.2
C56 OVARY
120
ICD
Histology
No.
2
1
1
3
1
1
1
3
3
1
656
0.3
0.2
0.2
0.5
0.2
0.2
0.2
0.5
0.5
0.2
100.0
8890
8891
8950
8980
8990
9000
9014
9082
9084
9090
Leiomyosarcoma, NOS
Epithelioid leiomyosarcoma
Mullerian mixed tumor
Carcinosarcoma, NOS
Mesenchymoma, malignant
Brenner tumor, malignant
Serous adenocarcinofibroma
Malignant teratoma, undifferentiated
Teratoma with malignant transformation
Struma ovarii, malignant
8140
8010
8001
Adenocarcinoma, NOS
Carcinoma, NOS
1
1
1
3
33.3
33.3
33.3
100.0
9100
8000
9104
8260
Choriocarcinoma
Neoplasm, malignant
Placental site trophoblastic tumor
3
2
1
1
7
42.9
28.6
14.3
14.3
100.0
8090
8070
8000
8010
Basal cell carcinoma, NOS

Neoplasm, malignant
Carcinoma, NOS
1
17
2
3
23
4.3
73.9
8.7
13.0
100.0
8980
8550
8500
8260
8140
8070
8000
8001
8010
8020
8120
Carcinosarcoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Carcinoma, NOS
1
7
4
1
380
3
27
2
53
21
3
502
0.2
1.4
0.8
0.2
75.7
0.6
5.4
0.4
10.6
4.2
0.6
100.0
9120
9085
9080
8070
8010
8000
8001
8020
8590
8640
8650
8890
8900
9064
Hemangiosarcoma
Carcinoma, NOS
Neoplasm, malignant
Sex cord-gonadal stromal tumor, NOS
Sertoli cell carcinoma
Leydig cell tumor, malignant
Leiomyosarcoma, NOS
Germinoma
1
2
4
1
5
5
3
4
1
1
1
1
1
10
1.4
2.7
5.4
1.4
6.8
6.8
4.1
5.4
1.4
1.4
1.4
1.4
1.4
13.5
C57 OTHER FEMALE GENITAL
C58 PLACENTA
C60 PENIS
C61 PROSTATE
C62 TESTIS
121
ICD
Histology
No.
9070
9061
9071
Embryonal carcinoma, NOS

Seminoma, NOS
Yolk sac tumor
1
26
7
74
1.4
35.1
9.5
100.0
8010
8070
8140
9081
Carcinoma, NOS
Adenocarcinoma, NOS
Teratocarcinoma
1
1
1
1
4
25
25
25
25
100
8960
9500
8959
8860
8312
8310
8140
8120
9364
8010
8000
8001
8012
8020
8050
8070
8260
8318
8800
8850
8851
Nephroblastoma, NOS
Neuroblastoma, NOS
Malignant cystic nephroma
Angiomyolipoma
Renal cell carcinoma, NOS
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
Renal cell carcinoma, sarcomatoid
Sarcoma, NOS
Liposarcoma, NOS
10
1
2
1
88
13
5
11
1
33
11
4
1
8
1
4
1
2
2
1
1
201
5.0
0.5
1.0
0.5
43.8
6.5
2.5
5.5
0.5
16.4
5.5
2.0
0.5
4.0
0.5
2.0
0.5
1.0
1.0
0.5
0.5
100.0
8120
8020
8070
8130
8810

Papillary transitional cell carcinoma
Fibrosarcoma, NOS
4
4
1
1
1
11
36.4
36.4
9.1
9.1
9.1
100.0
8120
3
3
100
100
8140
8130
8120
8070
8020
8010
8000
8001
8011
8050
8052
8071
8260
Adenocarcinoma, NOS
Carcinoma, NOS
Neoplasm, malignant
23
22
143
12
18
47
45
1
1
11
1
1
1
6.9
6.6
43.2
3.6
5.4
14.2
13.6
0.3
10.3
3.3
0.3
0.3
0.3
C63 OTHER MALE GENITAL
C64 KIDNEY
C65 RENAL PELVIS
C66 URETER
C67 BLADDER
122
ICD
Histology
No.
8480
8490
8852
9580
Myxoid liposarcoma
2
1
1
1
331
0.6
0.3
0.3
0.3
100.0
8140
8010
8050
8130
Adenocarcinoma, NOS
Carcinoma, NOS
8
2
1
1
12
66.7
16.7
8.3
8.3
100.0
9500
9510
8140
8070
8000
8010
8011
8020
8800
8900
9100
9120
9511
Neuroblastoma, NOS
Retinoblastoma, NOS
Adenocarcinoma, NOS
Neoplasm, malignant
Carcinoma, NOS
Sarcoma, NOS
Hemangiosarcoma
Retinoblastoma, differentiated
1
15
4
5
2
1
1
1
1
1
2
1
2
37
2.70
40.54
10.81
13.51
5.41
2.70
2.70
2.70
2.70
2.70
5.41
2.70
5.41
100.00
Meningioma, malignant
Primitive neuroetodermal tumor, NOS
Medulloblastoma, NOS
Oligodendroglioma, NOS
Glioblastoma, NOS
Pilocytic astrocytoma
Cerebellar sarcoma, NOS
Oligodendroblastoma
Ganglioglioma, anaplastic
Meningeal sarcomatosis
Atypical teratoid/rhabdoid tumor
Papillary meningioma
Medulloepithelioma, NOS
Neuroblastoma, NOS
Meningothelial meningioma
Transitional meningioma
Gliosarcoma
Oligodendroglioma, anaplastic
Giant cell glioblastoma
Neurilemoma, malignant
Astrocytoma, anaplastic
Astroblastoma
Astrocytoma, NOS
Myxopapillary ependymoma
Papillary ependymoma
Malignant peripheral nerve sheath tumor
Ependymoma, NOS
Choroid plexus carcinoma
Mixed glioma
Glioma, malignant
Malig.periph.nerve sheath tumor, rhabdomyoblas. difftn.
77
6
21
12
66
1
2
1
4
2
1
1
1
24
1
1
9
3
2
16
3
2
45
1
3
5
10
1
2
39
1
16.3
1.3
4.5
2.5
14.0
0.2
0.4
0.2
0.8
0.4
0.2
0.2
0.2
5.1
0.2
0.2
1.9
0.6
0.4
3.4
0.6
0.4
9.6
0.2
0.6
1.1
2.1
0.2
0.4
8.3
0.2
C68 OTHER URINARY ORGANS
C69 EYE
C70-72 BRAIN, NERVOUS SYSTEM

9530
9473
9470
9450
9440
9421
9480
9460
9505
9539
9508
9538
9501
9500
9531
9537
9442
9451
9441
9560
9401
9430
9400
9394
9393
9540
9391
9390
9382
9380
9561
123
ICD
Histology
No.
9364
9150
8003
8002
8000
8001
8010
8140
8260
8481
8500
8070
8800
8802
8806
9064
9080
9081
9085
9120
9170

Hemangiopericytoma, malignant
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
Sarcoma, NOS
Giant cell sarcoma (except of bone)
Desmoplastic small round cell tumor
Germinoma
Teratocarcinoma
Hemangiosarcoma
Lymphangiosarcoma
1
1
1
1
54
23
1
5
1
1
1
1
3
1
1
4
3
1
1
2
1
471
0.2
0.2
0.2
0.2
11.5
4.9
0.2
1.1
0.2
0.2
0.2
0.2
0.6
0.2
0.2
0.8
0.6
0.2
0.2
0.4
0.2
100.0
8850
8340
8330
8290
8260
8070
8050
8021
8010
8000
8011
8020
8052
8076
8140
8331
8332
8350
8480
8503
8510
Liposarcoma, NOS
Papillary carcinoma, follicular variant
Follicular adenocarcinoma
Oxyphilic adenocarcinoma
Carcinoma, NOS
Neoplasm, malignant
Adenocarcinoma, NOS
Follicular adenocarcinoma, well differentiated
Follicular adenocarcinoma, trabecular
Nonencapsulated sclerosing carcinoma
Intraductal papillary adenocarcinoma with invasion
2
27
78
1
33
3
146
8
33
45
1
21
1
1
20
2
5
1
2
1
3
434
0.5
6.2
18.0
0.2
7.6
0.7
33.6
1.8
7.6
10.4
0.2
4.8
0.2
0.2
4.6
0.5
1.2
0.2
0.5
0.2
0.7
100.0
9500
8700
8370
8000
8010
8020
8070
8140
Neuroblastoma, NOS
Pheochromocytoma, malignant
Adrenal cortical carcinoma
Neoplasm, malignant
Carcinoma, NOS
Adenocarcinoma, NOS
9
1
2
3
2
2
1
1
21
42.9
4.8
9.5
14.3
9.5
9.5
4.8
4.8
100.0
9580
8140
8000

Adenocarcinoma, NOS
Neoplasm, malignant
1
18
5
1.9
34.0
9.4
C73 THYROID
C74 ADRENAL GLAND
C75 OTHER ENDOCRINE
124
ICD
Histology
No.
8001
8010
8020
8070
8210
8272
8281
8334
8711
9064
9085
9362
9350
9380

Carcinoma, NOS
Adenocarcinoma in adenomatous polyp
Pituitary carcinoma, NOS
Mixed acidophil-basophil carcinoma
Macrofollicular adenoma
Glomus tumor, malignant
Germinoma
Pineoblastoma
Craniopharyngioma
Glioma, malignant
1
1
2
1
3
8
1
1
1
4
1
3
1
1
53
1.9
1.9
3.8
1.9
5.7
15.1
1.9
1.9
1.9
7.5
1.9
5.7
1.9
1.9
100.0
9663
9659
9665
9652
9650
9651
Hodgkin lymphoma, nodular sclerosis, NOS

Hodgkin lymphoma, nodular lymphocyte pre
Hodgkin lymphoma, nodular sclerosis, grade 1
Hodgkin lymphoma, mixed cellularity, NOS
Hodgkin lymphoma, NOS
Hodgkin lymphoma, lymphocyte-rich
9
1
1
1
53
2
67
13.4
1.5
1.5
1.5
79.1
3.0
100.0
Follicular dendritic cell sarcoma

Precursor cell lymphoblastic lymphoma, N
Cutaneous T-cell lymphoma, NOS
Mature T-cell lymphoma, NOS
Follicular lymphoma grade 3
Follicular lymphoma , NOS
Burkitt lymphoma, NOS
Malignant lympgoma, large B-cell, diffus
Mantle cell lymphoma
Malignant lympgoma, small B lymphocytic
Malignant lymphoma, non-Hodgkin, NOS
Malignant lymphoma, NOS
Composite Hodgkin and non-Hodgkin lymphoma
Malignant lymphoma, lymphoplasmacytic
Mediastinal large B-cell lymphoma
Malig.lymphoma,large B-cell, diffuse, immunoblas. NOS
Follicular lymphoma, grade 2
Follicular lymphoma, grade 1
Marginal zone B-cell lymphoma, NOS
Mycosis fungoides
Anaplastic large cell lymphoma, T cell/Null cell type
Primary cutaneous CD30+ T-cell lymphoprolif. disorder
NK/T-cell lymphoma, nasal and nasal-type
Mast cell sarcoma
1
1
2
14
2
24
9
95
1
8
407
101
15
1
2
1
1
3
2
3
10
1
3
2
709
0.1
0.1
0.3
2.0
0.3
3.4
1.3
13.4
0.1
1.1
57.4
14.2
2.1
0.1
0.3
0.1
0.1
0.4
0.3
0.4
1.4
0.1
0.4
0.3
100.0
1
1
100.0
100.0
143
18
5
14
30
64.7
8.1
2.3
6.3
13.6
C81 HODGKIN DISEASE
C82-C85;C96 NON-HODGKIN LYMPHOMA

9758
9727
9709
9702
9698
9690
9687
9680
9673
9670
9591
9590
9596
9671
9679
9684
9691
9695
9699
9700
9714
9718
9719
9740
C88; C90 MULTIPLE MYLOMA MULTIPLE MYELOMA

9761
Waldenstrom macroglobulinemia
C91 LYMPHOID LEUKAEMIA

9835
9823
9827
9826
9820
Precursor cell lymphoblastic leukaemia, NOS

B-cell chronic lymphocytic leukaemia/smal
Adult T-cell leukaemia/lymphoma (HTLV-1 p)
Burkitt cell leukaemia
Lymphoid leukaemia, NOS
125
ICD
Histology
No.
9836
9837
9940
Precursor B-cell lymphoblastic leukaemia

Precursor T-cell lymphoblastic leukaemia
Hairy cell leukaemia
5
4
2
221
2.3
1.8
0.9
100.0
9861
9863
9866
9867
9945
9860
9931
9930
9840
9872
9875
9876
9896
9910
Acute myeliod leukaemia, NOS

Chronic myeloid leukaemia
Acute promyelocytic leukaemia, t(15;17)(q
Acute myelomonocytic leukaemia
Chronic myelomonocytic leukaemia, NOS
Myeloid leukaemia, NOS
T-cell large granular lymphocytic leukaemia
Myeloid sarcoma
Acute myeloid leukaemia, M6 type
Acute myeloid leukaemia, minimal differentiation
Chronic myelogenous leukaemia, BCR/ABL positive
Atypical chronic myeloid leukaemia, BCR/ABL negative
Acute myeloid leukaemia, t(8;21)(q22;q22)
Acute megakaryoblastic leukaemia
222
88
16
8
1
33
3
8
13
1
1
4
2
1
401
55.4
21.9
4.0
2.0
0.2
8.2
0.7
2.0
3.2
0.2
0.2
1.0
0.5
0.2
100.0
9801
9800
9805
Acute leukaemia, NOS

Leukaemia, NOS
Acute biphenotypic leukaemia
107
10
2
119
89.9
8.4
1.7
100.0
C92-94 MYELOID LEUKAEMIA
C95 LEUKAEMIA UNSPEC
126

NCR 2007

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

NCR 2007

Uploaded by

Copyright:

Available Formats

National Cancer

Ministry of Health Malaysia

National Cancer Registry, Malaysia

List of State Cancer Registries

Denominator (population-at-risk estimates)

Pathology and morphology

Description of statistical methods

Crude incidence rate (CR)

Age-specific rate (AR)

Age-standardised rate (ASR)

Standard error (SE)

95% Confidence Limit of ASR (95% CL)

Cumulative rate (CR74)

Cumulative risk (CumR)

National Cancer Registry Report

Malaysia Cancer Statistics Data and Figure 2007

Overall cancer incidence and burden

Variation in cancer incidence by sex and ethnicity

CANCER INCIDENCE IN MALAYSIA 2007

Overall cancer incidence

Cancer incidence by site

Sex differences in cancer incidence by site and major ethnicity

Cancer incidence in Malay, by sex and site

Cancer incidence in Chinese, by sex and site

Cancer incidence in Indian, by sex and site

SELECTED CANCER SITES

CANCER INCIDENCE BY STATE, 2007

Five most frequent cancer in each state, Malaysia 2007

Federal Territory of Kuala Lumpur

National Cancer Registry Report

Malaysia Cancer Statistics Data and Figure 2007

National Cancer Registry Report

Malaysia Cancer Statistics Data and Figure 2007

The NCR would like to thank especially the following:

Penang Cancer Registry

Our appreciation also to the following individuals for their contributions:

National Cancer Registry Report

Malaysia Cancer Statistics Data and Figure 2007

Members of the National Cancer Registry

Dr. Lokman Hakim Bin Sulaiman

Dr. Zainal Ariffin Bin Omar

Dr. Nor Saleha Ibrahim Tamin

Koraiza Binti Mohd Yussof

Raja Rohanira Binti Raja Talib

Technical Committee Members of the National Cancer Registry

Dr. Zainal Ariffin Bin Omar

Dr. Md Khadzir Bin Sheikh Ahmad

Dato Dr. Norain Karim

Dr. Inderjeet Kaur Gill

Dr. Norlida Binti Abdullah

Dr. Zubaidah Binti Zakaria

Dr. Azizah Binti Abdul Manan

Dr. Nor Saleha Ibrahim Tamin

National Cancer Registry Report

Malaysia Cancer Statistics Data and Figure 2007

Ethnicity and sex status for Malaysia, 2007

Proportion of citizens and non-citizens in Malaysia, 2007

Age, sex and major ethnic distribution of Malaysian population 2007

10 Principle Cause of Deaths in Ministry of Health Malaysia (MOH) Hospitals, 2007

Cancer Incidence, Malaysia 2007

Ten most frequent cancers, all residence, Malaysia 2007

Ten most frequent cancers, males, Malaysia 2007

Ten most frequent cancers, females, Malaysia 2007